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Mast cells contribute to numerous physiological processes and diseases including
immunological and neurological roles. Mast cells degranulate, releasing potent mediators,
following signal transduction initiated by receptor crosslinking. Previously, we showed that the
environmental toxicant arsenic and the antibacterial agent triclosan inhibit mast cell
degranulation; thus, we have investigated the mechanisms underlying their inhibitory action. We
have discovered that arsenic targets early steps in the mast cell signaling pathway: it inhibits
phosphorylation of early tyrosine kinase Syk and of Syk’s direct substrate PI3K. Arsenic’s
tyrosine phosphorylation inhibition causes inhibition of calcium influx into the cytosol, a key
event necessary for degranulation.
Pharmaceutical agent triclosan also inhibits calcium influx but, in contrast to arsenic,
does not inhibit early steps in the pathway. We have discovered that one of triclosan’s targets in
the mast cell signaling pathway is phospholipase D (PLD): PLD activity is decreased by
triclosan. Triclosan does not inhibit activity of key enzyme protein kinase C but does delay its
translocation to the plasma membrane and translocation of its substrate MARCKS to the cytosol.
In addition, we have shown that another mechanism of triclosan toxicity, mitochondrial
uncoupling, also occurs in vivo. We developed a high-throughput assay to measure bioenergetics

of living zebrafish embryos and showed that triclosan exposure decreases ATP production
without causing mortality of zebrafish.
Finally, in preparation for comparative studies of toxicant effects on mast cells in vivo
using zebrafish and in vitro using the mast cell model RBL-2H3, we aimed to develop a tryptase
assay of mast cell degranulation that could be used in both systems. However, we discovered that
RBL-2H3 cells express neither mRNA nor protein of several tryptase genes. Overall, the
findings in this thesis provide biochemical and cellular explanations for known human health
effects of triclosan and arsenic and set the stage for future comparative toxicology studies of
mast cell function.
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CHAPTER 1
INTRODUCTION
1.1 Mast cell signaling pathway
1.1.1 Mast cell
Mast cells (MCs) are immune-effector cells that are well-known for their roles in allergic
reactions. MCs are present in all chordates, which possess a notochord (Kuby, 1997; Prykhozhij
and Berman, 2014). Chordates include the vertebrates, the urochordate (e.g. sea squirts), and the
cephalochordates (e.g. lancelets), thus MCs are likely one of the most conserved immune cells, a
fact which implies their crucial roles evolutionarily in an organisms’ survival and function. In
fact, not only are MCs found in most species, but also found in nearly every tissue (Kuby, 1997).
They are involved in myriad physiological and pathophysiological processes, including
host defense against infectious agents, innate and acquired immunity, homeostatic responses,
wound repair, tissue remodelling, allergy, asthma, autoimmunity, infectious disease, cancer,
inflammatory bowel disease, and even central nervous system disorders such as autism, anxiety,
and multiple sclerosis (Metcalfe et al., 1997; Williams and Galli, 2000; Galli et al., 2005a;
Silver and Curley, 2013; Girolamo et al., 2017).
These diverse actions of MCs result from diverse mediators released from MCs. In
response to a wide range of stimuli, MCs degranulate, secreting stored mediators in cytoplasmic
granules, such as histamine, neutral protease (e.g. chymase, tryptase, carboxypeptidase), βhexosaminidase, serotonin, heparin, and some cytokines (Schwartz and Austen, 1980). Also,
activated MCs can synthesize cytokines, chemokines, lipid mediators, and other inflammatory
mediators de novo (Galli et al., 2005a; Shelburne and Abraham, 2011). MCs derive from
hematopoietic cells in the bone marrow and migrate to various tissues for maturation (Rodewald
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et al., 1996; Chen et al., 2005). MCs are found in nearly all tissue types, including at interfaces
with the environment, such as skin, gastrointestinal linings, oral mucosa, blood capillaries,
lymphatic vessels, and near nerve terminals (Theoharides et al., 2012a; Blank and Benhamou,
2013). This positioning is advantageous for MCs to serve as a first line of defense to pathogens
and to coordinate inflammatory reactions to outside stimuli (Abraham and St John, 2010).
MCs are phenotypically and functionally heterogeneous depending on the
microenvironment in which they mature. Thus the ubiquity of MCs’ presence among species and
tissues have induced different MC subtypes, while some of basic constituents of MCs are still
conserved (Baccari et al., 2011). For example, human MCS are subcategorized into MCTC and
MCT, by the presence of proteases (Irani et al., 1986). Tryptase is often utilized as a granuleassociated MC marker since it is presented all human MC subtypes.
Since the discovery of MC by Paul Ehrlich in 1878, many studies on MC biology and
function have been reported. Because of difficulty in isolation and culturing primary mast cells,
several immortalized mast cell models have been established, including rat basophilic leukemiaclone 2H3 (RBL-2H3), human HMC-1, and human LAD2. MCs contain several extracellular
receptors including the FcεRI, Toll-like receptors, interleukin receptors, c-kit receptor, and more
(Metcalfe, 2008; Passante et al., 2009). Among those mast cell models, RBL-2H3 cells are the
most commonly utilized for over 40 years, since they are easy to grow, display mature mast cell
characteristics, have robust expression of the high affinity receptor for IgE (FcεRI) on the plasma
membrane, and most importantly encompass core signaling machinery of human mast cells
(Barsumian et al., 1981). Therefore, RBL-2H3 (“RBL”) cells have been extensively used to
study interactions of IgE high affinity receptor FcεRI with its ligands and the signaling pathway
leading to degranulation is well-described. Other mast cells also have been employed in MC
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studies; however, each has its own limitations: HMC-1 cells are poorly granulated and lack
FcεRI (Nilsson et al., 1994) and LAD2 cells require long doubling time (> 2 weeks).
Measurement of degranulation from RBL cells is typically performed by quantifying the release
of β-hex or histamine, which will be detailed later in this chapter.

1.1.2 Mast cell signaling
Degranulation is classically initiated by antigen (Ag)-crosslinking of immunoglobulin E
(IgE)-bound FcεRI receptor (Kuby, 1997). FcεRI is a tetrameric receptor composed of one
extracellularly-exposed α chain plus membrane-spanning β (one) and γ (two) chains (Metzger et
al., 1982; Metzger et al., 1986; Ravetch and Kinet, 1991). FcεRI β and γ subunits possess
cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) (Reth, 1989; Cambier,
1995; Daeron, 1997). Antigen crosslinking of FcεRI causes phosphorylation of ITAMs by nonreceptor protein tyrosine kinase (PTK) Lyn (Xiao et al., 2005). Phosphorylated ITAMs bind
proteins with Src-homology-2 (SH2) domains, leading to activation (Cohen et al., 1995;
Furumoto et al., 2004; de Castro et al., 2010; Siraganian et al., 2010). Phosphorylated sites on 
become docking areas for another PTK spleen tyrosine kinase (Syk), which contains an SH2
domain (de Castro et al., 2010; Siraganian et al., 2010). Binding to FcεRI causes a
conformational change in Syk, resulting in autophosphorylation (Benhamou et al., 1993;
Minoguchi et al., 1994; Pribluda et al., 1994; Zhang et al., 2000) and results in Syk’s
phosphorylation/activation by Lyn.
In addition to the Lyn-propagated signaling pathway, the complementary PTK Fyn pathway is
initiated upon FcεRI receptor aggregation (Rivera and Gilfillan, 2006). Fyn signaling leads to
activation of the phosphatidylinositol-3-OH kinase (PI3K) pathway (Gu et al., 2001).
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Importantly, Syk is essential for FcεRI-mediated signaling in mast cells since Syk is required for
both Lyn-directed and Fyn-directed pathways (Costello et al., 1996; Zhang et al., 1996).

Figure 1. 1. Overview of the mast cell degranulation signaling pathway.
Crosslinking of IgE-bound FcεRI by multivalent antigen (Ag) results in phosphorylation
cascade to activate several enzymes (Lyn, Syk, PI3K and PLCγ). Activated PI3K generates
PIP3 from PIP2. PLCγ hydrolyzes PIP2 to DAG and IP3. IP3 binds to its cognate receptor on
the ER, causing depletion of Ca2+ from internal ER storage to the cytosol, resulting in STIM1
(calcium sensor in the ER membrane) interaction with Orai1 (subunit of CRAC channel) for
influx of Ca2+ across plasma membrane into the cell. ER stores get replenished by reuptake
of cytosolic Ca2+ into the ER through SERCA pump. Ca2+ and/or DAG activate PKC.
Activated PKC translocates from cytosol to the plasma membrane where it phosphorylates
substrates in its proximity, such as MARCKS, which tightly binds to PIP2. Phosphorylated
MARCKS dissociates from the plasma membrane and enters the cytosol, thus exposing PIP2
to be accessible to other proteins. Another major target of PKC is PLD, which is localized
either to cytoplasmic granules or at the plasma membrane, to facilitate granule translocation
and fusion to the plasma membrane. Granules are mobilized along with microtubules for
degranulation. Degranulation process generates and requires ROS.
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Activated Syk phosphorylates the adaptor protein linker for activation of T cells (LAT)
(Saitoh et al., 2003), which physically brings together proteins such as Grb2 (Growth factor
receptor-bound protein 2), Gads, SLP-76, Vav, and the enzyme phospholipase C γ (PLC γ).
Next, PLC 1 is phosphorylated by Syk or by a Tec family tyrosine kinase, Itk (Interleukin-2inducible T-cell kinase) or Btk (Bruton’s tyrosine kinase) (Ishiai et al., 2000). Gads (Grb2related adaptor downstream of Shc) binds SLP-76 (SH2 domain-containing leukocyte protein of
76 ) (Ishiai et al., 2000), which is phosphorylated by Syk and then which binds Btk and Vav
(Kettner et al., 2003). Next, Lyn phosphorylates and activates Btk, which activates PLC 1
(Benhamou et al., 1992; Beaven and Metzger, 1993) via its Pleckstrin Homology (PH) domain.
Btk binds to plasma membrane lipids phosphatidylinositol 4, 5-bisphosphate (PIP2) and
phosphatidylinositol 3, 4, 5-trisphosphate (PIP3) (Fluckiger et al., 1998; Scharenberg and Kinet,
1998).
Syk activates PI3K, which converts PIP2 into PIP3 (Kitaura et al., 2000). PIP3 activates
Rac/Rho GTPases resulting in remodeling of the actin cytoskeleton, also called membrane
ruffling (“ruffles” of the polymerized actin cytoskeleton) (Hawkins et al., 1995; Parker, 1995).
PI3K also activates sphingosine kinase-S1P (sphingosine-1-phosphate), which produces S1P,
thus supporting Ca2+ mobilization (Choi et al., 1996; Melendez and Khaw, 2002; Urtz et al.,
2004), protein kinase C (PKC) activation, and degranulation (Olivera et al., 2007).
PLC γ hydrolyzes PIP2 to yield inositol-1, 4, 5-trisphosphate (IP3) and diacylglycerol
(DAG). IP3 then binds to its receptor IP3R in the endoplasmic reticulum (ER) membrane, thereby
releasing Ca2+ from ER to the cytosol (Berridge, 1993; Taylor and Thorn, 2001). This emptying
of ER Ca2+ leads to second influx of Ca2+ across the plasma membrane into the cytosol through
calcium release-activated calcium (CRAC) channels. STIM-1 (Stromal interaction molecule 1) in
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the ER membrane and Orai1 (the pore subunit of CRAC channels) are responsible for this event.
When ER Ca2+ is depleted, STIM1 goes through a conformational change (Liou et al., 2005;
Fahrner et al., 2013) and binds to Orai1(Feske et al., 2006; Vig et al., 2006). This interaction
causes opening of CRAC channels, inducing a flood of extracellular Ca2+ coming into the cytosol
(Roos et al., 2005; Hogan et al., 2010), which is termed “store operated calcium entry” (SOCE)
(Putney, 1986; Putney, 1990; Clapham, 1995). Sarco/endoplasmic Ca2+-ATPase (SERCA)
pumps refill Ca2+ into the ER after cytosolic Ca2+ influx (Ma and Beaven, 2011), for later usage.
Replenishment of the ER Ca2+ can be inhibited by selective SERCA inhibitor thapsigargin,
which will be utilized in Chapter 2 for arsenic mechanism studies (Thastrup et al., 1990; Lytton
et al., 1991).
Another of PLC γ’s products, DAG, along with elevated Ca2+ and reactive oxygen
species (ROS), are involved in activation of PKC. It has been known that intracellular ROS is
generated as well as required during mast cell degranulation (Swindle et al., 2004; Min and
Shin, 2009; Weatherly et al., 2018). PKC is family of Ser/Thr kinases, which is categorized into
three subfamilies, classical (cPKC), novel (nPKC), and atypical (aPKC), based on their
biochemical and structural properties of their bindings to DAG and/or Ca2+ (Ozawa et al., 1993b;
Newton, 1995; Newton, 2001). The cPKC isoforms (PKC α, βI, βII, and γ) contain conserved
functionally active C1 domains (which bind DAG) (Newton, 2001) as well as C2 domains
(which bind Ca2+ and acidic phospholipids). The nPKC isoforms (PKC δ, ε, θ, and η) contain the
C1 domain, but lack functional C2 domains, thus, are activated by DAG and unresponsive to
Ca2+ (Newton, 1995).
PKC β (cPKC) and δ (nPKC) are particularly important in IgE–mediated degranulation
and ruffling (Nechushtan et al., 2000; Cho et al., 2004). Activation of PKC changes its affinity
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to the plasma membrane, causing to translocate to the plasma membrane. Translocated PKC is
then fully active via conformational changes to reveal its active site (Newton, 2010). Stimulation
of RBL-2H3 cells causes a rapid translocation of PKC δ from the cytosol to the plasma
membrane (Cho et al., 2004). Also, PKC δ translocation and degranulation are inhibited by ROS
attenuation (Cho et al., 2004). Myristoylated alanine-rich C-kinase substrate (MARCKS) is one
of the abundant PKC substrate (Aderem, 1992). MARCKS tightly binds to PIP2 at the plasma
membrane in unstimulated cells (Heo et al., 2006). In stimulated MCs, translocated PKC
phosphorylates MARCKS, which dissociates from the plasma membrane, thus exposing PIP2 to
be accessible to other proteins (e.g. PLC γ) for sustained signaling for degranulation (Gadi et al.,
2011). Also, PIP2 is necessary in assembly of the soluble N-ethylmaleimide–sensitive factor
attachment protein receptor (SNARE) machinery required for degranulation (Tadokoro et al.,
2015).
Another target of activated PKC is phospholipase D (PLD) in mast cells (Lin and
Gilfillan, 1992) . PLD hydrolyzes phosphatidylcholine (PC) into phosphatidic acid (PA), which
plays important roles as a second messenger for diverse cellular functions(Wakelam et al., 1997;
Cockcroft, 2001; O'Luanaigh et al., 2002; Zeniou-Meyer et al., 2007). Also PA can be
converted to DAG by PA phosphohydrolase, resulting in a secondary rise in DAG levels in the
cells (Nakashima et al., 1991; Lin et al., 1992), important for the sustained activation of the
DAG-dependent PKC isoforms (Baldassare et al., 1992; Nishizuka, 1995; Peng and Beaven,
2005). Additionally, PA plays a critical role in regulating mast cell morphology (MarchiniAlves et al., 2012). Structurally, mammalian PLD contains lipid (PIP3 and PIP2) -binding
domains and a PKC-binding domain, but lacks a Ca2+ binding domain (Henage et al., 2006;
Selvy et al., 2011). However, studies showed that Ca2+ and PIP2 act as crucial cofactors for
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mammalian PLD activation (Sciorra et al., 2002; Henage et al., 2006; Selvy et al., 2011), even
though mammalian PLD activity is insensitive to changes in cytosolic Ca2+ concentration in vitro
(Hammond et al., 1997).
Also several studies showed that PLD can be activated by agents to elicit intracellular
Ca2+ rise, such as Ca2+ ionophore (Lin and Gilfillan, 1992), thapsigargin (Cissel et al., 1998) and
PMA (Lin and Gilfillan, 1992). In addition, compound 48/80, a MC secretagogue, induces PLD
activation (Chahdi et al., 2000).
Mammalian PLD is expressed as two isoforms: PLD1 has low basal activity and is
located at the cytoplasmic granules. In stimulated MC, PLD1 undergoes translocation to the
plasma membrane (Choi et al., 2002; Lee et al., 2006). PLD2 is constitutively expressed near
the plasma membrane (Choi et al., 2002; Lee et al., 2006). These spatial distinctions of two
isoforms have led scientists to postulate that PLD1 is involved in granule translocation to the
plasma membrane while PLD2 is involved in membrane fusion of MC granules (Choi et al.,
2002). However, a recent study using PLD1- and PLD2-knockout mice found that PLD1 is a
positive regulator in MC degranulation, but PLD2 is a negative regulator, since PLD2 deficiency
enhanced microtubule formation (Zhu et al., 2015).
MC granule transport is facilitated by microtubules, while granule docking and fusion to
the plasma membrane is assisted by SNARE complexes (Guo et al., 1998; Baram et al., 1999;
Paumet et al., 2000; Blank et al., 2002; Logan et al., 2003; Puri and Roche, 2008; Tiwari et al.,
2008; Woska and Gillespie, 2012). Microtubule polymerization is indispensable for
degranulation (Urata and Siraganian, 1985; Tasaka et al., 1991; Marti-Verdeaux et al., 2003;
Smith et al., 2003). SNAREs are located on vesicular (v-SNAREs) and target membranes (tSNAREs) (Woska and Gillespie, 2012) and mediates the final stages of priming, docking, and
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fusion of granules with the plasma membrane (Puri and Roche, 2008). SNAREs form a complex
by direct interaction with synaptotagmins (Syts) with help of PIP2 (Dai et al., 2007a; Tadokoro
et al., 2015). Syt is a Ca2+ sensor protein, which contains C2 calcium-binding domains (Dai et
al., 2007a). Even though Syts were first characterized as a neuronal Ca2+ sensor in the presynaptic axon terminal, several studies have identified Syts homologs in MCs (Baram et al.,
1998; Baram et al., 1999; Baram et al., 2001; Kimura et al., 2001). In addition, a study
revealed that PIP2 enhanced synaptotagmin- SNARE-mediated membrane fusion of MC granules
only in the presence of Ca2+ (Tadokoro et al., 2015). Therefore, the components of a quaternary
complex (SNARE- PIP2- synaptotagmin- Ca2+) are all necessary for granule docking, fusion and
exocytosis.
The result of mast cell signaling is degranulation, but also causes F-actin polymerization
simultaneously. PI3K activation of Rac/Rho GTPases leads to actin rearrangements, resulting in
membrane “ruffling,” or the rearrangement of the actin cytoskeleton. Lamellipodia that fail to
establish stable adhesions become detached from the substrate and retracted toward the cell
body; during this retraction process, actin-rich membrane protrusions, or membrane ruffles, are
formed (Giannone et al., 2007). Ruffles are compartments of active actin reorganization (Borm
et al., 2005). Actin cytoskeletal rearrangement is not an essential element of the degranulation
pathway (degranulation occurs even when ruffling is stopped by actin inhibitor cytochalasin D
(Holowka et al., 2000)), but the two share common events such as activation of PKC and influx
of Ca2+ (Pfeiffer et al., 1985; Yanase et al., 2011). A recent study has shown that the use of
inhibitors of PKCβ and PKCα inhibited both ruffling and degranulation. The Rho guanine
nucleotide exchange factor Vav and also Cdc42 have been shown to be associated with mast cell
degranulation and ruffling (Guillemot et al., 1997; Pivniouk et al., 2003; Zeng et al., 2003).
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PLD2 also is important for membrane ruffle formation, in a mechanism involving PLD2
interactions with Grb2 and Rac (Mahankali et al., 2011).

1.1.3 Mast cell granule-associated mediators
Most of the physiological and pathophysiological functions of mast cells are closely
associated with the actions of the myriad immunomodulatory granule mediators. The preformed
and pre-activated compounds in the granules are released rapidly (~seconds to minutes) for
immediate and acute reactions, such as alteration of vascular permeability, vasodilation, and
adhesiveness (Metcalfe et al., 1997; Theoharides et al., 2012a). These mediators include
histamine, proteases (tryptase, chymase, carboxypeptidase A and cathepsin G), βhexosaminidase, proteoglycans (heparin), serotonin, and some cytokines (e.g. tumor necrosis
factor-α [TNF-α] (Olszewski et al., 2006; Olszewski et al., 2007), Interleukin-4 [IL-4] (Wilson
et al., 2000; Hines, 2002). Newly synthesized mediators are also released to the extracellular
environment, such as leukotriene C4 (LTC4), prostaglandin D2 (PGD2), platelet-activating factor,
chemokines, and other cytokines (Metcalfe et al., 1997; Galli et al., 2005b), which plays an
immunoregulatory function by recruiting macrophages, neutophils, dendritic cells and T-cells to
the site of infection (Abraham and St John, 2010).
Histamine is probably the most well-known pro-inflammatory granule-associated
mediator, but it is not exclusively released by mast cells. The action of histamine is local and
short-lived since it gets rapidly degraded upon release (Hines, 2002), which is modulated by
binding to its receptors (H1, H, H3 and H4), found in many cell types, such as smooth muscle,
epithelia, and neurons, causing vasodilation, bronchoconstriction, and edema (Theoharides et al.,
1982). Furthermore, these histamine receptors are expressed in other immune cells, including
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neutrophils, eosinophils, lymphocytes, and macrophages, implying that histamine can modulate
the function of these cells (Carlos et al., 2006).
Many MC granule constituents are proteases, in particular, tryptase and chymase.
Positively charged granule proteases bind tightly to negatively charged proteoglycans, which
serve as a scaffold for stable complexes of charged molecules (Pejler et al., 2007).
Mast cell tryptase is a family of trypsin-like serine proteases (Caughey, 2011) that cleave
sites after basic amino acids such as Arg and Lys (Lehninger et al., 2005). Tryptase requires the
proteoglycan heparin to be enzymatically active (Hallgren et al., 2001). In general, tryptases can
be grouped into three main types, α (I-II), β (I-III), and γ (transmembrane). The main tryptases in
humans are β-tryptases, which are the products of two genes, TPSB2 and TPSAB1 (Caughey,
2011). The orthologues of β-tryptases are found in mouse and rat, which are mMCP-6, mMCP-7,
Tpsb2, and Tpsab1. Tryptase acts upon many substrates, receptors and zymogens (Schwartz,
1990), leading to host defense, tissue -remodeling/repair, pro-inflammatory as well as antiinflammatory reactions (Caughey, 2007). For example, lung tryptase elicits bronchial
constriction to protect airways from entry of pathogens or foreign substances, by degrading
bronchodilating peptides (Tam and Caughey, 1990), cleaving extracellular matrix in the
bronchial wall (Gruber et al., 1989), or activating protease-activated receptor (PAR)-2 which
modulates inflammatory responses (Dai et al., 2007b). Another important role of tryptase is
wound healing and tissue remodeling, by promoting the proliferation of fibroblasts and type 1
collagen production (Hartmann et al., 1992). Anti-inflammatory action of tryptase is also
reported that tryptase destroys pro-inflammatory cytokines, such as IL-6, IL-13 and TNF-α,
consequently reducing inflammation (Zhao et al., 2005). Intriguingly, tryptase is closely related
to neurological diseases, such as schizophrenia and multiple sclerosis (MS). In MS, tryptase level
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is remarkably elevated (Rozniecki et al., 1995). In murine models, β-tryptase expression is
upregulated during the inflammatory reaction against a parasitic infection (Ide et al., 1995) and
formation of keloid tissue (Ong et al., 2010). Overall, tryptase is a crucial player in
inflammation, tissue homeostasis, and innate immunity.
Because MC tryptase is an abundant mediator unique to mast cells, it serves as a
canonical biomarker for anaphylaxis, mastocytoma, and systemic mastocytosis. In clinical
settings, tryptase level in the patient plasma is measured for diagnosis of MC diseases
(Bussmann et al., 2007). In the laboratory, active tryptase can be measured by incubation with a
substrate such as N-α-benzoyl-DL-Arg-p-nitroanilide (BAPNA) or tosyl-Gly-Pro-Lys-pnitroanilide: tryptase cleaves the bond between the Arg or Lys and the p-nitroaniline (pNA),
releasing chromogenic pNA, measurable in a plate reader (Lavens et al., 1993).
Another serine protease, chymase, also participates in anti- and pro-inflammatory
reactions and host defense. It facilitates maintenance of gut barriers, bronchoconstriction,
vasoconstriction, and defense against parasites (Nakano et al., 1997; Caughey, 2007). Chymase
along with carboxypeptidase A3 play a prominent role in degrading venom-associated peptides
and toxins (Akahoshi et al., 2011). Carboxypeptidase A3 also controls systemic toxicity of
endogenous vasoconstricting peptides during sepsis (Maurer et al., 2004).
β- hexosaminidase (β-hex) is an exoglycosidase that cleaves terminal sugars (Schwartz et
al., 1979). β-hex enzyme catalyzes degradation of GM2 ganglioside, and mutations in this
enzyme lead to neurodegenerative diseases (Bayleran et al., 1987; Tifft and Proia, 1997). β-hex
has been successfully used as a MC function marker because it is released in parallel with
canonical MC marker histamine (Schwartz et al., 1979). For many of the studies using RBL
cells, degranulation has been quantified via measurement of released β-hex by incubating with
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substrate resulting fluorescent product, easily detected in a microplate reader (Naal et al., 2004),
but tryptase release has not typically been used as a RBL-2H3 degranulation marker.

1.2 Zebrafish as a model for mast cell and mitochondria
1.2.1 Zebrafish as models for toxicology
Zebrafish (Danio rerio) have emerged as a powerful vertebrate model organism for
genetic and developmental biology because of their small size, low-cost maintenance, high
fecundity, short generation time, easy gene manipulation, external transparent development, and
availability of extensive genomic resources (Ward and Lieschke, 2002; Sullivan and Kim, 2008;
Ellett and Lieschke, 2010). In addition, their physiological equivalence with mammalian
systems provides an intriguing model of human disease (Ward and Lieschke, 2002; Yoder et al.,
2002; Lieschke and Currie, 2007).
Zebrafish (ZF) are gaining popularity in toxicology as an attractive system as well, owing
to their striking similarities to mammalian toxicity profiles, and their easily-monitored drug or
toxicant effects (Spitsbergen and Kent, 2003; Link et al., 2006; Lieschke and Currie, 2007;
Scholz et al., 2008; Oppedal and Goldsmith, 2010; Lam et al., 2012). Moreover, ZF are
currently the best-suited vertebrate model for high-throughput toxicity screening, capable of
bridging the in vitro cell-based systems and in vivo mammalian models (Sukardi et al., 2010;
Tanguay, 2018).
ZF represent a more pertinent and valuable model organism for environmental toxicants
(Bambino and Chu, 2017), especially toxicants that are detected in aquatic environments (Scholz
et al., 2008) which provide information for both human health and aquatic toxicology and
ecology, since aquatic pollution has become a serious global issue. For example, Mizell and
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Romig utilized ZF embryos to monitor effects of common aquatic pollutants, such as dioxin (e.g.
TCDD), benzene, and toluene (Mizell and Romig, 1997). The continuous observation of
phenotypic changes upon toxicant exposure owing to transparent body and rapid growth are sure
to provide significant advantages to developmental toxicologists.
Numerous studies have examined the effects of endocrine disruptor chemicals (EDCs),
including bisphenol A (BPA), ethinyl estradiol (EE2), and polybrominated diphenyl ethers
(PBDEs), using ZF embryos and larvae, on changes in gene transcription and hormonal levels
(Chung et al., 2011; Velasco-Santamaria et al., 2011; Chen et al., 2012; Cardoso et al., 2017;
Souder and Gorelick, 2018). Also, metal toxicology studies have employed ZF: those metal
toxicants include mercury, zinc, cadmium, lead, and arsenic (Chan et al., 2006; Senger et al.,
2010; Richetti et al., 2011; Wu et al., 2012). The rise of organic pollutants in the environment,
mostly polyaromatic hydrocarbons (PAHs), has been reported as a serious health concern in
recent years. The sources of PAHs include pesticides, naphthalene, benzopyrene, and
dichlorophenol products. Many ZF studies have found adverse effects of PAHs on development,
gene expression, nucleic acid, oxidative stress and endocrine systems of ZF embryos (Kienle et
al., 2009; Hawliczek et al., 2012; Huang et al., 2012; Ma et al., 2012; Shao et al., 2012; Xing
et al., 2012).
It is worth noting that the ZF model is equipped with genomic data [its genome has been
fully sequenced and annotated (Howe et al., 2013)], numerous transgenic morphants, and easy
genetic-manipulation. Since technologies in molecular/genetics/bioinformatics have advanced
remarkably, recent toxicological studies have expanded the scope to elucidating molecular
mechanisms and cellular targets, in addition to describing end-point toxicity to chemicals. Thus,
the increased and augmented recognition and usage of ZF in toxicology is promising.
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1.2.2 Zebrafish in mast cell studies
Despite the many advantages of ZF, utilizing ZF in mast cell studies has not been
extensively explored yet, partly because of the lack of information on ZF mast cells up until
recently. Only a decade ago, the Berman lab first characterized ZF mast cells (Dobson et al.,
2008); thus, this area of ZF MC studies are still at an early but promising stage. In those studies,
carboxypeptidase A5 (cpa5), which is homologous to human CPA1 and mouse Cpa3, was
identified as a MC specific marker in ZF (Dobson et al., 2008; Da'as et al., 2012). Application
of an anti-human FcεRI and anti-human tryptase antibody to ZF revealed FcεRI receptor-like and
tryptase homologs in ZF (Da'as et al., 2011). Furthermore, techniques were developed to
monitor MC degranulation in adult ZF by injecting c48/80 (MC stimulant) and quantifying the
release of tryptase using a N-alpha-benzoyl-DL-arginine-p-nitroanilide (BAPNA), chromogenic
synthetic tryptase substrate (Dobson et al., 2008; Da'as et al., 2011). A systemic mastocytois
(SM) model has been developed in ZF, which is characterized by excessive accumulation of
MCs, by inducing genetic mutaion in the c-Kit receptor to generate transgenic animal (Balci et
al., 2011; Balci et al., 2014). Overall, these studies found that ZF MCs share similarities in
innate and adaptive immune responses with humans (Dobson et al., 2008; Da'as et al., 2011;
Da'as et al., 2015).
Additionally, the Berman laboratory has developed a mast cell degranulation assay using
adult ZF to study by tryptase as a degranulation marker (Dobson et al., 2008; Da'as et al., 2011).
After adult ZF were injected intraperitoneally with MC stimulant c48/80, blood samples are
collected by cardiac puncture and incubated with BAPNA. This assay showed an increase in
blood tryptase levels, ~60% above controls (Dobson et al., 2008). Later, this tryptase assay also
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produced a significant readout for MC degranulation by injection of mouse IgE followed by
DNP-BSA antigen injection in adult ZF (Da'as et al., 2011).
Although these studies done by the Berman lab (2018 and 2011) demonstrate the
feasibility of using ZF as a model to study MCs in vivo, using adult ZF to measure MC
degranulation has drawbacks: their small size (3-4 cm) precludes large-scale extraction of plasma
where tryptase is detected. In addition, all the chemicals need to be injected intraperitoneally and
blood samples are collected manually with frequent anesthetization of the animals. Therefore,
this method is costly, labor-intensive and low-throughput. Recently, Yang et al.(2015) reported
an in vivo, microplate-based colorimetric tryptase assay using ZF embryos (Yang et al., 2015),
rather than adult ZF. In this method, all the drugs and reagents, including c48/80 and BAPNA,
are directly added to the fish water and animals are arrayed in microplate for direct readout of
signals in a microplate reader. Thus, this method can be utilized as a high-throughput assay.
β-hexosaminidase release as a MC degranulation marker has been utilized in the RBL2H3 cell line, which is one of the most widely used in vitro MC systems. Thus, previous findings
on ZF MCs have strongly motivated us to establish tryptase assay in vitro models using RBL
mast cells, to be able to parallel studies of MCs in vitro and in vivo. However, in Chapter 4, we
detail our finding that RBL cells do not express tryptase genes.

1.2.3 Zebrafish in mitochondrial studies
Mitochondria are often noted as powerhouses which generate energy (adenosine
triphosphate, ATP) in all eukaryotic cells. Also, mitochondria are involved in regulation of
calcium signaling since they can store and release calcium in concert with the ER (Pacher et al.,
2000). During ATP synthesis, mitochondria also consume oxygen as the final electron acceptor;
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thus, ATP production and oxygen consumption in mitochondria are tightly coupled, and this
process is called oxidative phosphorylation (Lehninger et al., 2005).
Because of the important roles of mitochondria, they have been a subject of studies in
various scientific fields. However, most of studies on mitochondria have been done in cell
culture or mitochondria isolated from animal models (Newton et al., 2005; Ajao et al., 2015).
Due to the unique features of ZF being transparent and possessing advanced genetic tools,
scientists have utilized ZF to investigate mitochondria in a living, intact organism (Kim et al.,
2008; Paquet et al., 2014; Noble et al., 2015; Bergamin et al., 2016; Zhou et al., 2018).
Our lab has previously showed that the antimicrobial agent triclosan (TCS) suppresses
MC degranulation in vitro (Palmer et al., 2012; Weatherly et al., 2013). In our search of
mechanisms underlying MC inhibition by TCS, we found that TCS is a proton ionophore
mitochondrial uncoupler (MU) in multiple cell types (Weatherly et al., 2016). Proton ionophore
MUs interfere with ATP synthesis by transporting hydrogen ions across the inner mitochondrial
membrane, thus bypassing the proton channel of ATP synthase (Heytler and Prichard, 1962).
Disruption of the proton gradient also causes the electron transfer chain to operate more
vigorously, so oxygen consumption rate (OCR) is increased by proton ionophore MUs.
Additionally, we and others have revealed that TCS inhibits mitochondrial membrane potential
(Attene-Ramos et al., 2015; Weatherly et al., 2018).
To align with our in vitro studies, we developed a novel in vivo assay using ZF embryos
in 96-well high-throughput format utilizing XFe 96 Extracellular Flux Analyzer, to measure
mitochondrial bioenergetics (Shim et al., 2016b)—see Chapter 5. As expected, ATP-linked
respiration decreases and OCR increases on TCS exposure. There are other studies using
zebrafish for mitochondrial bioenergetics; however, these studies employed relatively low-
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throughput 24-well plates and required laborious placement of screens into each individual well
to contain ZF within the well during the signal acquisition (Stackley et al., 2011; Bestman et al.,
2015).
A recent study by Paquet et al. (2014) reported development of a transgenic ZF which is
labeled with mitochondrial markers attached to fluorescent proteins (“MitoFish”). The authors
used MitoFish to examine mitochondrial dynamics in real-time via in vivo imaging (Paquet et al.,
2014). Similarly, another group generated the transgenic ZF line MTS-Kaede, in which
mitochondria are labeled in neurons, to study mitochondrial transport (Bergamin et al., 2016).
Dopaminergic neuron-specific (Noble et al., 2015) and neutrophil-specific (Zhou et al., 2018)
mitochondria transgenic ZF lines have also established recently. Thus, the potential for use of
zebrafish in toxicity testing of mitochondrial function is great and growing.

1.3 Arsenic and triclosan
1.3.1 Arsenic
Arsenic (As) exposure is a global concern since it is ubiquitously detected in soil, water,
and air, from natural or anthropogenic sources (Abdul et al., 2015). The major route of human
exposure is diet, via foods or drinking water, with the additional concern of occupational-related
arsenic exposure for certain groups (Arslan et al., 2017). In the United States, the allowed level
of As in drinking water set by Environmental Protection Agency (EPA) is 10 ppb; however,
there are many parts of the world (e.g. West Bengal, Bangladesh, Taiwan, and South America)
which the As level in drinking water is very high: hundreds of ppb to ppm. Thus, across the
world, hundreds of millions people are at risk of As exposure.
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Many human epidemiological studies have reported strong association between
populations exposed to high levels of As and prevalence of numerous disorders and diseases.
The International Agency for Research on Cancer (IARC) has classified inorganic arsenic as a
carcinogen. A study done in Argentina showed that inorganic As exposure is associated with
high incidence of colorectal, lung, breast, prostate, and skin cancers (Bardach et al., 2015).
Many other studies also reported that urinary arsenic concentration is positively correlated with
frequency of lung cancer (Steinmaus et al., 2010; Melak et al., 2014), bladder cancer (Melak et
al., 2014), squamous cell carcinoma (Gilbert-Diamond et al., 2013), basal cell carcinoma
(Leonardi et al., 2012), and non-melanoma skin cancer (Kim et al., 2017). Also, a high As level
detected in blood is also related to bladder cancer and renal cancer (Mostafa and Cherry, 2013).
Arsenic exposure is also correlated to diabetes (James et al., 2013; Grau-Perez et al.,
2017), cardiovascular disease (Wade et al., 2015; Wu et al., 2015), skin lesions (Chung et al.,
2006; Rahman et al., 2006; Mondal et al., 2016), chronic kidney diseases (Hsueh et al., 2009),
hypertension (Guha Mazumder et al., 2012), and child pneumonia (George et al., 2015).
Additionally, a study done by Wu et al. (2011) found a positive correlation between arsenic
exposure and birth defects (Milton et al., 2010; Wu et al., 2011). Human health problems caused
by As are reviewed in (Abdul et al., 2015).
Our lab has previously demonstrated that mast cell degranulation is dampened by
inorganic Arsenite in Ag-stimulated RBL cells (Hutchinson et al., 2011). We then have sought
out the mechanisms of arsenic’s inhibitory action on MCs and revealed that early tyrosine kinase
phosphorylation was significantly decreased by As exposure. Specifically, the levels of
phosphorylation of Syk kinase and one of the Syk substrates, PI3K, are reduced upon As
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exposure in activated RBL cells (Shim et al., 2016a). This mechanistic study is detailed in
Chapter 2.
Interestingly, arsenic has been employed in traditional Chinese medicine over 5000 years
to treat asthma. Our findings of inhibitory action of As on mast cells, which is a key player for
asthma, might be the mechanism of this treatment. Moreover, As has shown to decrease asthma
symptoms in mice (Chu et al., 2010) and to abrogate anaphylactic response in guinea pigs
(Poriadin et al., 1977).

1.3.2 Triclosan
Triclosan (TCS) is a broad-spectrum antimicrobial agent that has been widely used in
consumer products since its original usage in clinical settings in 1972. During 2003–2004, the
National Health and Nutrition Examination Survey (NHANES) measured triclosan in urine and
TCS was detected in approximately 75% of the people tested (Calafat et al., 2008). More recent
survey studies in Korea, Denmark, and China reported 93% (Kim et al., 2011), 79% (Frederiksen
et al., 2013) and 100% (Li et al., 2013) detection rates of TCS from 140-300 test subjects.
By the late 2000s, TCS was found in over 90% of soap products (FDA, 2013) until it
was banned by the FDA in consumer soap products in 2016 (Kux, 2016) and hospital sterilizing
products in 2017 (Fischer, 2017). However, TCS remains in other consumer products, such as
toothpaste, and other household products (e.g. toys, kitchenware, bedding, fabric etc.).
Numerous emerging epidemiological studies report adverse human health consequences
to TCS exposure. Since several studies have demonstrated that TCS is an endocrine disrupting
chemical (Wang and Tian, 2015; Wang et al., 2015; Ruszkiewicz et al., 2017), and an
epidemiological study showed prenatal TCS exposure affects thyroid hormone levels (Wang et
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al., 2017). Also maternal TCS level is strongly associated with reproduction (Wang et al., 2015;
Hua et al., 2017) and fetal growth and development, such as fatal abnormalities, birth weight,
head circumference (Lassen et al., 2016; Etzel et al., 2017; Wei et al., 2017). Additionally,
studies done in 2018 reported abnormalities of sperm morphology (Jurewicz et al., 2018), and
lowered cognitive test scores in children (Jackson-Browne et al., 2018) linked to triclosan
exposure. Intriguingly, while urinary TCS concentration level is inversely associated with body
mass index and waist size (Li et al., 2015), one epidemiological study presented a positive
correlation between TCS exposure and high risk of gestational diabetes (Ouyang et al., 2018).
Most of mechanisms causing these health consequences by TCS are not fully elucidated,
however, several studies have provided molecular and biochemical data about TCS. TCS
increases reactive oxygen species (ROS) generation, which leads to oxidative DNA damage (Lv
et al., 2016), or tumorigenesis (Yueh et al., 2014). TCS alters gene expression in mice (Yueh et
al., 2014; Marshall et al., 2015), which potentially induces cancer formation. Abnormal gene
expression profiles were observed in TCS-exposed sea urchins (Hwang et al., 2017). Calcium
homeostasis is also modulated by TCS exposure (Ahn et al., 2008; Cherednichenko et al., 2012;
Weatherly et al., 2018). Finally, TCS’s detrimental effects on mitochondrial function has been
explored by us and others (Ajao et al., 2015; Shim et al., 2016b; Weatherly et al., 2016).
Our lab has investigated the effects of TCS on mast cell degranulation. First, we have
developed the method to prepare TCS in aqueous buffer and determine the resultant
concentration by spectrophotometer, to avoid unnecessary confounding effects of organic
solvents (Weatherly et al., 2013). We found that TCS rapidly inhibits MC degranulation in Agmediated as well as Ca2+ ionophore-stimulated RBL cells (Palmer et al., 2012). This finding was
replicated in human (HMC-1) mast cells (Weatherly et al., 2016). Inhibited MC degranulation by
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TCS might be a potential explanation for the TCS usage as a treatment of atopic dermatitis (Tan
et al., 2010).
We then endeavoured to elucidate the mechanisms by which TCS disrupts degranulation.
Recently, we have demonstrated that TCS is a proton ionophore mitochondrial uncoupler (MU)
in several cell types (RBL, HMC-1.2, NIH-3T3, and primary human keratinocytes) and in living
zebrafish (Shim et al., 2016b). In both in vitro and in vivo models, TCS inhibits ATP production
and increases OCR. We also revealed that TCS disrupts mitochondrial structure, mitochondrial
membrane potential and calcium signaling (Weatherly et al., 2018). In addition, Popova et al.
(2018) demonstrated that TCS acts as a protonophore, which permeates artificial bilayer lipid
membranes, thus transporting protons across the membrane, resulting in membrane
depolarization. Interestingly, TCS showed more potent protonophoric activity than carbonyl
cyanide 3-chlorophenylhydrazone (CCCP), which is a canonical protonophore/MU. TCS’s
protonophoric activity was also tested using bacterial membrane and isolated rat liver
mitochondria: TCS elicited bacterial membrane depolarization and induced mitochondria
swelling in rat liver. This study also showed that TCS induces calcium efflux from mitochondria,
leading to disruption of calcium homeostasis, in agreement with our previous data by Weatherly
et al. (Popova et al., 2018; Weatherly et al., 2018). Thus, these studies strongly suggest that
TCS disrupts mitochondrial function and membrane potential.
We further investigate the targets of triclosan’s inhibitory action in the MC signaling
transduction pathway, in particular, two key signaling molecules downstream of Ca2+ influx:
protein kinase C (PKC) and phospholipase D (PLD). The detailed of mechanistic studies on
these molecules will be discussed in Chapter 3.
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1.4 Current studies
Mast cells are physiologically important cells, involved in myriad biological events as
well as various diseases. Thus, disruption of mast cell function might trigger many unfavourable
effects in an organism.
Arsenic exposure is a global concern since it is commonly detected in drinking water and
food sources. While arsenic is known to inhibit MC function (Hutchinson et al., 2011), until now
the underlying biochemical mechanisms were unknown. Chapter 2 describes the molecular
mechanisms underlying inorganic Arsenite inhibition of MC degranulation: by hampering early
tyrosine kinase Syk and its substrate PI3K.
Synthetic antimicrobial agent triclosan has also been shown to inhibit MC function, but
the underlying molecular mechanisms were previously unknown. Chapter 3 reveals triclosan’s
molecular targets in the MC signaling pathway, which are very different from arsenic’s targets.
Since our previous findings on TCS effects on Ca2+ mobilization in stimulated MCs, we
examined downstream key players post Ca2+ influx. We found that PLD activity was strongly
impeded, and subcellular translocations of PKC and its substrate, MARCKS, were delayed by
TCS.
In Chapter 4, we report that one of the most utilized MC cell culture model RBL-2H3
cells do not express the classical mast cell marker tryptase. We have developed and employed
several assays to detect tryptase release from the RBL cell supernatant, but no measureable
signals were detected. We also examined the expression of mRNA transcript of tryptase genes
from RBL by PCR, but no tryptase mRNA was detected. Before this study, the question of why
tryptase was not typically utilized in RBL-2H3 mast cell studies was unanswered for decades.
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Finally, Chapter 5 depicts a novel in vivo high-throughput assay using zebrafish embryos
to measure mitochondrial bioenergetics. Previously, TCS had been shown to be a proton
ionophoric mitochondrial uncoupler in numerous cell lines (Ajao et al., 2015; Weatherly et al.,
2016) and in isolated mitochondria (Newton et al., 2005), but this mitotoxicity had not yet been
confirmed in an animal. Using this method, we have demonstrated that TCS is a mitochondrial
uncoupler in a living organism, zebrafish.
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CHAPTER 2
ARSENIC INHIBITS MAST CELL DEGRANULATION VIA SUPPRESSION OF
EARLY TYROSINE PHOSPHORYLATION EVENTS1
2.1 Abstract
Exposure to arsenic (As) is a global health concern. We previously documented an
inhibitory effect of inorganic Arsenite on IgE- mediated degranulation of RBL-2H3 mast cells
(Hutchinson et al., 2011). Mast cells are tissue-resident cells that are positioned at the hostenvironment interface, thereby serving vital roles in many physiological processes and disease
states, in addition to their well-known roles in allergy and asthma. Upon activation, mast cells
secrete several mediators from cytoplasmic granules, in degranulation. The present study is an
investigation of Arsenite’s molecular target(s) in the degranulation pathway. Here, we report that
arsenic does not affect degranulation stimulated by either the Ca2+ionophore A23187 or
thapsigargin, which both bypass early signaling events. As also does not alter degranulation
initiated by another non-IgE-mediated mast cell stimulant, the G-protein activator compound
48/80. However, arsenic inhibits Ca2+ influx into antigen-activated mast cells. These results
indicate that target of arsenic in the degranulation pathway is upstream of Ca2+ influx. PhosphoSyk and phospho-p85 phosphoinositide 3-kinase enzyme-linked immunosorbent assays data
show that arsenic inhibits early phosphorylation events. Taken together, this evidence indicates
that the mechanism underlying arsenic inhibition of mast cell degranulation occurs at the early
tyrosine phosphorylation steps in the degranulation pathway.

1

A portion (50%) of this work was performed by Rachel Kenndey (Kennedy, R.H., 2013. Effects of endocrine
disrupting chemicals on mast cell function, Electronic Theses and Dissertations. University of Maine) with the
remainder being performed by Juyoung Shim.
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2.2 Short Abstract
Arsenite (As) inhibits IgE-mediated degranulation of RBL-2H3 mast cells. Mast cells
serve vital roles in many physiological processes and diseases. Upon activation, mast cells
secrete mediators from cytoplasmic granules, in degranulation. Here, we report that As does not
affect degranulation stimulated by Ca2+ ionophore A23187, thapsigargin, or the G-protein
activator compound 48/80, all of which bypass early signaling events. However, arsenic inhibits
Ca2+influx into antigen-activated mast cells. Syk and phosphoinositide 3-kinase ELISA data
show that arsenic inhibits early phosphorylation events.

2.3 Introduction
Exposure to arsenic is a major human health concern according to both the World Health
Organization and the Agency for Toxic Substances and Disease Registry (NRC, 2001; ATSDR,
2007). Millions of people worldwide are exposed to high levels of arsenic from a variety of
natural and anthropogenic sources, including drinking water, various foods, pesticides, mining
sites, and toxic waste sites. Many private water wells in the U.S., as well as those around the
world (such as South America and Bangladesh) routinely contain levels of As well above 50 ppb
(parts per billion; µg/L), and sometimes as high as 3000 ppb (ATSDR, 2007).
Chronic exposure to arsenic, in particular via drinking water, has been correlated to many
diseases, including severe dermatological disorders (Smith et al., 2000; Xia et al., 2009; Paul et
al., 2013), respiratory diseases (Smith et al., 1992; Hopenhayn-Rich et al., 1998; Putila and
Guo, 2011), diabetes/obesity (Abernathy et al., 1999; Maull et al., 2012), and cardiovascular
disease (Chen et al., 2009; Huang et al., 2009; Smith and Steinmaus, 2009; Abhyankar et al.,
2012; Das et al., 2012). Arsenic exposure also inhibits hematopoietic and immune systems
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(NRC, 2001) and causes neurological and cognitive impairments (Wasserman et al., 2004;
Wasserman et al., 2007; Chen et al., 2009). Moreover, arsenic is a known human carcinogen,
which affects almost all major organs including liver, kidney, bladder, skin and lung (Ferreccio
et al., 2000; Chiu et al., 2004; Liaw et al., 2008; Heck et al., 2009; Putila and Guo, 2011; LiuMares et al., 2013; Mostafa and Cherry, 2013; Naujokas et al., 2013; Saint-Jacques et al.,
2014).
We recently demonstrated that antigen-stimulated degranulation of the mast cell model
rat basophilic leukemia cells (RBL-2H3) is inhibited by non-cytotoxic doses of inorganic
Arsenite (Hutchinson et al., 2011). Mast cells are multi- effector immune cells that participate in
the first line of defense against parasites. Mast cells, found in most human tissues (Kuby, 1997),
are also major effectors in allergic responses, asthma, other innate immune processes, and
carcinogenesis. Mast cells are also involved in neurological conditions such as multiple sclerosis,
autism, and anxiety (Silver and Curley, 2013). The RBL-2H3 mast cell model is biologically
very similar to human basophils and rodent mucosal mast cells (Fewtrell, 1979; Seldin et al.,
1985; Metzger et al., 1986).
Arsenic can be detected in a variety of human samples, and urine and blood are usually
the major materials that are monitored for arsenic exposure (Kraus et al., 2000). However,
arsenic can be stored and concentrated in the tissues of many organs such as kidney, lung, skin,
and liver (Benramdane et al., 1999), and mast cells are found in most human organs, as we
discussed in Hutchinson, et al. (2011). In fact, the concentrations of arsenic found in tissue tend
to be higher (up to ~7-350 fold higher) than in blood (Benramdane et al., 1999). In a previous
article (Hutchinson et al., 2011), we noted several publications reporting human tissues
containing between 100 and 6000 ppb arsenic. For example, one study examined tissue arsenic
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concentrations in people who had regularly consumed drinking water containing 220-2000 ppb
arsenic and found several hundred to several thousand ppb arsenic (Schroeder et al., 1968).
Since mast cells function within tissues, it is necessary to study arsenic concentrations that are
found within tissues. Thus, the 100-750 ppb arsenic concentrations employed in this study are
biologically relevant.
Highly granulated, mast cells respond to various stimuli by partially or completely
releasing the contents of their granules, which include a range of mediators such as histamine
and serotonin. The mechanism underlying arsenic inhibition of the function of mast cell
degranulation is not yet known. Given the complexity of the degranulation signal transduction
pathway and the similarities to signaling pathways in other immune cells, such as T cells, there
are many potential targets for arsenic inhibition.
Degranulation is a process that classically begins with antigen crosslinking of IgE-bound
FcεRI receptors, which abound on the mast cell surface (Kuby, 1997). The physical aggregation
of the receptors results in their tyrosine phosphorylation by the protein tyrosine kinase Lyn
(Kinet, 1999; Xiao et al., 2005). Phosphorylation of the receptor causes the protein tyrosine
kinase spleen tyrosine kinase (Syk) to be recruited to the receptor (Benhamou et al., 1993; On et
al., 2004). The activation of Syk (Minoguchi et al., 1994; Zhang et al., 2000), leads to the
activation of phospholipase C (PLC) γ (Benhamou et al., 1992; Beaven and Metzger, 1993) and
results in Ca2+ mobilization (Ferris et al., 1989; Millard et al., 1989; Putney et al., 2001), which
is essential to degranulation (Zhang et al., 1996).
PLC 1 is an important player in Ag-receptor signaling: it catalyzes the hydrolysis of the
membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) to generate second
messengers inositol-1,4,5 - trisphosphate (IP3) and diacylglycerol (DAG). IP3 initiates the release
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of Ca2+ from internal stores (i.e., the endoplasmic reticulum [ER]), while DAG is responsible for
activation of an assortment of protein kinase C (PKC) isoforms (Kalesnikoff and Galli, 2008).
Activated PKC phosphorylates the cytoskeletal protein myosin, important for degranulation
(Ludowyke et al., 1989).
A second signaling pathway resulting in IP3 generation is initiated by phosphoinositide 3Kinase (PI3K), which is activated by Syk (Okkenhaug and Vanhaesebroeck, 2003; Mocsai et
al., 2010) and which phosphorylates inositol lipids to generate the signaling molecules PIP2 and
PIP3 (Kitaura et al., 2000). PIP2 is then used by PLC γ to generate IP3. PH domains within PLC
γ, Vav, Akt, Btk, and PDK1 mediate binding of these proteins to PIP2 and to PIP3, thus drawing
these proteins to the plasma membrane for activation (Kitaura et al., 2000; Abramson and Pecht,
2007). For example, PDK1 activation leads to activation of PKC δ, important for degranulation.
Overall, PI3K activates Ca2+ influx and degranulation of mast cells (Ching et al., 2001).
IP3 is crucial for degranulation. Activation of IP3 receptors initiates a biphasic increase in
intracellular Ca2+ (Berridge, 1993; Taylor and Thorn, 2001). The binding of IP3 to its receptors
in the ER causes Ca2+ to be released from the internal ER stores, causing depletion of Ca2+ from
the ER. IP3 receptors are ion channels that allow for passive diffusion of Ca2+ from the ER
(Scharenberg et al., 2007). Depletion of Ca2+ stores results in an influx of Ca2+ across the plasma
membrane through calcium release-activated calcium (CRAC) channels (Hogan et al., 2010),
which is referred to as “store operated calcium entry” (SOCE) (Putney, 1986; Putney, 1990;
Clapham, 1995), producing an extracellular Ca2+ influx and calcium-release activated current
(Kraft and Kinet, 2007). The major players in “store operated calcium entry” are STIM-1 (Liou
et al., 2005; Zhang et al., 2005), an ER calcium sensor which interacts directly with Orai1
channels (Feske et al., 2006; Vig et al., 2006), the pore subunit of CRAC channels within the
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plasma membrane, to couple depletion of ER Ca2+ with activation of CRAC channels. Influx of
Ca2+ across the plasma membrane permits reuptake of Ca2+ into the ER through
sarco/endoplasmic Ca2+-ATPase (SERCA) pumps (Ma and Beaven, 2011), which actively pump
Ca2+ from the cytosol into the ER to replenish internal stores (Scharenberg et al., 2007).
Depletion of the ER pool of Ca2+ by either IP3 or the compound thapsigargin (selective inhibition
of SERCA) (Thastrup et al., 1990; Lytton et al., 1991) leads to entrance of Ca2+ into the cell
(Ma and Beaven, 2011). Overall, the primary synergistic signals for secretion are an increase in
intracellular Ca2+ as well as activation of PKC (Ozawa et al., 1993a).
Next, increases in intracellular Ca2+ and PKC translocation work in tandem to activate
phospholipase D (PLD) (Lin and Gilfillan, 1992). In fact, PLD can be activated in RBL-2H3
cells via several means: FcεRI receptor crosslinkers (Dinh and Kennerly, 1991; Ali et al., 1996),
thapsigargin (Cissel et al., 1998), Ca2+ ionophore (Lin and Gilfillan, 1992), and compound 48/80
(Chahdi et al., 2000). PLD hydrolyzes phosphatidylcholine into phosphatidic acid (PA), which
has been shown to stimulate PLC γ (Nishizuka, 1995). PA is converted to DAG by PA
phosphohydrolase, thus causing a secondary rise in intracellular DAG levels (Nakashima et al.,
1991; Lin et al., 1992). These increases have been shown to be important for the translocation
and activation of the DAG-dependent isoforms of PKC (Lin et al., 1992; Nishizuka, 1995; Peng
and Beaven, 2005). PLD1 is involved in granule translocation, and PLD2 is involved in
membrane fusion of the granules (Choi et al., 2002). Granules are transported from the cell
interior to the plasma membrane with the help of microtubules, where they dock with the help of
multiple soluble N-ethylmaleimide-sensitive factor attachment protein receptors (Guo et al.,
1998; Baram et al., 1999; Paumet et al., 2000; Blank et al., 2002; Logan et al., 2003; Puri and
Roche, 2008; Tiwari et al., 2008; Woska and Gillespie, 2012). The result of mast cell signaling
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is fusion of intracellular granules with the plasma membrane, causing the release of histamine,
serotonin, leukotrienes, cytokines, β-hexosaminidase, and enzymes that trigger the symptoms of
allergy and asthma and that play many other crucial physiological roles (Kopeć et al., 2006).
Simultaneously, F-actin polymerization causes membrane “ruffling.”
Actin cytoskeletal rearrangement is not an essential element of the degranulation pathway
(degranulation occurs even when ruffling is stopped by actin inhibitor cytochalasin D (Holowka
et al., 2000)), but the two share common events such as activation of PKC and influx of Ca2+
(Pfeiffer et al., 1985; Yanase et al., 2011). In a recent paper by Yanase et al. (2011), it was
shown that the use of inhibitors of PKC β and PKC α inhibit both ruffling and degranulation.
PLD2 also is important for membrane ruffle formation.
As part of our investigation of arsenic’s mechanism of mast cell inhibition, we utilized
another non-IgE-mediated stimulating method, compound 48/80 (c48/80), a polybasic mast cell
secretagogue which has potent anaphylactic properties in vivo (Lagunoff et al., 1983; Chahdi et
al., 2000) and which effects degranulation from rat mast cells (Johnson and Moran, 1969).
Compound 48/80 is believed to act by the stimulation of heterotrimeric G-proteins (Chahdi et al.,
2000), in particular, via Gi-2 and Gi-3 in RBL-2H3 cells (Senyshyn et al., 1998). Pretreatment of
RBL-2H3 cells with the flavonoid quercetin causes an increase in histamine-containing
intracellular granules (Trnovsky et al., 1993) and an over-expression of Gi-3α and Gi-2α
(Senyshyn et al., 1998; Chahdi et al., 2000), so pre-incubation of RBL-2H3 cells with quercetin
is required prior to exposure with c48/80 in order to make the cells responsive to c48/80-induced
degranulation (Galli et al., 2008). Phospholipase D (PLD) is stimulated by c48/80 in quercetintreated RBL-2H3 cells (Aridor et al., 1990; Senyshyn et al., 1998; Chahdi et al., 2000).
Compound 48/80 induces a Ca2+ -dependent degranulation response that releases Ca2+ from
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intracellular pools (Aridor et al., 1990; Hirasawa et al., 1995; Senyshyn et al., 1998), and
transiently activates phospholipase C (PLC), possibly through indirect activation of PLD (Ali et
al., 1990; Aridor et al., 1990; Park et al., 1991; Yamada et al., 1992; Senyshyn et al., 1998).
Therefore, due to c48/80’s mechanism of action, we were able to assess the possibility of arsenic
targeting PLC, PLD, and calcium influx.
It is well established that Ca2+ influx is a crucial for mast cell degranulation. To explore
whether the level of FcεRI-mediated cytoplasmic Ca2+ in RBL-2H3 mast cells is changed by
arsenic exposure, we developed a microplate-based method to monitor the level of Ca2+ utilizing
the fluorescent Ca2+ indicator. Using this method, we were able to measure the cytosolic Ca2+
levels in real time for over 2h after cells were stimulated and exposed to arsenic.
Finally, we evaluated the effect of arsenic on key phosphorylation events, crucial early
signaling events in the mast cell degranulation pathway. It has previously been demonstrated that
arsenic affects tyrosine phosphorylation events (Qian et al., 2003), including T cell signal
transduction (Soto-Peña and Vega, 2008). Arsenic trioxide inhibits the PI3K/Akt pathway in
chronic lymphocytic leukemia cells (Goussetis and Platanias, 2010). PI3K is a heterodimeric
enzyme composed of a catalytic subunit (p110) and a regulatory subunit (p85) (Koyasu, 2003).
PI3K is activated by Syk kinase (Okkenhaug and Vanhaesebroeck, 2003). Here we have
examined the effect of arsenic on PI3K and Syk kinase by employing enzyme-linked
immunosorbent assays (ELISA). The global phosphorylated Syk levels in the Ag-activated RBL
cells were measured. For PI3K, both the phosphorylated p85 subunit of PI3K and the total PI3K
p85 subunit were evaluated.
In this study, we unraveled the molecular mechanism used by Arsenite to inhibit mast
cell function. We employed multiple experimental approaches in RBL-2H3 cells to determine
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the mechanism of arsenic inhibition of mast cell degranulation. Here we present mechanistic data
resulting from degranulation assays utilizing various stimulants, F-actin imaging, Ca2+
measurements, and ELISAs probing early phosphorylation events. We demonstrate that arsenic
acts very early in the signaling pathway leading to degranulation, inhibiting the nearly immediate
event of Syk kinase phosphorylation.

2.4 Materials and Methods
2.4.1 Chemicals and Reagents
A23187 ionophore, compound 48/80 (c48/80), quercetin, dimethyl sulfoxide (DMSO),
sodium azide, and sulfinpyrazone were purchased from Sigma Aldrich (St. Louis, MO, USA).
Thapsigargin (Tg) was obtained from Calbiochem/EMD Millipore (Billerica, MA, USA).
Tyrodes buffer, bovine serum albumin (BSA)-Tyrodes (BT), sodium acetate buffer, and glycine
carbonate buffer were prepared as previously described (Hutchinson et al., 2011). A low- Ca2+
Tyrodes (containing 0.9 mM rather than the typical 1.8 mM CaCl2) was used in all c48/80
experiments. Chemicals of the highest possible purity were used. All buffers and media were
sterile-filtered with VacuCap bottle-top filter devices (0.2 μM; Pall Life Sciences, Port
Washington, NY, USA).
Arsenic was prepared under sterile conditions as 10 mM stocks of inorganic sodium
(meta) arsenite (CAS no. 7784-46-5; manufactured by either JT Baker, Phillipsburg, NJ, USA; or
Fluka, Seelze, Germany), and dissolved in sterile cell culture water (BioWhittaker Lonza,
Walkersville, MD, USA). The stock was 0.2-μM filtered and stored as previously described by
(Hutchinson et al., 2011).
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Ca2+ ionophore A23187 was prepared by dissolving A23187 powder into 100% DMSO
for a final concentration of 2.5 mg/ml. The solution was transferred to a microcentrifuge tube
with a parafilmed lid and was wrapped in aluminum foil, for storage at -20 °C. On the day of an
experiment, this stock was diluted directly into BT solution to create ionophore concentrations of
1.5 x 10-7 M and 2 x 10-7 M (0.004% DMSO).
Tg was prepared as described in (Weatherly et al., 2016). The highest DMSO vehicle
concentration used in these experiments was 0.001 % (v/v).
Compound 48/80 was prepared using aseptic conditions as 30 mg/ ml stocks dissolved in
cell culture water, aliquoted into sterile polypropylene microfuge tubes, and frozen at -20 °C
until the day of use, so that each individual aliquot underwent only one freeze/thaw cycle.
Quercetin was prepared as a 60 mM stock from anhydrous quercetin powder in 100% DMSO.
Cells were treated with 20µM quercetin in RBL media (Hutchinson et al., 2011), resulting in a
DMSO vehicle concentration of 0.033 % (v/v).
Fluo-4/AM (Life technologies, Grand Island, NY, USA) was dissolved in 100% DMSO
to prepare a 911µM stock and stored at -20 °C until the day of use, so that each individual
aliquot underwent only one freeze/thaw cycle.

2.4.2 RBL-2H3 Cell Culture
Cell culture methods were those of (Hutchinson et al., 2011)

2.4.3 Cytotoxicity Assays
Trypan blue exclusion assays were performed as previously described in detail by
Hutchinson et al. (2011) and Palmer et al. (2012). In general, the details remained unchanged,
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with the exception of the use of c48/80, which required a slightly different procedure in order to
accommodate a 48h quercetin pre-treatment as well as the use of a low- Ca2+ Tyrodes buffer.
Accordingly, RBL-2H3 cells were plated into sterile tissue culture treated, six-well plates (VWR,
Radnor, PA, USA) at a density of 0.85 x 106 cells/well in RBL medium supplemented with 20
μM quercetin and incubated for 48 h at 37°C, 5% CO2. After 48 h, spent medium was discarded,
and fresh RBL medium was added to the cells for 30 min at 37°C, 5% CO2. This liquid was then
discarded, and low Ca2+ Tyrodes buffer ± 25 μg/ml c48/80 or vehicle ± arsenic was added to
each well for 15 min at 37°C, 5% CO2. This medium was removed, and wells were washed with
2 mL low Ca2+ Tyrodes to remove dead cells. Following removal of this wash, wells were rinsed
with 1 mL trypsin. Plates were then incubated with 1 mL fresh trypsin for 10 minutes at 37°C,
5% CO2 to allow cells to dislodge completely from the plates. Further removal of cells after this
incubation was accomplished by repeated pipetting of the cell-containing trypsin into the wells,
removing visible traces of cells from the surface of the well. The cell-containing trypsin was then
quenched by addition into 1 mL of RBL media. Equal volumes of this mixture and trypan blue
stain (Trypan Blue 0.4% solution in 0.85% NaCl; BioWhittaker Lonza) were then combined, and
cell viability was assessed by counting those cells able to exclude the trypan blue stain using a
hemocytometer (Bright-line, Hausser Scientific, Horsham, PA, USA). Values of living cells were
then normalized to the vehicle values for any given assay before data compilation.
Lactate dehydrogenase (LDH) assay was performed as previously described (Hutchinson
et al., 2011; Palmer et al., 2012).
ATP production and cytotoxicity were assayed via Promega (Madison, WI, USA) Toxglo
kit instructions as described in (Weatherly et al., 2016). Arsenic exposures lasted 1 h.
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2.4.4 Antigen-Mediated Degranulation Assay
Cells were sensitized by IgE, as described in (Weatherly et al., 2013). IgE-bound FcεRI
receptors of RBL cells were aggregated by dinitrophenyl (DNP)-BSA multivalent Ag ± arsenic
(for 1 h). Degranulation (release of β-hexosaminidase) was measured via a fluorescence-based
96-well microplate reader assay, as illustrated in (Weatherly et al., 2013).

2.4.5 Confocal Imaging of Membrane Ruffling
Experiments were performed as in (Palmer et al., 2012). Arsenic was used in place of
triclosan; thus, vehicle in control samples was cell culture water.

2.4.6 Ca2+ Ionophore-Stimulated Degranulation in RBL-2H3 Cells
This assay was essentially performed as described by (Weatherly et al., 2013), except that
two different Ca2+ ionophore A23187 doses (1.5 x 10-7 M and 2 x 10-7 M) were used, based on
their ability to elicit a low-range and mid-range level of degranulation, respectively, with this lot
of A23187. Additionally, arsenic (in place of triclosan) was diluted into A23187/BT solution at
the noted concentrations (0.004% DMSO vehicle in all samples).

2.4.7 Thapsigargin-Induced Degranulation
To test the ability of arsenic to alter an earlier Ca2+ signaling event than that induced by
A23187 Ca2+ ionophore, we used Tg, a known inhibitor of SERCA in mammalian cells.
Degranulation experiments were conducted similarly to antigen-stimulated RBL-2H3
degranulation experiments (Weatherly et al., 2013), except that there was no IgE pretreatment
and that RBL-2H3 cells were treated with 4.6 nM Tg for one hour (37 °C and 5% CO2) in the
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presence of 0-750 ppb arsenic. To combine multiple experiments, data were normalized to the
response elicited by 4.6 nM Tg in the presence of arsenic vehicle only (cell culture water).

2.4.8 Compound 48/80-Mediated Degranulation
RBL cells were harvested after 2-5 days of growth via trypsinization, and were
resuspended at a density of 0.25 x 106 cells/ml in fresh RBL medium ± 20μM quercetin. One
hundred microliter of this suspension per well was plated in black flat-bottom, tissue culturetreated, sterile, 96-well plates (Greiner Bio-One, Monroe, NC, USA). After 48 h in a 5% CO2
incubator at 37°C, spent RBL medium ± quercetin was removed by decanting. From here,
sample wells were washed twice with 0.9 mM Ca2+ (low-calcium) Tyrodes, and 100 μl/well
fresh RBL medium was added to cells for 30 min (Galli et al., 2008). Stimulated cell samples
then received 200μl aliquots of c48/80, spontaneous release cells received plain low Ca2+
Tyrodes, and lysed cells received Triton-X 100 diluted to 0.2% (v/v) in low- Ca2+ Tyrodes.
Degranulation (release of β-hexosaminidase) was quantified as previously described (Weatherly
et al., 2013).

2.4.9 Calcium measurement assay
RBL-2H3 cells (100µL/well) were plated in a 96-well plate in RBL media at a density of
0.5 x 106 cells/ml and incubated overnight at 37°C and 5% CO2. Also, 2 mM sulfinpyrazone
solution in Tyrodes buffer was prepared, vortexed, and rotated at 37°C overnight. On the
following day, cells were sensitized with 0.1 µg/ml anti-DNP IgE (Sigma) (in RBL media;
100µL per well) for 1 h at 37°C and 5% CO2. Sulfinpyrazone solution (2mM) was sterilized
using syringe filtration (0.2 µm), after its pH was adjusted to 7.4, and then was diluted to 0.6 mM
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using BT (2 mg/mL BT). The stock of 911µM Fluo-4/AM dye was diluted to 4.55 µM using BT.
For DMSO control samples, 0.5% DMSO-BT was also prepared. Some of the 4.55 µM Fluo4/AM-BT was further diluted to be 2.5 µM using 0.6 mM sulfinpyrazone in BT (Fluo-4/AMsulfinpyrazone-BT) and 0.27% DMSO-sulfinpyrazone- BT was also prepared as the
corresponding vehicle control.
After 1h IgE-sensitization, cells were washed with warm BT (200 µL per well), followed
by addition of 100 µL per well of 4.55 µM Fluo-4/AM-BT, 0.5% DMSO-BT, or BT (all in the
absence of sulfinpyrazone), to the appropriate wells for 1 min. Immediately after 1 min, these
solutions were discarded, and 200 µL per well of 2.5 µM Fluo-4/AM-sulfinpyrazone- BT, 0.27%
DMSO-sulfinpyrazone-BT, or 0.6 mM sulfinpyrazone- BT was added for 30 min at 37°C. After
30 min of Fluo-4 incubation, cells were washed twice with 0.6 mM sulfinpyrazone - BT (200 µL
per well), and then 250 µL per well of 0.6 mM sulfinpyrazone-BT were added for the baseline
fluorescence reading at 485 nm excitation and 528 nm emission for 2 min (42 s intervals between
readings). The sulfinpyrazone-BT solutions were discarded from the plate, and 240 µL per well
of 0.6 mM sulfinpyrazone-BT ± 0.0002 µg/mL antigen ± 750 ppb arsenic were added to the
corresponding wells. Fluorescence readings, at 485 nm excitation and 528 nm emission, were
taken for 1 h post- stimulation (42 s intervals between readings).
After the hour, for maximal Ca2+ readings, which are a measurement of cell number per
well, 10 µL of 10% Triton-X 100 (TX-100) was added to each well. The fluorescence reading
was taken after a10 min incubation (with agitation) at 37°C. TX-100 fluorescent values for all
replicates were averaged, and no differences among samples were determined by one-way
ANOVA followed by Tukey’s post- test (data not shown), indicating that all wells contained
equal numbers of cells.
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Finally, 50 µL of 0.5M EDTA (USB, Cleveland, OH, USA), which chelates Ca2+ and
lowers the fluorescent signal to the background level, was added to each well, and the
fluorescence reading was taken after a 5 min incubation. Fluorescence levels dropped to no-Fluo4 background levels, and no statistically significant differences among samples were found (data
not shown), indicating that measured fluorescence signals were due to the interaction of Fluo-4
dye and Ca2+.

2.4.10 Phospho-p85 PI3K ELISA
A Fast Activated Cell-based ELISA Kit (Active Motif, Carlsbad, CA, USA) was used, to
detect the levels of both phosphorylated and total PI3K p85 in the cell, according to the
manufacturer’s instructions. RBL-2H3 cells (100 µL per well) were plated in a clear 96-well
plate at a density of 0.5 x 106 cells/ml and incubated for 12-16 h at 37°C and 5% CO2. On the
following day, after 1 h sensitization with 0.1 µg/ml anti-DNP IgE (Sigma), cells were
stimulated with either 1µg/ml DNP-BSA antigen or BT (control) ± 750 ppb arsenic for 5 min at
37°C. Next, cells were fixed with 4% formaldehyde (Sigma) in PBS (Lonza, Rockland, ME,
USA) solution at room temperature for 20 min. Once the formaldehyde mixture was discarded,
cells were washed three times with 1X wash buffer provided in the kit (200 µL per well per
wash; 5 min gentle shaking per wash). The remaining steps were carried out according to the
manufacturer’s directions. Absorbance was measured (at 450 nm) immediately after the addition
of the “stop” solution. Cells were then stained with crystal violet, following the manufacturer’s
protocol, and absorbance was read at 595 nm. The measured OD450 reading was then corrected
for cell number by dividing the OD450 value by the OD595 value for each well.
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2.4.11 Phospho-Syk ELISA
PathScan® Phospho-Syk sandwich ELISA kit (Cell Signaling Technologies, Beverly,
MA, USA) was used to detect endogenous levels of phosphorylated Syk according to the
manufacturer’s instructions. This is a pan-tyrosine ELISA, able to detect altered phosphorylation
for all Syk’s key Tyr residues. For this assay, RBL-2H3 (1.75 x 106 cells/mL) were plated on 10
cm2 tissue-culture treated, sterile dishes (Cellstar, Greiner Bio-One, Monroe, NC, USA) at a
volume of 6.5 mL per well (final cell density of 1.14x107 cells per dish), and were incubated
overnight (12-16 h) at 5% CO2 and 37°C. Cells were sensitized overnight by addition of 1µg/ml
anti-DNP IgE (generously provided by Drs. Barbara Baird and David Holowka, Cornell
University) in RBL media or the following day for 1 h with 0.1 µg/ml anti-DNP IgE (Sigma).
Following the overnight incubation, each dish was checked to ensure a cell confluence of
80-90%. After IgE-sensitization (37°C and 5% CO2), spent IgE-media mixture was discarded,
and dishes were washed twice with 5 ml BT to remove any unbound IgE. The 5 ml treatments
added next included either BT for the unstimulated controls or DNP-BSA antigen at 1µg/ml for
stimulated samples; all samples included arsenic or water vehicle (cell culture water, Lonza,
Rockland, ME, USA). Dishes were incubated for exactly 5 min in a bacterial incubator at 37°C.
Immediately, dishes were placed on ice, washed once with ice-cold PBS (~5 mL), and lysed with
0.4 mL of ice-cold 1X lysis buffer containing phenylmethanesulfonyl fluoride solution for 5 min.
(The 10X lysis buffer provided in the kit was diluted with sterile water before use;100 mM
phenylmethanesulfonyl fluoride [Sigma] stock dissolved in ethanol was added at a concentration
of 1 mM immediately prior to buffer addition). Next, cells were harvested by scraping and were
placed into pre-cooled 2mL microcentrifuge tubes. Cell suspensions were sonicated three times
on ice by introducing a clean sonicating probe directly into the sample. The sonicator (Branson
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Sonifier, Branson Ultrasonics Corporation, Danbury, CT, USA) was set at output control of 5,
duty cycle of 30, Timer at 2, 1 s in duration, with a 10 s break on ice in between sonications
(these sonicating conditions were found to result in complete cell lysis; data not shown). Finally,
the sonicated lysates were spun down at 14400xg for 10 min at 4°C. A volume of 100 µL of
clarified supernatant was transferred to new, pre-cooled tubes containing 100 µL sample diluent
(provided in kit). After a brief vortex, 100 µL of each diluted sample was placed into an
appropriate ELISA well, sealed with parafilm, and incubated for 16-20 h at 4°C. The remaining
steps were carried out according to the manufacturer’s directions. Absorbance was measured
immediately after the addition of the “stop” solution.

2.4.12 Statistical analyses
Unless otherwise indicated in individual figures, results from degranulation experiments
(using Ag ± A23187 Ca2+ ionophore, Tg, or c48/80) are reported as mean ± SEM, with
significant differences determined using Graphpad Prism software (San Diego, CA, USA). For
multiple-comparison testing, Tukey’s post hoc test was used following one-way ANOVA. In
several cases, data required normalization in order to control for day-to-day variation of cell
culture; in these instances, Tukey’s comparisons are reported with regard to a low dose of the
agent used that was not significantly different from the 0 control to which all values were
normalized. In the event that normalization was not required, significance was directly made to
the 0 control.
For calcium measurement assay, the data were analyzed as areas under the curve (AUC),
a measure of total calcium response over a 30 or 60 min period. First, the fluorescence values
before antigen stimulation (baseline) were averaged, then subtracted from the corresponding
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antigen-stimulated samples’ fluorescence values. Next, those values were normalized to the last
0 ppb arsenic time point. These normalized values were used to determine AUC via Graphpad
Prism software. The AUC values were further normalized to each day’s 0 ppb arsenic AUC
value, and the data from multiple days of experiments were expressed as a bar graph. The
statistical significance was determined via one-way ANOVA with Tukey’s post hoc test
For the phospho-p85 PI3K ELISA, the average value from the antigen + 750 ppb arsenic
group was normalized to the average value from the antigen + 0 ppb arsenic group from each day
before compiling multiple experiments, and significance was determined by one-sample
unpaired t-test. For phospho-Syk ELISA, treatment samples (antigen ± 750 ppb arsenic) were
expressed as a % increase over spontaneous control (no IgE/antigen) sample, and the statistical
analysis was done by unpaired t-test.

2.5 Results
2.5.1 Short term exposure of arsenic inhibits antigen-mediated degranulation in RBL-2H3
mast cells without cytotoxicity
We have previously reported the ability of arsenic to inhibit degranulation in RBL-2H3
mast cells following 1 h exposure to DNP-BSA antigen (Ag) (Hutchinson et al., 2011) (Fig.
2.1).
We next tested whether degranulation is inhibited within 15min of antigen and arsenic
exposure. Based on initial 15-min DNP-BSA antigen dose response data (not shown), 0.0004
μg/ml DNP-BSA antigen was chosen. This antigen dose was chosen because, in the absence of
arsenic, it elicited a degranulation value of 9.4% ± 0.8% (SEM), which is similar to the response
of the 0 ppb arsenic sample in Figure 2.1(Hutchinson et al., 2011). Arsenic (750 ppb) causes a
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15% ± 2% (SEM) inhibition of the 0 ppb control value (Fig. A.1A). These data indicate the
dampening effect of arsenic on antigen-mediated degranulation begins to occur quite rapidly in
RBL mast cells. Arsenic has no significant effect on spontaneous degranulation (1.4% ± 0.1%
[SEM]) during this time period (Fig. A.1B).

Figure 2.1. Arsenic inhibits RBL-2H3 cell degranulation following 1 h exposure to
dinitrophenyl-bovine serum albumin antigen. Effects of various concentrations of arsenic on 1 h,
0.00016 μg/ml antigen-mediated degranulation were assessed as described (Hutchinson et al.,
2011). In the absence of arsenic, this antigen dose elicited an average absolute degranulation
response of 12 ± 2% (SEM; ~23% of the maximal response). Values represent means ± SEM for
five independent experiments, where three replicates per dose were performed for each
experiment. One-way ANOVA with Tukey’s post-tests (compared to the 1 ppb sample) were
performed using Graphpad Prism software; *p< 0.05, ***p< 0.001. Reprinted from (Hutchinson
et al., 2011) (Copyright 2010 John Wiley & Sons, Ltd.)

To confirm the lack of cytotoxicity of high dose arsenic (up to 1500 ppb) seen in our
previous work (Hutchinson et al., 2011), an additional cytotoxicity/mitochondrial function assay
that measures both plasma membrane integrity and ATP production was performed. ATP is
required for degranulation (Burgoyne and Morgan, 2003). Arsenic (up to 1500 ppb) is not only
non-cytotoxic, but also does not disrupt ATP production (Fig. A2), even under buffer and timing
conditions that allow for robust arsenic inhibition of antigen-stimulated degranulation (data not
shown). Due to mammalian cell generation of ATP via both oxidative phosphorylation and
glycolysis, glucose-free, galactose-containing media (“galactose media”) was utilized to avoid
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ATP production via glycolysis in this experiment (Fig. A2 A-B). In addition, neither
cytotoxicity nor ATP depletion is observed in experiments utilizing glucose-containing media
(Fig. A2 C-D), wherein cells produce sufficient ATP via glycolysis.

2.5.2 Membrane ruffling of F-actin in RBL-2H3 cells is not qualitatively affected by arsenic
RBL-2H3 cells were stained with Alexa 488-conjugated phalloidin to label F-actin and
imaged with an Olympus confocal microscope. In the absence of FcεRI engagement (treatment
with plain BT only, a “spontaneous release” control), cytoskeletal membrane ruffling is very
limited or is not observed in cells (Fig. 2.2A). As seen in Fig. 2.2B, the addition of 750 ppb
arsenic without an IgE-FcεRI crosslinking agent also does not lead to visible changes in F-actin
distribution. Conversely, when IgE-bound FcεRI receptors were crosslinked by 0.00016 μg/ml
DNP-BSA antigen, multiple membrane protrusions are observed (Fig. 2.2C). At this same
antigen concentration (0.00016 μg/ml DNP-BSA) with the addition of 750 ppb arsenic, little or
no qualitative difference is observed (Fig. 2.2D) compared to the no-arsenic control. Similar
results are obtained with a mid-range dose of 0.0004 μg/ml Ag in the presence and absence of
750 ppb arsenic (Fig. A3). In summary, co-incubation of RBL-2H3 with DNP-BSA antigen and
750 ppb arsenic does not appear to substantially affect the extent of ruffling.

2.5.3 As does not inhibit degranulation of RBL-2H3 cells when stimulated with A23187
Ca2+ ionophore
Stimulation of RBL-2H3 cell degranulation using Ca2+ ionophore has been detailed in the
scientific literature (Siraganian et al., 1975; Beaven et al., 1984; Hanson and Ziegler, 2002).
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This method of degranulation bypasses engagement of FcεRI receptors, causing Ca2+ influx
across the plasma membrane. Use of Ca2+ ionophore therefore allows identification of arsenic’s
cellular targets as being upstream or downstream of Ca2+ influx. Doses of A23187 ionophore
were selected based on their non-cytotoxicity in a lactate dehydrogenase (LDH) assay (Fig. A4),
in the presence of up to 750 ppb arsenic, which did not affect LDH enzyme activity (Fig. A5).

B)

A)

D)

C)

Figure 2 2. F-actin ruffling during antigen-stimulated degranulation of RBL-2H3 cells. F-actin
was visualized using Alexa Fluor 488 conjugated phalloidin. RBL-2H3 cells were exposed to (A)
no antigen; (B) no antigen+750 ppb arsenic; (C) 0.00016 μg/ml antigen; (D) 0.00016 μg/ml
antigen+750 ppb arsenic for 1 h before being fixed. A representative set of images is shown.

DMSO has been linked to inhibition of interleukin-8 production (Deforge et al., 1992),
decreased NF-κB activation in macrophage cells (Kelly et al., 1994), and has been shown to
activate PKC and scavenge free radicals (Ogura et al., 1995). Arsenic an oxygen radical
scavenger, DMSO has also been shown to inhibit the production of reactive oxygen species
(ROS) in experimental studies (Hei et al., 1998; Liu et al., 2001). As ROS production has been
shown to be vital to mast cell inflammatory responses (reviewed in (Swindle and Metcalfe,
2007)), and there is a strong relationship between ROS and degranulation in RBL-2H3 (Suzuki
et al., 2003), it was important that we ensure the level of DMSO used in these ionophore
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experiments does not impact degranulation in this way. We demonstrated that degranulation
experiments containing 0.004% DMSO retain statistically significant inhibition, due to arsenic,
of antigen-stimulated RBL-2H3 cells, and that DMSO at this concentration does not impact the
cell’s ability to degranulate. A two-way ANOVA in Prism was performed to compare antigenstimulated degranulation experiments in the presence and absence of 0.004% DMSO: no
statistically-significant difference was found (Fig. A6). These control data demonstrate that the
degranulation values obtained from the A23187 Ca2+ ionophore tests are not impacted by the
vehicle conditions.
We used the probe 2',7'-dichlorodihydrofluorescein diacetate (Cell Biolabs; San Diego,
CA), which measures various intracellular ROS, in order to directly test whether arsenic
modulates ROS under the treatment conditions of the degranulation experiments. Neither 500
nor 750 ppb arsenic affect intracellular ROS production at any time point measured for 1 h at 1-2
min intervals (data not shown).
Figure 5.3B
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Figure 2.3. Arsenic does not inhibit A23187 Ca2+ ionophore-stimulated degranulation in RBL2H3 cells. RBL-2H3 cells were harvested and plated as described in the “Methods” section. Cells
were stimulated to degranulate for 1 h with either (A) 1.5 x 10-7 M (which caused an average
absolute degranulation response of 11.5% ± 2.8% [SEM]) or (B) 2.0 x 10-7 M (which caused an
average absolute degranulation response of 18.1% ± 3.2% [SEM]) A23187 Ca2+ ionophore.
Resultant β-hexosaminidase was measured as described in “Methods.” Values are means ± SEM
from seven independent experiments per A23187 dose, each with three replicates per
experiment. No statistical significance was determined by one-way ANOVA followed by
Tukey’s post- test, where multiple comparisons were made to the 100 ppb sample. As, arsenic.
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Regarding the use of Ca2+ ionophore on RBL-2H3 cells, 1 h treatment of 1.5 x 10-7 M
A23187 elicited an average absolute degranulation response of 11.5% ± 2.8% (SEM) in the
absence of As (Fig.2.3A); exposure to 2.0 x 10-7 M A23187 resulted in a degranulation value of
18.1% ± 3.2% (SEM) (Fig.2.3B). Co-exposure to A23187 ionophore and arsenic (0-750 ppb)
revealed no arsenic inhibition of degranulation (Fig.2.3). The lack of an inhibitory response due
to As on Ca2+ ionophore-mediated degranulation strongly suggests a pathway target upstream of
Ca2+ influx across the plasma membrane.

2.5.4 As does not inhibit degranulation of RBL-2H3 cells when stimulated with
thapsigargin
There is a biphasic calcium modulation in RBL-2H3 cells. Before Ca2+ being shuttled
across the plasma membrane in the degranulation pathway (which we facilitated, as detailed
above, using A23187 ionophore), Ca2+ is released from internal ER stores. To investigate this
earlier Ca2+ signaling event, we utilized the pharmacological agent Tg. We have found Tg to be
extremely vulnerable to oxidation, requiring immediate use within 1-2 days of preparation. In the
absence of arsenic, the average % degranulation response for 4.6 nM Tg was 11.9 + 3.9%;
spontaneous release was 2.3 + 0.9% (mean ± SEM). As seen in Fig 2.4A, no significant
difference in Tg-stimulated degranulation is caused by arsenic (Fig. 2.4A). A series of
cytotoxicity experiments were performed to test whether 4.6 nM Tg ± arsenic is toxic to RBL2H3 cells. Trypan blue exclusion (Fig. 2.4B) and LDH (Fig. 2.4C) data demonstrate no
cytotoxicity for Tg and arsenic concentrations tested in degranulation experiments after 1 h
exposure. Collectively, these results indicate that arsenic’s cellular target is upstream of Ca2+
release from internal ER stores.
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Figure 2.4. Arsenic does not inhibit Tg -induced degranulation. (A) Relative degranulation
response of RBL-2H3 cells treated for 1hr with 4.6 nM Tg (which caused an average absolute
degranulation response of 11.9 + 3.9% [SEM]), ± As. Values represent mean ± SEM of three to
five experiments of triplicate samples per dose per experiment. A spontaneous release
measurement (no Tg or As present) is depicted for reference. No significant difference was
determined by one-way ANOVA. (B) trypan blue exclusion assays, the percentage of living cells
present in the 0 nM Tg control is plotted against concentration of Tg (1.5 and 4.6 nM); all
samples contain 750 ppb As. Values are means of two experiments, each with triplicate samples,
where data were normalized to the 0 control (with no Tg and no As, but containing Tg vehicle of
0.001% dimethyl sulfoxide). No significant difference was determined by one-way ANOVA. (C)
Short-term cytotoxicity was determined using an LDH cytotoxicity detection kit; concentration
of Tg is plotted against the percentage LDH released in the absence or presence of 750 ppb As;
values represent individual wells (n = 6-9), and error bars are SD. No significant difference was
determined by one-way ANOVA. As: arsenic; LDH, lactic dehydrogenase; Tg, thapsigargin.

2.5.5 As does not affect c48/80-mediated degranulation in RBL-2H3 cells
To establish c48/80-mediated degranulation assays as a functional means to measure
toxicant effects, it was first determined that 48 h treatment with quercetin (20 μM) followed by
15 min treatment with c48/80 (Senyshyn et al., 1998) induces statistically significant increases in
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β-hexosaminidase release by RBL-2H3 cells in a dose-dependent manner (data not shown) and
non-cytotoxic manner (Fig.2.5B). We additionally confirmed that treatment with c48/80 and
quercetin has no effect on background fluorescence as measured in the degranulation assay (data
not shown). Although we determined that 25 μg/ml c48/80 induces a non-cytotoxic increase in βhexosaminidase release in the absence of quercetin pre-treatment, this modest response is
enhanced by 48 h quercetin treatment (data not shown), allowing for greater dynamic range in
which to study potential effects due to arsenic treatment.c48/80 LDH assay (no As vs. 750ppb As)
A

B
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Figure 2.5. Arsenic does not affect c48/80-induced degranulation of RBL-2H3 cells. (A) Effect
of As on c48/80-mediated degranulation. Cells were pre-treated with quercetin and then coexposed to 25 μg/ml c48/80 (which caused an average absolute degranulation response of 7.7% ±
0.6% [SEM]) and varying concentrations of As (0-750 ppb) for 15 minutes, followed by βhexosaminidase quantification as described in “Methods.” Data were normalized to the 0 ppb As
response value of each experiment (n = 5). (B) LDH cytotoxicity assay indicating noncytotoxicity of 25 μg/ ml c48/80 treatment (n = 3). Cells were treated as in (A), and LDH release
was measured as described in “Methods.” (A-B) values represent means ± SEM; statistical
significance was determined by one-way ANOVA followed by Tukey’s post test (in A,
comparison made to 100 ppb; in B, direct comparison is made to 0 μg/ml 48/80); *p< 0.05,
***p< 0.001. As, arsenic; LDH, lactic dehydrogenase.

In Fig. 2.5A, it is clear that arsenic does not affect c48/80-mediated degranulation
responses, despite similar absolute levels of degranulation induced by c48/80 (7.7% ± 0.6%
[SEM]) to the antigen used in the 15 min assay in Fig A.1A. The lack of inhibition is not due to
synergistic cell membrane damage between compound 48/80 and arsenic, since the combination
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of c48/80 and arsenic does not cause cytotoxicity (Fig. 2.5B). While 50 ug/mL c48/80 is
cytotoxic (Fig. 2.5B), this concentration was not used in the degranulation experiments (Fig.
2.5A), which employed the non-cytotoxic dose of 25 μg/mL c48/80.

2.5.6 As inhibits antigen-stimulated Ca2+influx
Ca2+ influx is a key event in the signal transduction pathway leading to mast cell
degranulation. To directly measure cytosolic Ca2+ levels, RBL-2H3 cells were incubated with
fluo 4/AM fluorescent dye for 30 min, to allow dye uptake, and then were exposed to 0.0002
μg/ml DNP-BSA antigen ± 750ppb arsenic. Next, fluorescence indicating levels of Ca2+ inside
the cell were measured in a plate reader for 1 h post stimulation. Our data indicate that arsenic
dampens Ca2+ influx into antigen-activated mast cells (Fig. 2.6). These results suggest that
arsenic’s target lies upstream of the Ca2+ influx event.
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2.5.7 As inhibits phosphorylation of phosphoinositide 3-kinase
PI3K is involved in a variety of cell functions because it catalyzes the production of
many crucial lipid signaling molecules, including PIP2. PIP2 enables recruitment of a wide range
of proteins containing Pleckstrin homology domains, thus drawing these proteins to the plasma
membrane for activation (Abramson and Pecht, 2007). PIP2 is used by PLC γ to generate IP3, an
important player in Ca2+ mobilization (Kalesnikoff and Galli, 2008). Overall, PI3K activation
supports Ca2+ mobilization and degranulation. Therefore, we examined whether PI3K is affected
by arsenic exposure. We utilized a commercially available Fast Activated Cell-based ELISA kit,
which quantifies activated PI3K and/or total PI3K. Two primary antibodies provided from this
ELISA kit recognize either phosphorylated p85, the regulatory subunit of PI3K or total PI3K p85
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Using this ELISA, we detected a significant decrease in phosphorylation of the p85
subunit of PI3K due to 750 ppb arsenic exposure, compared to the 0 ppb arsenic group (Fig.
2.7A). Because PI3K is constitutively associated with the kit receptor and because RBL-2H3
cells’ kit receptor is known to be constitutively active, there is a high level of phosphorylated
PI3K even in the absence of Ag stimulation in RBL-2H3 cells (Tsujimura et al., 1995). Thus, the
data were normalized to the antigen-stimulated, 0 ppb arsenic samples, not to the unstimulated, 0
ppb arsenic sample. The level of total p85 protein was unchanged regardless of arsenic treatment
(Fig. 2.7B). These results suggest that arsenic interferes with antigen-activated phosphorylation
of PI3K.

2.5.8 As inhibits phosphorylation of Syk kinase
Previous studies report that the regulatory subunit (p85) of PI3K is one of the direct
binding partners of Syk protein (Okkenhaug and Vanhaesebroeck, 2003; Mocsai et al., 2010).
Since we observed the reduction of phosphorylation/activation level of PI3K (Fig. 2.7), we
sought to investigate arsenic effects on phosphorylated Syk protein using a commercially
available pan-tyrosine phosphorylated Syk ELISA. Using this ELISA, we detected significant
changes in phosphorylated Syk protein between antigen-stimulated and spontaneous-release
samples. Figure 2.8 compares antigen-stimulated samples ± 750 ppb arsenic and shows a
significant decrease in phosphorylation of Syk protein due to arsenic treatment. Phospho-Syk
ELISA data provide evidence that arsenic is interfering with early tyrosine phosphorylation
events in the degranulation pathway in mast cells.
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2.6 Discussion
Previously, we determined that arsenic’s inhibition of mast degranulation, an important
event in many physiological states and diseases, is not caused by its direct interference with the
crosslinker-IgE interaction at the IgE-bound FcεRI receptors at the plasma membrane: the level
of arsenic inhibition of crosslinker-stimulated degranulation was equivalent, regardless of the
type of crosslinker used (i.e., DNP-BSA antigen or anti-IgE IgG; as long as the absolute level of
degranulation triggered in the absence of arsenic was held constant) (Hutchinson et al., 2011).
Additionally, arsenic showed no induction of degranulation response and no inhibition of
spontaneous granule release in the absence of degranulation-triggering treatments such as IgE
receptor crosslinking (Hutchinson et al., 2011). These data indicated that crosslinking of the
FcεRI receptors is a necessary co-treatment for arsenic’s inhibition of degranulation.
The main finding of the current study is that the cellular target for arsenic inhibition of
mast cell degranulation lies early in the signaling pathway, likely involving altered
phosphorylation of tyrosine kinase Syk (Fig. 2.8) and subsequently affecting the activation of
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downstream target proteins of Syk, such as PI3K (Fig. 2.7). Syk and PI3K are both activated
rapidly (within min) after antigen exposure. In our previously published study (Hutchinson et al.,
2011), degranulation was inhibited by As in a 1 h treatment with DNP-BSA antigen. When we
examined the same DNP-BSA antigen treatment in a shorter period (15 min), we found that As
inhibits degranulation at this earlier time point as well, indicating that its effects are acute and
rapid (Fig. A.1A). We also performed experiments with chronic arsenic exposure of mast cells
and found that longer exposure of arsenic did not alter the extent of arsenic’s inhibition of
degranulation (data not shown).
Acute arsenic poisoning, at very high arsenic concentrations, can lead to inhibition of
glycolysis and cellular ATP production, due to arsenic substitution for phosphate (DeMaster and
Mitchell, 1973). While we earlier showed, via multiple methods, that arsenic is not cytotoxic to
RBL-2H3 mast cells at the concentrations used in this study (Hutchinson et al., 2011), we had
not yet determined whether arsenic affects ATP production under these experimental conditions.
Here we show that arsenic doses up to 1500 ppb do not affect ATP production (Fig A2),
suggesting that inhibition of catabolism and widespread phosphate substitution is not occurring.
Under the same glucose-free conditions, the canonical mitochondrial uncoupler carbonyl cyanide
3-chlorophenylhydrazone, which also inhibits degranulation of RBL-2H3 cells, decreases ATP
production, with an EC50 of 0.8µM – 1.6 µM (95% Cl),with no cytotoxicity (Weatherly et al.,
2016).
To narrow down arsenic’s target(s) in the mast cell signaling pathway, we investigated
whether arsenic affects the F-actin rearrangement or “membrane ruffling” in RBL-2H3 cells,
another phenotype of activated mast cells. This strategy tests for potential cellular targets for
arsenic that are common to both the degranulation and membrane ruffling pathways, such as
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PKC (Pfeiffer et al., 1985; Yanase et al., 2011). Our finding of no or a small arsenic effect on
membrane ruffling (Fig 2.2) supports the conclusion that cellular targets that are downstream of
Ca2+ influx and that are common to both degranulation and ruffling are unaffected by arsenic.
Ca2+ ionophore A23187 was utilized to bypass FcεRI and the early tyrosine
phosphorylation events and to stimulate the release of granules through the influx of Ca2+ alone
into the cell (Siraganian et al., 1975). In experiments utilizing A23187, we determined that
arsenic does not inhibit degranulation (Fig 2.3), indicating that arsenic’s pathway target is
upstream of Ca2+ influx across the plasma membrane.
We also used the pharmacological agent Tg, which is a potent, cell permeable, IP3independent intracellular Ca2+ releaser/SERCA pump blocker that acts a mast cell secretagogue
(Rasmussen and Christensen, 1978; Patkar et al., 1979). Like A23187 Ca2+ ionophore, Tg
stimulates mast cell degranulation while by passing FcεRI crosslinking and early tyrosine
phosphorylation events. However, unlike with A23187-induced cell activation, Tg stimulation
does involve STIM-1 in the ER and the plasma membrane CRAC channels. Our data indicate
that, with the use of the non-cytotoxic dose of 4.6 nM Tg to elicit degranulation, As does not
inhibit degranulation (Fig 2.4). This concentration of Tg is within the documented IC50 for
inhibiting SERCA (4-13 nM) (Calbiochem production information). Thus, these data show that
arsenic’s cellular target not only lies upstream of Ca2+ influx across the plasma membrane, but
also is not STIM-1 or other players in ER Ca2+ mobilization.
In view of the fact that c48/80 activates degranulation via PLD in a Ca2+- dependent
manner, c48/80-mediated degranulation assays can be used to measure toxicant effects on these
portions of the degranulation pathway. Because there is no arsenic effect on cells stimulated to
degranulate with c48/80 (Fig. 2.5), arsenic’s inhibitory actions on the degranulation pathway are
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likely on some portion of the pathway that lies upstream of PLD and Ca2+ influx. Combined, the
A23187 (Fig. 2.3), Tg (Fig. 2.4), and c48/80 (Fig. 2.5) data strongly suggest that arsenic’s
inhibitory action lies upstream of all calcium signaling in the degranulation pathway. In addition,
these data indicate that PKC, PLD and other enzymes activated following Ca2+ mobilization are
not arsenic’s direct targets in RBL-2H3 mast cells.
To investigate arsenic effects on events upstream of Ca2+ influx, we developed a
microplate-based assay to measure the level of cytoplasmic Ca2+ after antigen exposure, ±
arsenic, in RBL-2H3 mast cells. We found a strong inhibition of the antigen-stimulated Ca2+
level in the cells due to arsenic exposure after both 30 min and 60 min of exposure (Fig. 2.6).
The dampened Ca2+ influx into arsenic-exposed cells is another indicator that arsenic’s target lies
upstream of Ca2+ influx. Therefore, we investigated the effects of arsenic on early tyrosine
phosphorylation events, which occur immediately after FcεRI receptor activation.
Previous researchers have reported that arsenic may interfere with phosphorylation events
during signal transduction. For example, Cheng et al. (2004) found that sodium Arsenite inhibits
the Janus kinase signal transducer and activator of transcription cascade, via inhibition of
phosphorylation of STAT3 specifically at tyrosine resides (Cheng et al., 2004). Moreover, SotoPeña et al. (2008) demonstrated that arsenic can interfere with phosphorylation of the kinases
Lck and Fyn during T-cell signal transduction (Soto-Peña and Vega, 2008). In this study, we
have found that arsenic inhibits phosphorylation of both PI3K and Syk kinases in antigenactivated RBL-2H3 cells (Fig. 2.7 and 2.8), thus providing a mechanism for arsenic inhibition of
mast cell degranulation.
Arsenite has been shown in certain cases to interact with sulfhydryl groups of kinases and
to form reactive oxygen species (ROS), which affect kinase activity (Liu et al., 2001). In this
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study, we have found that arsenic does not affect ROS levels under the treatment conditions of
these experiments. However, arsenic can directly bind to sulfhydryl groups of certain proteins,
causing detrimental structural modification or denaturation (Chang et al., 2012). Syk kinase
(both human and rat) contains numerous cysteine residues, five of which are located specifically
in its kinase domain. Therefore, derangement of normal phosphorylation activity of Syk, via
arsenic-sulfhydryl interactions, may be a mechanism underlying the inhibition of both antigenstimulated Syk phosphorylation and degranulation of mast cells.
The implications of this mechanistic study can assist researchers to better understand a
mode of arsenic toxicity that is likely to not be organism-specific or even mast-cell specific.
Classic immunoreceptors, such as B cell receptors, T cell receptors, and Fc receptors, signal via
similar mechanisms, and the signal transduction pathways present in mast cells share many
similarities with those of T and B cells. Arsenic’s inhibition of Syk activity (and, subsequently,
PI3K) in mast cells suggests that arsenic inhibits Syk and similar proteins in the same manner in
numerous cell types. Syk has garnered attention as a potentially novel target for treatment of
allergic and inflammatory disorders (Wong et al., 2004; Ulanova et al., 2005; Bajpai et al.,
2008). Because arsenic has now been shown to inhibit this vital process in allergy and asthma
development, mast cell degranulation, our data strongly suggest that Syk could be a drug target
to treat these diseases.
In fact, arsenic has been employed in Chinese medicine to treat asthma (ATSDR, 2007).
While arsenic inhibition of mast cells in vivo has not yet been directly demonstrated, arsenic has
been shown to block anaphylactic responses in guinea pigs (Poriadin et al., 1977) and to alleviate
asthma responses in mice (Zhou et al., 2006; Chu et al., 2010). Also, arsenic-exposed, parasiteinfected children in Bangladesh were found to be thinner than controls also exposed to parasites
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but not to arsenic (Minamoto et al., 2005), a result that suggests that arsenic exposure could
inhibit mast cells in vivo, thus increasing helminth burden and wasting. Inhibition of mast cell
function by arsenic was not offered as an explanation for these findings but is a possible
mechanism of the in vivo effects described in these studies.
In conclusion, we have shown that arsenic inhibits mast cell degranulation at
environmentally relevant, non-cytotoxic doses, via inhibition of early tyrosine phosphorylation
events. These data provide a molecular mechanism for arsenic’s effects on this ubiquitous cell
type and suggest that As will have similar molecular targets in many additional cell types.
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CHAPTER 3
MOLECULAR MECHANISMS UNDERLYING ANTIMICROBIAL AGENT
TRICLOSAN’S INHIBITION OF MAST CELL SIGNALING: ROLES
OF PROTEIN KINASE C AND PHOSPHOLIPASE D
3.1 Abstract
Humans are exposed to antimicrobial agent triclosan (TCS) through use of TCScontaining products. Exposed tissues contain mast cells, which are involved in numerous
biological functions and diseases by secreting various chemical mediators through a process
termed degranulation. We previously demonstrated that TCS inhibits mast cell degranulation.
Previously, we discovered that TCS inhibits Ca2+ influx into antigen (Ag)-stimulated mast cells.
Here, we have investigated TCS effects on protein kinase C (PKC) and phospholipase D (PLD),
crucial signaling enzymes that are activated downstream of Ca2+ rise. Using fluorescent
constructs and confocal microscopy, we found that TCS delays the timing Ag-induced
translocations of PKC βII, PKC δ, and PKC substrate MARCKS, even while the overall ability
of these molecules to translocate is unaffected by TCS. Surprisingly, TCS does not inhibit PKC
activity and actually increases PKC activity by 45 min post Ag. While TCS does not
significantly affect the ability of PLD1 to translocate toward the plasma membrane in response to
Ag stimulation, TCS does strongly inhibit overall PLD activity within 15 min post Ag. Our
studies elucidate the biochemical mechanisms underlying triclosan’s inhibition of degranulation
and pinpoint the timing of defects by TCS on the mast cell signaling pathway. These results
offer molecular predictions of triclosan’s effects on other mammalian cell types which share
these crucial signal transduction elements and provide explanations for recent epidemiological
findings implicating TCS in human health problems.
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3.2 Introduction
Triclosan (TCS) is a synthetic antimicrobial agent that was recently banned by the FDA
from both consumer (Kux, 2016) and hospital soap products (Fischer, 2017). However, TCS still
remains, at high concentrations, in other top-selling consumer products, such as toothpaste and in
other “antibacterial” household products (e.g., toys, kitchenware, etc.). TCS from consumer
products is readily absorbed when applied to human tissues, where it is not rapidly metabolized
or cleared. The resulting human tissue levels are comparable to exposure levels used in this
current cell study (TCS exposure is reviewed in (Weatherly and Gosse, 2017)). Additionally,
micromolar levels of TCS have been found in human body fluids in several published studies
(also reviewed in (Weatherly and Gosse, 2017)). Thus, TCS dosages used in this current
manuscript (10 µM in cell media for ≤ 1h) are directly relevant to actual human exposures to
TCS products such as toothpaste.
Clinically, TCS has been used primarily as an antimicrobial (Daoud et al., 2014) and
anti-gingival (Rover and Leu-Wai-See, 2014), and there have also been some potentially positive
findings of TCS treatment of atopic dermatitis (Tan et al., 2010), which may be due to triclosan’s
ability to inhibit mast cell function (Palmer et al., 2012). However, numerous recent
epidemiological studies report detrimental TCS effects on human health, including problems
with thyroid function (Wang et al., 2017), reproduction (Hua et al., 2017), immune function,
development (Wei et al., 2017) (reviewed in (Weatherly and Gosse, 2017)). Additional recent
epidemiological studies have also revealed increased risks of gestational diabetes (Ouyang et al.,
2018), abnormalities of sperm morphology (Jurewicz et al., 2018), and lowered cognitive test
scores in children (Jackson-Browne et al., 2018), due to triclosan exposure. The cellular,
molecular, and biochemical reasons for these health effects of TCS are not completely
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understood but include mitochondrial toxicity (Ajao et al., 2015; Shim et al., 2016b; Weatherly
et al., 2016), reactive oxygen species (ROS) generation (Lv et al., 2016), interference with
cellular calcium dynamics (Ahn et al., 2008; Cherednichenko et al., 2012; Weatherly et al.,
2018), endocrine disruption (Ruszkiewicz et al., 2017), and modulation of cytokine gene
expression (Yueh et al., 2014; Marshall et al., 2015).
As noted above, TCS inhibits mast cell (MC) function (Palmer et al., 2012; Weatherly et
al., 2013). MCs are found in nearly every human body tissue and in numerous other species
(Kuby, 1997). They are particularly enriched in tissues subject to contact with outside
environmental stimuli, such as the skin, gastrointestinal tract, oral mucosa (Walsh, 2003), and
respiratory mucosa (Abraham and St John, 2010)—and thus are targets for exposure to chemicals
from personal care product application. MCs are key players in many physiological and
pathological processes including allergy, asthma, autoimmunity, infectious disease, cancer, and
even many central nervous system disorders such as autism, anxiety, and multiple sclerosis
(Metcalfe et al., 1997; Williams and Galli, 2000; Galli et al., 2005a; Silver and Curley, 2013;
Girolamo et al., 2017). Therefore, inhibition of MC function has many potential consequences
on human health. Many of the biochemical events crucial to MC function (such as cytoskeletal
involvement, calcium signaling, protein kinase C, etc.) are also essential to signaling in
numerous distinct cell types, including neurons and T cells. Thus, discovery of the biochemical
mechanisms underlying TCS disruption of MCs leads to predictions of TCS effects in disparate
cell types that share common signal transduction elements.
Mast cells are activated by binding of multivalent antigen (Ag) to immunoglobulin E
(IgE)-bound cell surface FcεRI receptors (Kinet et al., 1983), resulting in secretion of
cytoplasmic granules which contain mediators such as histamine, tryptase, β-hexosaminidase,
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serotonin, cytokines, chemokines, and lipid mediators (Schwartz and Austen, 1980). This process
is termed as mast cell degranulation. FcεRI crosslinking by Ag leads to a tyrosine
phosphorylation cascade that activates phospholipase C (PLC) γ, which catalyzes the hydrolysis
of phosphatidylinositol 4,5-bisphosphate (PIP2) to yield diacylglycerol (DAG) and inositol 1,4,5trisphosphate (IP3). While DAG activates protein kinase C (PKC) (Steinberg, 2008), IP3 binds to
its receptor in the endoplasmic reticulum (ER) causes an efflux of Ca2+ from the ER (Berridge,
1993), into the cytosol and also into mitochondria (Takekawa et al., 2012; Furuno et al., 2015).
Next, calcium release-activated calcium (CRAC) channels in the plasma membrane are
activated, resulting in a flood of calcium into the cytosol (Putney et al., 2001).
Within the cytosol, this elevated Ca2+, along with DAG and ROS (Swindle et al., 2004),
binds to and activates the Ser/Thr family of protein kinase C (PKC) (Ozawa et al., 1993b;
Steinberg, 2008). PKC isozymes are categorized into three subfamilies (classical [cPKC], novel
[nPKC], and atypical [aPKC]), according to their biochemical and structural properties, such as
their binding to DAG and/or Ca2+ (Ozawa et al., 1993b; Newton, 1995; Newton, 2001). Of
particular importance in mast cells are certain cPKC isoforms (PKC α, βI, βII, and γ), which
have conserved C1 domains (which bind DAG) (Newton, 2001) and C2 domains (which bind
Ca2+ and acidic phospholipids). Also important to mast cell function are certain nPKC isoforms
(PKC δ, ε, θ, and η), which are activated by DAG by binding to the C1 domain but which are
lacking functional C2 domains and, thus, are lacking Ca2+ responsiveness (Newton, 1995). In
addition to DAG, activators of PKC δ include various agents such as phorbol esters, UV or
ionizing radiation, growth factors, and ROS (Yoshida, 2007; Lee and Yang, 2010). PKC β and
δ, which belong to cPKC and nPKC, respectively, are particularly important in IgE–mediated
mast cell degranulation (Nechushtan et al., 2000; Cho et al., 2004; Yanase et al., 2011).
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Stimulation of RBL-2H3 cells with either Ag or Ca2+ ionophore causes a rapid translocation of
PKC δ from the cytosol to the plasma membrane (Cho et al., 2004). Also, PKC δ translocation
and degranulation are both activated by ROS generation in mast cells (Cho et al., 2004).
Activation of PKC causes its translocation from the cytosol to the plasma membrane,
serving as a hallmark for PKC activation (Kraft and Anderson, 1983). Inactive PKC is located in
the cytosol and autoinhibited by a pseudosubstrate (Nishizuka, 1995; Brown and Kholodenko,
1999). When Ca2+ binds to cytosolic PKC and alters its electrostatics and, hence, membrane lipid
affinity (Codazzi et al., 2001), it can then bind DAG in the plasma membrane, leading to full
activation of PKC by removal of pseudosubstrate from the active site. In other cases, DAG alone
can recruit cytosolic PKC to the plasma membrane and induce conformational changes to
activate PKC (Nishizuka, 1995; Jaken and Parker, 2000). Once PKC is translocated and active,
it phosphorylates substrates in its proximity in or near the plasma membrane. One PKC substrate
is myosin, the phosphorylation of which is important for actin cytoskeletal rearrangements
(“membrane ruffling”) and degranulation (Ludowyke et al., 1989; Choi et al., 1994).
Another of PKC’s substrates is myristoylated alanine-rich C-kinase substrate (MARCKS)
(Aderem, 1992). In unstimulated cells, MARCKS tightly binds to PIP2 at the inner leaflet of the
plasma membrane (Heo et al., 2006). When phosphorylated by activated/translocated PKC,
MARCKS dissociates from the plasma membrane and enters the cytosol, thus exposing PIP2 to
be accessible to other proteins (such as PLC γ, for generation of more second messengers) for
signaling leading to degranulation (Gadi et al., 2011). In addition, along with Ca2+, PIP2 is
involved in the soluble N-ethylmaleimide–sensitive factor attachment protein receptor
(SNARE)-mediated exocytotic machinery required for degranulation (Tadokoro et al., 2015).
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Another major target of PKC is phospholipase D (PLD). Increases in intracellular Ca2+
and PKC translocation work in tandem to activate PLD in mast cells (Lin and Gilfillan, 1992) .
Although there are many studies in other cell types showing that intracellular Ca2+ activates PLD
activity (Exton, 1999; Qin et al., 2009), the mechanisms of PLD activation by Ca2+ remain to be
elucidated. Structural analyses have shown that mammalian PLD does not contain a Ca2+
binding domain but does contain lipid (PIP3 and PIP2) -binding domains and a PKC-binding
domain (Henage et al., 2006; Selvy et al., 2011). While a study showed that mammalian PLD
activity is insensitive to changes in cytosolic Ca2+ concentration in vitro (Hammond et al., 1997),
Ca2+ and PIP2 act as essential cofactors for mammalian PLD activation within cells (Sciorra et
al., 2002; Henage et al., 2006; Selvy et al., 2011). PLD activation involves Ca2+-dependent
PKC isoforms (Wakelam et al., 1997; Qin et al., 2009). A study using RBL-2H3 mast cells
showed that PKC inhibitors decrease PLD activity and, subsequently, inhibit degranulation,
suggesting a close relationship between PKC/PLD activation and degranulation in mast cells
(Chahdi et al., 2002).
PLD hydrolyzes phosphatidylcholine, creating phosphatidic acid (PA), an important
second messenger for numerous cellular functions (Wakelam et al., 1997; Cockcroft, 2001;
O'Luanaigh et al., 2002; Zeniou-Meyer et al., 2007). PA stimulates PLC γ (Nishizuka, 1995)
and also can be converted directly into DAG by PA phosphohydrolase—leading to a secondary
rise in intracellular DAG levels (Nakashima et al., 1991). These increases in DAG are involved
in activation of the DAG-dependent PKC isoforms (Baldassare et al., 1992; Nishizuka, 1995;
Peng and Beaven, 2005), suggesting that PKC-PLD activation is closely regulated in a
complementary manner between the two enzymes in mast cells. Additionally, PA plays a critical
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role in regulating mast cell morphology (Marchini-Alves et al., 2012). Continual activity of
PLD2 is required for membrane ruffling in mast cells (O'Luanaigh et al., 2002).
Two mammalian isoforms, PLD1 and PLD 2, are expressed in mast cells. PLD1 localizes
to cytoplasmic granules and has low basal activity whereas PLD2 is constitutively expressed at a
high level and is located at the plasma membrane (Choi et al., 2002; Lee et al., 2006).
Stimulation of mast cells activates both PLD isoforms, but only PLD1 undergoes translocation to
the plasma membrane and drastic upregulation of its activity (Brown et al., 1998). Even though
many studies have agreed on the location and expression of PLD isoforms in mast cells, there
have been controversial and conflicting data regarding the functions of these isoforms. Several
studies have reported positive roles of both PLD isoforms in mast cell degranulation (Brown et
al., 1998; Chahdi et al., 2002; Peng and Beaven, 2005; Lee et al., 2006), with PLD1 involved
in granule translocation and with PLD2 involved in membrane fusion of these granules (Choi et
al., 2002). However, one intriguing recent study using PLD1- and PLD2-knockout mice found
that PLD1 positively regulates degranulation, while PLD2 is a negative regulator (PLD2
deficiency enhanced microtubule formation) (Zhu et al., 2015).
Microtubule polymerization is another essential player: granules are mobilized to the
plasma membrane along microtubules for degranulation (Smith et al., 2003). Agents that inhibit
microtubule polymerization inhibit degranulation (Urata and Siraganian, 1985; Tasaka et al.,
1991; Marti-Verdeaux et al., 2003). Once granules are moved to the plasma membrane, they
dock and fuse to the membrane with the help of PLD and multiple SNAREs in a Ca2+-dependent
process (Guo et al., 1998; Baram et al., 1999; Paumet et al., 2000; Blank et al., 2002; Woska
and Gillespie, 2012), resulting in degranulation.
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Previously, we discovered that non-cytotoxic doses of TCS (5-20 μM), within 1 hour (15
min-1 hour) cause strong, dose-dependent inhibition of degranulation (in either the rat mast cell
model RBL-2H3 or the human mast cell line HMC-1) (Palmer et al., 2012; Weatherly et al.,
2013; Weatherly et al., 2016), and here we have sought to determine the underlying molecular
mechanisms. Recently, we discovered that TCS drastically interferes with mast cell Ca2+
dynamics, at the ER, mitochondria, and cytosolic influx across the plasma membrane (Weatherly
et al., 2018). Therefore, we hypothesized that the cellular translocation and activity of Ca2+activated PKC and PLD enzymes, as well as the translocation of PKC substrate MARCKS,
would be inhibited by TCS exposure.
Here, we report that the effects of TCS on PKC, MARCKS, and PLD localization and
activity in Ag-stimulated RBL-2H3 mast cells using biochemical assays and live-cell/real-time
confocal microscopy. We have discovered that TCS delays translocation of PKC βII and δ to the
plasma membrane and subsequently delays MARCKS dissociation from the plasma membrane,
even while, surprisingly, overall PKC activity is uninhibited by TCS. Furthermore, we found that
PLD activity in Ag-stimulated RBL-2H3 mast cells is decreased even while PLD1 translocation
is unaffected by TCS. Together with our earlier published findings, these results paint a
mechanistic picture of triclosan’s mode of action on mast cells and pinpoint the timing of TCSinduced defects in the mast cell signaling pathway.

3.3 Methods
3.3.1 Chemicals and reagents
TCS (99%; Sigma-Aldrich) was freshly prepared each day in aqueous Tyrodes buffer as
described in (Weatherly et al., 2013) and was used at non-cytotoxic doses (Palmer et al., 2012).
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5-Fluoro-2-indolyl des-chlorohalopemide (FIPI) (Calbiochem) was dissolved in 100% DMSO to
obtain 1 mM stock. Further dilutions were made in bovine serum albumin (BSA)-Tyrodes (BT)
buffer to make 75nM (0.0075% DMSO) and 150 nM (0.015% DMSO). Phenylmethanesulfonyl
fluoride (PMSF; Sigma) was dissolved in 100% ethanol to be 200 mM and was stored at -20 °C.

3.3.2 Cell culture
RBL-2H3 (“RBL”) mast cells were cultured as in (Hutchinson et al., 2011) and
(Weatherly et al., 2013).

3.3.3 Protein kinase C activity assay (ELISA)
A PKC Kinase activity kit (Enzo Life Science) was used to simultaneously measure the
activity of multiple PKC isoforms (PKC α, βI, βII, γ, δ, ε, η, and θ). RBL-2H3 cells were plated
in 10 cm2 tissue culture-treated sterile dishes (Greiner Bio-One) (1.14 × 107 cells per dish, in 6.5
mL media) and were incubated overnight (12–16 h) at 37 °C/5% CO2. The following day, cells
were sensitized with 0.1 μg/mL monoclonal anti-dinitrophenol (DNP) mouse immunoglobulin E
(IgE; Sigma-Aldrich) for 1 hour at 37 °C/5% CO2 in RBL media. After IgE sensitization, spent
IgE media was discarded, and cells were washed with warm BT to remove excess IgE. Next,
cells were exposed to either BT (control) or multivalent DNP–BSA antigen (Ag) in BT ± 10 μM
TCS for 10 to 45 minutes at 37 °C. Cell lysis buffer (1X; Cell Signaling Technology) was
prepared from 10X stock, via dilution in PBS. Immediately before use, PMSF was added to this
1X cell lysis buffer for a final concentration of 1mM PMSF. After incubation, cells were washed
with ice-cold PBS, then incubated for 1.5 minutes on ice with 400µL of ice-cold 1X cell lysis
buffer containing 1mM PMSF. Next, cells were harvested by cell scraper (Falcon) and were
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placed into pre-chilled microcentrifuge tubes and further lysed using a sonicator (Branson
Sonifier, Branson Ultrasonics Corporation; set at output control 5 Watts, duty cycle of 30, 1 sec
duration per sonication pulse, with a 5 sec break on ice in between sonications). Finally, the
sonicated cells were centrifuged at 14,400xg for 10 minutes at 4°C, and lysate supernatants
(technical duplicates, 30 µL per ELISA well, from each cell lysate) were used in the ELISA
following the manufacturer’s protocol (except 1x lysis buffer was used as a background in place
of the kinase assay dilution buffer included in the kit). PKC activity was determined by
measuring the absorbance at 450 nm using a microplate reader (Synergy 2; Biotek). During the
90 min primary antibody incubation step of the PKC ELISA, a 25 µL aliquot of the remaining of
cell supernatant of each sample was diverted for use in total protein concentration determination.
The bicinchoninic acid (BCA) assay was performed, using Pierce BCA protein assay kit
(Thermo), following the manufacturer’s protocol.
Raw absorbance ELISA data were processed by first subtracting average background
values (kit reagents in 1X lysis buffer with no cell supernatant) from each sample, and the
background-subtracted duplicates were then averaged. These values were then divided by the
total protein concentration of that particular sample, and finally were normalized to the
unstimulated (no Ag) control for each experimental day. The percent increase of PKC activity
over control was determined by subtracting the normalized control value from the normalized Ag
or Ag + TCS values and dividing this number by the control value.

3.3.4 Confocal imaging
RBL-2H3 cells were transfected via electroporation using Amaxa Nucleofector kit T
(Lonza) as described in (Weatherly et al., 2018). Constructs used were YFP-PKCβII-YFP (a gift
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from Alexandra Newton; Addgene plasmid #14866; “PKC βII”; (Violin et al., 2003)), GFPPKCδ -C1(2) (a gift from Tobias Meyer; Addgene plasmid # 21216; (Codazzi et al., 2001)),
mRFP-MARCKS-ED (generously provided by Dr. Barbara Baird and Dr. David Holowka,
Cornell University; “MARCKS”; (Gadi et al., 2011)), or PLD1-EGFP construct (generously
provided by Dr. Michael Frohman of Stony Brook University and Dr. Shamshad Cockcroft of
University College London; (O'Luanaigh et al., 2002; Du et al., 2003)). Regarding GFP-PKCδC1(2) (sometimes referred to herein as “PKC δ”), this short form of PKC δ, which only contains
C1 (2) domains, has previously been employed to effectively investigate PKC δ translocation
(Codazzi et al., 2001; Mogami et al., 2003). Both PKC constructs were cloned from R.
norvegicus (rat) (Codazzi et al., 2001; Violin et al., 2003), and MARCKS-ED and PLD1 DNA
were from human (Du et al., 2003; Gadi et al., 2011). The percent identities of PKC β, PKC δ,
ED domain of MARCKS, and PLD1, between human and rat, from pairwise alignments using
NIH Blast, are 98%, 90%, 96%, and 87%, respectively.
Following electroporation, cells were plated (100,000 or 125,000 cells/well in 8-well
ibidi plates) for overnight incubation in phenol red-free media (recipe is found in (Weatherly et
al., 2018)), then sensitized with IgE, stimulated with Ag, and imaged via confocal microscopy as
detailed in (Weatherly et al., 2018). For YFP-PKCβII-YFP, GFP-PKCδ-C1(2), and PLD1EGFP, a 30 milliwatt multi-argon laser (515nm excitation for YFP and 488 nm excitation for
GFP and EGFP, emission 505-605 nm bandpass filter) was used. For mRFP-MARCKS-ED, a 1
milliwatt HeNe-Green laser (543 nm excitation, 560-660 nm emission filter) was used. Image
acquisition speed was 10 µs/pixel.
Images were then analyzed using NIH Fiji ImageJ software to examine individual
transfected cells from each experiment. Only cells that appeared healthy (in DIC images), in
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focus, and fluorescent above background (autofluorescence) levels were utilized for analysis. To
determine the “percentage translocation of transfected cells,” each transfected cell with
movement of the fluorescent construct to (or, for mRFP-MARCKS-ED, away from) the plasma
membrane at any time point during the 10 min post-Ag exposure video acquisition was noted,
and the total percentage of transfected cells that underwent this movement was calculated. For
only transfected cells that underwent translocation, the “time to first translocation” was defined
as the time stamp of first image frame in which PKC moved to the plasma membrane, exhibiting
a clear complete ring formation around the plasma membrane (in the case of mRFP-MARCKSED, the time stamp utilized was that of the first image frame showing movement of the construct
away from the plasma membrane).
As a control to verify triclosan’s ability to inhibit mast cell function under these
experimental conditions, the percentage of membrane ruffling, of transfected cells only, was
calculated: differential interference contrast images were collected along with fluorescence
images, and construct-transfected cells undergoing classical membrane ruffling (Palmer et al.,
2012) post Ag exposure were noted, as a percentage of all transfected cells, ± TCS.

3.3.5 Phospholipase D Activity assay
To examine PLD activity, the Amplex® Red phospholipase D assay kit (Molecular
Probes) (which measures activity of both isoforms PLD1 and PLD2 simultaneously) was
utilized. The kit reagents were prepared as described in the manufacturer’s protocol with the
exception of using Tyrode’s buffer in place of 1X Reaction Buffer.
RBL-2H3 cells (1.5 × 106 per well) were plated in tissue culture-treated, sterile 6-well
plates (Greiner Bio-One) and incubated overnight (12–16 h) at 37 °C/5% CO2. On the second
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day, cells were sensitized with IgE, then washed with BT as described in the “Protein kinase C
activity assay (ELISA)” section above. Cell samples were then exposed to either BT or Ag (0.1
or 0.001 μg/ mL), ± TCS or FIPI for 15 min at 37 °C. Immediately following this exposure, cells
were placed on ice and washed with ice-cold PBS buffer. Triton-X 100 (Surfact-Amps X-100,
10%, low carbonyl and peroxide; Thermo; “TX”) was diluted to 0.2% TX in PBS (Lonza). After
removing all traces of the wash buffer, this 0.2% Triton-X (TX) buffer was added to the cells
(300 μL/well). Next, cells were harvested by cell scraper (Falcon) into microcentrifuge tubes on
ice, thoroughly vortexed and underwent a freeze-thaw cycle using liquid nitrogen immersion for
30 seconds, followed by room temperature thawing. Lysed cells were then centrifuged for 10
min at 14,400xg at 4°C. Each sample’s supernatant (100 μL/well) was then transferred to a well
within a black-side, clear-bottom, sterile 96-well plate (Greiner Bio-One), in technical
duplicates. Background fluorescence was measured by preparing control samples with 0.2% TX
in PBS. The remaining steps were carried out according to the manufacturer’s directions. PLD
activity was determined by measuring fluorescence intensity by microplate reader (Synergy 2;
Biotek) at 530/25 nm excitation and 590/35 nm emission.
Raw data were processed by subtracting average background fluorescence (substrate and
kit reagents in 0.2% TX-PBS with no cell supernatant) from each sample, and the backgroundsubtracted duplicates were then averaged. These values were then normalized to the unstimulated
(no Ag) control for each experimental day. The percent increase of PLD activity over control
was determined by subtracting the normalized control value from the normalized Ag or Ag +
TCS values and dividing this number by the control value.
The effect of TCS on the activity of purified PLD from Arachis hypogaea and
Streptomyces chromofuscus was measured as described above, except these purified PLD
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preparations were used in place of supernatant from the cell lysates. Purified PLD from
Streptomyces chromofuscus (Sigma), purchased as a glycerol stock (50,000 units/mL), was
diluted to be 0.125 units/mL in 0.2% TX-PBS before being used in the assay. Purified PLD from
Arachis hypogaea (Sigma) was purchased as a lyophilized powder and first reconstituted in
Tyrode’s buffer to 500 units/mL and then further diluted in 0.2% TX-PBS to a final
concentration to be 2.5 units/mL. Because the optimal temperature for Arachis hypogaea PLD is
at 30°C, experiments with this PLD, which were carried out at 37°C in order to match the
cellular experiments, were performed with extended exposure time with TCS: 1 hour, instead of
15 min.

3.3.6 Degranulation Assay
Degranulation was assayed via detection of β-hexosaminidase, a granule marker, as
described in (Weatherly et al., 2013).

3.3.7 Statistical analyses
All analyses were done in Graphpad Prism. Numbers of technical replicates and
independent days of experiments are noted each figure legend. Significance levels were assessed
via one-tailed t-tests or one-way ANOVA with Tukey’s post-hoc tests.

3.4 Results
We previously showed that, within a 60 minute co-exposure to TCS and antigen (Ag),
non-cytotoxic TCS doses (5 µM and higher) inhibit RBL-2H3 mast cell degranulation elicited by
a wide range of Ag doses (Palmer et al., 2012), including doses that elicit either minimal or
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maximal degranulation responses. Additionally, modest amounts of degranulation (~7%
absolute degranulation) elicited by short 15 min exposures to low Ag doses are inhibited by TCS
during as few as 15 min of co-exposure (Palmer et al., 2012). However, the higher levels of
degranulation (~35% absolute degranulation) elicited by high Ag doses (0.005 and 0.1μg/mL,
used throughout much of this current manuscript) are not inhibited within the first 10 to 15 min
of TCS exposure (data not shown) –even as degranulation is eventually and robustly inhibited by
TCS within the full hour of co-exposure (Palmer et al., 2012). In this study, we have examined
TCS effects on several of the biochemical events that lead to full degranulation within 60 min of
Ag exposure in order to pinpoint the timing of the molecular mechanisms leading to TCS
inhibition of mast cell degranulation.

3.4.1 Triclosan increases protein kinase C activity in Ag-stimulated RBL-2H3 mast cells.
PKC is a key signaling enzyme involved in mast cell degranulation (Ludowyke et al.,
1989; Ozawa et al., 1993a; Gadi et al., 2011), and is activated by Ca2+ (Kang and Othmer,
2007; van Rossum and Patterson, 2009; Land and Rubin, 2017) and by diacylglycerol (Ozawa
et al., 1993b; Steinberg, 2008). Because TCS decreases cytosolic Ca2+ mobilization (Weatherly
et al., 2018), we hypothesized that TCS inhibits PKC activity, thereby inhibiting degranulation in
mast cells. To probe this hypothesis, we utilized a PKC activity ELISA (Enzo life science) that
measures the activity of eight PKC isoforms (α, βI, βII, γ, δ, ε, η, and θ) simultaneously.
RBL-2H3 (RBL) mast cells were stimulated by 0.1μg/mL DNP-BSA Ag for 10 min, or
by 0.005 μg/mL DNP-BSA Ag for 15, 30, and 45 minutes, with and without 10 μM TCS. A
control (no Ag stimulation) was also prepared. The lysates from each of the cell samples were
used in the PKC activity ELISA. These data were normalized by the total protein concentration
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values. Exposure of RBL cells to 0.1μg/ml Ag for 10 minutes causes a robust (~67%) increase in
PKC activity over controls, as expected (Fig. 3.1A).

Figure 3.1. TCS effects on PKC activity in Ag-stimulated RBL-2H3 mast cells. Cells were
stimulated with 0.1 g/ml Ag ± 10 µM TCS for 10 min (A) or with 0.005 g/ml Ag ± 10 µM
TCS for 45 min (B) in BT. After exposure, PKC activity was measured via ELISA, and
absorbance was read at 450 nm using a microplate reader. Raw data were processed as described
in the Methods section to normalize to both total protein concentration and to unstimulated
controls, in order to calculate percentage increase of PKC activity over unstimulated control.
Data presented are means ± SEM of at least three independent experiments; duplicates per
treatment per experiment. Statistically significant results, comparing Ag-stimulated cells ± TCS
exposure, are represented by * p < 0.05, determined by one-tailed t-test.

Surprisingly, TCS has no effect on the ability of Ag to stimulate PKC activity at this 10
min timepoint (Fig.3.1A). Because cytosolic Ca2+ levels are only inhibited by ~10% by TCS
within the first 10 min of Ag co-exposure, next we hypothesized that later time points would
reveal TCS inhibition of PKC activity due to the greater reduction in cytosolic Ca2+ (compared to
Ag-only control) caused by TCS at 15 min (~20% inhibition) and 60 min (~50% inhibition) postAg stimulation (Weatherly et al., 2018). However, similar results were found in 15 and 30 min
exposure experiments (Fig. B1), which showed robust Ag-stimulated increases in PKC activity
that are, again, unaffected by TCS (Fig. B1A-B). Interestingly, there is a significant TCSinduced increase in Ag-stimulated PKC activity at the 45 min time point (Fig 3.1B). Previous
researchers showed that reactive oxygen species (ROS) can activate certain PKC isoforms
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(thereby activating degranulation) (Bouwman et al., 2004; Lee and Yang, 2010). Also, we had
previously found that ROS levels are increased by TCS exposure of Ag-stimulated RBL cells at
this 45 min timepoint (Weatherly et al., 2018), which may explain triclosan’s activation of PKC
at 45 min (Fig. 3.1B).

3.4.2 Triclosan delays PKC βII and PKC δ translocation to plasma membrane in Agstimulated RBL-2H3 mast cells
Because the ELISA assay of PKC activation simultaneously measures eight PKC
isoforms (Fig. 3.1), we hypothesized that potential TCS inhibition of key isoforms essential for
degranulation may be masked by that measurement method. Previous studies have reported that
PKC β and PKC δ isoforms are particularly important for mast cell degranulation (Nechushtan et
al., 2000; Cho et al., 2004), so we investigated the activation of those individual key isoforms
by monitoring their translocation using confocal microscopy. PKC translocation, to the plasma
membrane, is known to be a hallmark of its activation (Mochly-Rosen et al., 1990). Thus, we
utilized YFP-PKC βII-YFP and PKC δ C1 (2)-EGFP plasmids and transfected them via
electroporation into RBL-2H3 mast cells, for transient expression. The translocation of PKC in
real time in live cells over the course of 10 minutes was imaged by confocal microscopy.
In unstimulated RBL mast cells, the majority of PKC βII and PKC δ are located in the
cytosol (as shown in representative still frame images from the videos; “Control [No Ag]”
columns in Fig. 3.2A, 3.3A). Antigen (0.005μg/mL) stimulation causes both PKC isoforms to
translocate rapidly to the plasma membrane (Fig. 3.2A, 3.2C, 3.3A, 3.3C). While addition of
Ag+10 µM TCS does not affect the overall spatial translocation to the plasma membrane
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compared to Ag-alone (Fig. 3.2A-B, 3.3A-B), temporal translocations of both PKC βII and PKC
δ are delayed significantly by TCS (Fig. 3.2C, 3.3C, Table 3.1).

Figure 3.2. TCS effects on PKC βII translocation to the plasma membrane in Ag-stimulated
RBL-2H3 cells. RBL cells were transfected with the YFP-PKC βII-YFP plasmid. Live cell timelapse images were taken for 10 min immediately after addition of 0.005 µg/ml Ag or 0.005
µg/ml Ag + 10 µM TCS in the cells by confocal fluorescence microscopy. Representative
images per group, pre-exposure and at ~200 sec post-exposure are shown in (A). Scale bar, 10
µm. As described in Methods, the percentage of transfected cells with PKC βII that translocated
from the cytosol to the plasma membrane within 10 min post addition of Ag ± 10 µM TCS are
plotted in (B); first time of this translocation is plotted in (C). As a control showing cellular
inhibition by TCS, the percentage of transfected cells undergoing membrane ruffling within 10
min (D) was calculated using Fiji image J. For (B-D), values presented are derived from analysis
of N= 43 for Ag-only cells and N=50 for Ag + 10 µM TCS cells. Percentage translocation and
percentage ruffling values in (B) and (D) are from six independent days of imaging, ± SEM.
Translocation time values in (C) are averages over the 43 (Ag) and 50 (Ag + 10 M TCS) cells,
± SEM. Statistically significant results, comparing Ag-stimulated cells ± TCS exposure, are
represented by * p<0.05, ** p<0.01, determined by one-tailed t-test.
Analyses of individual cells revealed that about two-thirds of transfected cells expressing
PKC βII and nearly all cells expressing PKC δ undergo PKC translocation to the plasma
membrane within 10 min of Ag stimulation, regardless of TCS exposure (Fig. 3.2B, 3.3B). Also
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in both PKC βII- and PKC δ-transfected cells, following the first rapid translocation to the
plasma membrane, periodic oscillations of PKC translocation between the plasma membrane and
the cytosol were observed in Ag-stimulated cells, and were unaffected by TCS exposure (data
not shown); these oscillations were previously documented for PKC βI in RBL cells (Gadi et al.,
2011). However, the average time for PKC to translocate to the plasma membrane for the first
time is increased significantly by TCS: a delay of about 80 sec for both PKC βII and PKC δ)
(Fig. 3.2C, 3.3C, Table 3.1).
To verify that TCS does, indeed, inhibit mast cell function under these experimental
conditions (10 min of imaging of individual PKC-transfected, Ag-stimulated RBLs), we utilized
the previously-shown TCS inhibitory effect on mast cell ruffling (Palmer et al., 2012). We
analyzed the percentage PKC-transfected cells that underwent cytoskeleton ruffling within 10
min of Ag addition, ± TCS, which showed both the expected robust stimulation of membrane
ruffling by Ag and triclosan’s inhibition (Fig. 3.2D, 3.3D). This ruffling analysis (Fig. 3.2D,
3.3D) also serves as a control showing that overexpression of the PKC constructs does not
interfere with triclosan’s ability to inhibit mast cell signaling.
Additionally, to further rule out unwanted effects of overexpression of PKC by transfection in
RBLs, we measured the degranulation as described in (Weatherly et al., 2013), of PKCtransfected, Ag-stimulated RBLs, ± TCS. Exogenous overexpression of either PKC βII or PKC
δ did not affect levels of mast cell degranulation compared to untransfected cells, and TCS
inhibition of degranulation was, likewise, unaffected in these transfected cells (data not shown).
Together, these controls confirm the validity of these transfection/confocal experiments for
assessing TCS toxicity in mast cells.
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Overall, Figures 3.2 and 3.3 indicate that TCS causes defects in PKC βII and PKC δ signaling
by delaying their translocation to the plasma membrane. However, these PKC isoforms do
(eventually) translocate and display oscillatory movement in the presence of TCS, suggesting
that their activity is not the major target of TCS in its inhibition of mast cell function.

Figure 3.3. TCS effects on PKC δ C1 (2) translocation to the plasma membrane in Agstimulated RBL-2H3 cells. RBL cells were transfected with the PKC δ C1 (2)-EGFP plasmid.
Live cell time-lapse images were taken for 10 min immediately after addition of 0.005 µg/ml Ag
or 0.005 µg/ml Ag + 10 µM TCS in the cells by confocal fluorescence microscopy.
Representative images per group, pre-exposure and at ~200 sec post-exposure are shown in (A).
Scale bar, 5 µm. As described in Methods, the percentage of transfected cells with PKC δ C1 (2)
that translocated from the cytosol to the plasma membrane within 10 min post addition of Ag ±
10 µM TCS are plotted in (B); first time of this translocation is plotted in (C). As a control
showing cellular inhibition by TCS, the percentage of transfected cells undergoing membrane
ruffling within 10 min (D) was calculated using Fiji image J. For (B-D), values presented are
derived from analysis of N= 29 for Ag-only cells and N=47 for Ag + 10 µM TCS cells.
Percentage translocation and percentage ruffling values in (B) and (D) are from five independent
days of imaging, ± SEM. Translocation time values in (C) are averages over the 29 (Ag) and 47
(Ag + 10 M TCS) cells, ± SEM. Statistically significant results, comparing Ag-stimulated cells
± TCS exposure, are represented by ** p<0.01, determined by one-tailed t-test.
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3.4.3 Triclosan delays MARCKS translocation to the cytosol in Ag-stimulated RBL-2H3
mast cells
In order to directly assess whether PKC activity is affected by TCS in individual, living
RBL cells, we assessed TCS effects on MARCKS. MARCKS is one of the most abundant
substrates for PKC in mast cells (Blackshear, 1993; Gadi et al., 2011). In resting cells,
MARCKS is held at the plasma membrane via specific electrostatic interactions with membrane
phospholipids at its basic effector domain (ED) domain. Upon Ag stimulation, serine residues
within the ED domain are phosphorylated by translocated PKC, resulting in MARCKS
dissociation from the plasma membrane (Graff et al., 1989; Graff et al., 1989b). Thus, to
determine whether TCS affects PKC kinase activity on its MARCKS substrate, we transfected
the fluorescent construct mRFP-MARCKS-ED into RBL mast cells and monitored its
translocation by confocal microscopy.
Upon Ag (0.005μg/mL) stimulation, mRFP-MARCKS-ED dissociates from the plasma
membrane and moves into the cytoplasm (Fig. 3.4A). TCS (10μM) does not affect the overall
ability of mRFP-MARCKS-ED to translocate to the cytosol (Fig 3.4A, 3.4B). Thus, these results
indicate that overall PKC kinase activity is not hindered by TCS, in agreement with Fig. 3.1A
and Fig. B1. Also, oscillatory behavior in which mRFP-MARCKS-ED dissociates from and reassociates with the plasma membrane in Ag-stimulated mast cells (Gadi et al., 2011) was
observed, and the periodicity of mRFP-MARCKS-ED oscillations is not altered by TCS
exposure (data not shown).
We analyzed the percentage MARCKS-transfected cells that underwent cytoskeleton
ruffling within 10 min of Ag addition, ± TCS, which showed both the expected robust
stimulation of membrane ruffling by Ag and triclosan’s inhibition (Fig. 3.4D). This ruffling
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analysis (Fig. 3.4D) also serves as a control showing that overexpression of the MARCKS
constructs does not interfere with triclosan’s ability to inhibit mast cell signaling.

Figure 3.4. TCS effects on MARCKS translocation to the cytosol in Ag-stimulated RBL-2H3
cells. RBL cells were transfected with the mRFP-MARCKS-ED plasmid. Live cell time-lapse
images were taken for 10 min immediately after addition of 0.005 µg/ml Ag or 0.005 µg/ml Ag
+ 10 µM TCS in the cells by confocal fluorescence microscopy. Representative images per
group, pre-exposure and at ~200 sec post-exposure are shown in (A). Scale bar, 5 µm. As
described in Methods, the percentage of transfected cells with MARCKS that translocated to the
cytosol within 10 min post addition of Ag ± 10 µM TCS are plotted in (B); first time of this
translocation is plotted in (C). As a control showing cellular inhibition by TCS, the percentage
of transfected cells undergoing membrane ruffling within 10 min (D) was calculated using Fiji
image J. For (B-D), values presented are derived from analysis of N= 80 for Ag-only cells and
N=45 for Ag + 10 µM TCS cells. Percentage translocation and percentage ruffling values in (B)
and (D) are from three independent days of imaging, ± SEM. Translocation time values in (C)
are averages over the 80 (Ag) and 45 (Ag + 10 M TCS) cells, ± SEM. Statistically significant
results, comparing Ag-stimulated cells ± TCS exposure, are represented by ** p<0.01,
determined by one-tailed t-test.

Further analyses of individual MARCKS-transfected, Ag-stimulated RBL cells revealed
that TCS causes a defect in MARCKS signaling by delaying MARCKS dissociation from the
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plasma membrane (by about 70 sec) (Fig 3.4C, Table 3.1). Overall, figure 3.4 data indicate that
TCS causes a defect in PKC activity and MARCKS signaling, shown by delayed translocation to
the plasma membrane. However, MARCKS does (eventually) translocate and displays normal
oscillatory movement in the presence of TCS, suggesting that MARCKS is not the major target
of TCS in its inhibition of mast cell function.
Table 3.1. Average time of first translocation of transfected cells
Ag+ 10μM TCS exposure (sec)

170 ± 20

# of cells
(N)
43

250 ± 20

# of cells
(N)
50

160 ± 20
170 ± 20

29
80

240 ± 20
240 ± 30

47
45

Sample

Ag exposure (sec)

PKC βII-YFP
PKC δ (C1)-EGFP
mRFP-MARCKS-ED

3.4.4 Triclosan and FIPI, a PLD inhibitor, decrease PLD activity in Ag-stimulated RBL2H3 mast cells
Cytosolic Ca2+ and PKC translocation work in tandem to activate phospholipase D (PLD)
(Lin and Gilfillan, 1992), which is another key player in the mast cell signaling pathway leading
to degranulation (Chahdi et al., 2002). To examine whether TCS affects PLD activity, we
utilized the fluorescence-based Amplex® Red phospholipase D assay kit, which measures the
activity of both PLD1 and PLD2 isoforms at the same time.
First, we performed Ag-dose response assays measuring PLD activity by the Amplex®
kit (data not shown). From these dose responses, we chose two Ag doses, 0.1µg/mL and
0.001µg/mL, which both produced robust activation of PLD activity, for further cellular PLD
activity experiments with TCS exposure. With 0.1µg/mL Ag stimulation for 15 min, PLD
activity is increased ~30% over the basal level in unstimulated control cells (Fig. 3.5A). This Agstimulated PLD activity is inhibited (decrease by ~50%) by 10µM TCS (Fig. 3.5A). A similar
level of PLD inhibition was observed in cells stimulated by 0.001µg/mL Ag (data not shown).
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These inhibitory effects of TCS on PLD activity were only observed in Ag-stimulated mast cells,
not in resting RBL cells (data not shown).

Figure 3.5. TCS effects on PLD activity in Ag-stimulated RBL-2H3 mast cells. Cells were
stimulated with 0.1 g/ml Ag ± 10 µM TCS for 15 min (A) or with 0.1 g/ml Ag ± 75 nM FIPI
for 15 min (B) in BT. After exposure, PLD activity was measured via Amplex® Red kit, and
fluorescence was read using a microplate reader. Raw data were processed as described in the
Methods section to normalize to unstimulated controls, in order to calculate percentage increase
of PLD activity over unstimulated control. Data presented are means ± SEM of at least three
independent experiments; triplicates per treatment per experiment. Statistically significant
results, comparing Ag-stimulated cells ± TCS or FIPI exposure, are represented by * p < 0.05,
determined by one-tailed t-test. (C) Degranulation was measured described in (Weatherly et al.,
2013) after cells were exposed to 0.1g/ml Ag ± FIPI, for 1 hour. Spontaneous represents control
cells that are not exposed to either antigen or FIPI. Values were then normalized to 0.1g/ml
Ag+ 0 nM FIPI. Data presented are means ±SEM of five independent experiments; three
replicates per experiment. No significance among FIPI exposures was determined by one-way
ANOVA followed by Tukey’s post-hoc test.

As a control, degranulation was also measured under the same experimental conditions
used for these cellular PLD assays: modest degranulation responses were stimulated by Ag
(0.1µg/mL and 0.001µg/mL) and were inhibited by TCS within the 15 min timeframe of these
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experiments (data not shown). We also confirmed that triclosan’s inhibition of PLD activity is a
true cellular effect and is not due to TCS interference with the components of the Amplex® kit
(Fig. B2).
In another control experiment, we employed a known direct PLD inhibitor, FIPI, which
irreversibly binds to the HKD (histidine, lysine, aspartic acid) domain in the catalytic site of PLD
and inhibits both the PLD1 and the PLD2 isoforms (Su et al., 2009b). As expected, Agstimulated PLD activity is strongly inhibited by 75 nM FIPI (Fig. 3.5B). Interestingly, inhibition
of PLD activity by 75 nM FIPI, and even higher doses of FIPI at 150 nM, did not lead to
inhibition of degranulation (Fig. 3.5C), in agreement with a study done by Yanase et al. (Yanase
et al., 2009).

3.4.5 Triclosan does not significantly affect PLD1 translocation to the plasma membrane in
Ag-stimulated RBL-2H3 mast cells
Previous studies have shown that the PLD1 isoform, not PLD2, translocates toward the
plasma membrane upon activation (Brown et al., 1998). Also, while activity of both PLD
isoforms is measured simultaneously by the Amplex® kit, recent literature suggests that only the
PLD1 isoform is positive regulator of degranulation (Zhu et al., 2015). Thus, we next performed
real-time fluorescence imaging of PLD1-EGFP translocation to detect the spatiotemporal
changes of PLD1 after co-exposure of Ag and TCS.
Upon Ag (0.1 μg/mL) stimulation, PLD1-EGFP translocates gradually to the plasma
membrane, with variable onset times of ~2 to 10 minutes following Ag addition (Fig. 3.6A)—in
contrast to the rapid and complete translocation patterns exhibited in the PKC βII, PKC δ, and
MARCKS translocations. Further analyses showed that even though co-exposure of Ag with
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TCS appears to modestly decrease PLD1 translocation toward the plasma membrane, the effect
is not statistically significant (Fig. 3.6A-B).

Figure 3.6. TCS effects on PLD1 translocation toward the plasma membrane in Ag-stimulated
RBL-2H3 cells. RBL cells were transfected with the EGFP- PLD1 construct. Live cell time-lapse
images were taken for 10 min immediately after addition of 0.1µg/ml Ag or 0.1µg/ml Ag + 10
µM TCS in the cells by confocal fluorescence microscopy. Representative images per group,
pre-exposure and at ~8 min post-exposure are shown in (A). Scale bar, 5 µm. As described in
Methods, the percentage of transfected cells with PLD1 that translocated toward the plasma
membrane within 10 min post addition of Ag ± 10 µM TCS are plotted in (B). As a control
showing cellular inhibition by TCS, the percentage of transfected cells undergoing membrane
ruffling within 10 min (C) was calculated using Fiji image J. For (B and C), values presented are
derived from analysis of four independent days of imaging, with 4-13 cells analyzed per
treatment per day, with error shown as SEM. Statistically significant results, comparing Agstimulated cells ± TCS exposure, are represented by ** p<0.05, determined by one-tailed t-test.

No oscillatory behavior of PLD1-EGFP movement was displayed: PLD1 stayed at or
near the plasma membrane once translocated, at least within the 10-15 min imaging period. As in
Figures 3.2-3.4, we again analyzed the percentage PLD1-EGFP-transfected cells that underwent
cytoskeleton ruffling within 10 min of Ag addition, ± TCS, which showed both the expected
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robust stimulation of membrane ruffling by Ag and triclosan’s inhibition of it (Fig. 3.6C). This
ruffling analysis (Fig. 3.6C) shows that overexpression of the PLD1-EGFP construct does not
interfere with triclosan’s ability to inhibit mast cell signaling.

3.4.6 TCS does not directly inhibit PLD activity
To determine whether TCS directly binds to and inhibits PLD activity, we used purified
PLD from Arachis hypogaea (peanut), which contains two HKD domains, similar to those found
in mammalian PLD isoforms (Guo et al., 2006). Purified PLD was prepared in buffer conditions
that mimic our cell-based PLD activity assays and then was exposed to varying concentrations of
TCS (0 – 20 μM). There was no effect of TCS on PLD from Arachis hypogaea (Fig. 3.7),
suggesting the triclosan’s inhibition of mammalian PLD activity (Fig. 3.5A) may not be due to
direct binding of TCS to PLD. A similar lack of direct TCS effect on PLD activity was found in
experiments using a different purified PLD, from Streptomyces chromofuscus (Fig. B3).

Figure 3.7. TCS effects on purified PLD from Arachis hypogaea. PLD activity was measured
using the Amplex® Red PLD assay kit after incubating purified Arachis hypogaea PLD with 0
to 20 µM TCS for 1 hour. Values were normalized to the control (0µM TCS) and presented as
means ± SEM of three independent days of experiments; with triplicates per treatment per
experiment. No significance was determined by one-way ANOVA followed by Tukey’s post-hoc
test.
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3.4.7 Structural analysis of triclosan’s inhibition of mast cell degranulation: comparison to
sucralose
In order to investigate the roles of triclosan’s chemical structural features in its ability to
inhibit mast cell degranulation, we assayed degranulation upon co-exposure of Ag with sucralose
(main ingredient in Splenda®) which has structural similarities to TCS (Fig. B4). We found that
sucralose, at doses relevant to human exposure, does not affect degranulation, at least during the
one hour time frame assessed (Fig. B4). These data indicate that presence of two carbon rings
(combined in ether linkage) decorated with three chlorines is insufficient to affect mast cell
function. This result lends further support to the idea that the proton ionophore nature of TCS is
the key structural determinant of its modulation of mast cells (Weatherly et al., 2016).

3.5 Discussion
In this investigation of the biochemical mechanisms underlying triclosan disruption of
mast cell signaling, we have revealed triclosan’s effects on activity and on spatial and temporal
subcellular localization of crucial signaling molecules. We found that, although TCS surprisingly
does not inhibit Ag-stimulated PKC activity, TCS delays the translocations of PKC isoforms βII
and δ to the plasma membrane and dissociation of the PKC substrate MARCKS from the plasma
membrane (events which occur during the 10 min period following Ag stimulation). Conversely,
TCS inhibits Ag-stimulated PLD activity by 15 min post Ag stimulation but does not affect
translocation of PLD1 toward the plasma membrane, movement which largely occurs within the
first 10 min post Ag. Of interest, a previous study also found that inhibition of PLD activity (via
primary alcohol treatment) suppresses mast cell degranulation but does not affect translocation of
PLD1 (Brown et al., 1998).
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An overarching finding of this mechanistic investigation of TCS degranulation
suppression is that, during the first ~10 min following Ag stimulation, several of the major early
biochemical events are not significantly inhibited by TCS, despite strong TCS inhibition of
degranulation within 1 hour (Weatherly et al., 2013). Originally, we had hypothesized that PKC
activity (measured by ELISA, Fig. 3.1 and by translocation of its substrate MARCKS, Fig. 3.4)
would be inhibited because TCS reduces the cytosolic Ca2+ concentration following Ag
stimulation (Weatherly et al., 2018). A PKC isoform key to mast cell degranulation (Yanase et
al., 2011), βII, contains a C2 domain (Blobe et al., 1996) responsible for modulating Ca2+responsive activation of the enzyme. However, TCS actually increases efflux of Ca2+ out of the
endoplasmic reticulum (and into the cytosol) within the first 3 min post-Ag and increases influx
of Ca2+ into the mitochondria within the first 4 min post-Ag (Table 3.2 and (Weatherly et al.,
2018)): changes that promote degranulation.
Additionally, intracellular levels of reactive oxygen species (ROS) are enhanced by TCS
(Table 3.2 and (Weatherly et al., 2018)) — another TCS effect that is actually supportive of
degranulation because ROS activates degranulation (Swindle et al., 2004). Reduction in the
level of Ca2+ within the cytosol (the cellular compartment that contains PKC) does not occur
until at least 10 min post Ag exposure (Weatherly et al., 2018) and does not reach ~20%
inhibition (area under the curve) until 15 min (and ~50% inhibition until 1 hour). Thus, even
though PKC activity is robustly stimulated by Ag within 10 min, it is unaffected by TCS (Fig.
3.1A), likely both due to the longer time frame required (>10 min) for TCS to robustly inhibit
cytosolic Ca2+ (Weatherly et al., 2018) and due to triclosan’s stimulation of ROS leading to
stimulation of ROS-activated PKC isoforms such as PKCδ (Cho et al., 2004; Yoshida, 2007;
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Lee and Yang, 2010)(Fig. 3.1B). Table 3.2 summarizes TCS effects on biochemical events in
the mast cell degranulation pathway and their timing.
These data support the conclusion that PKC can still do its job (translocate to the plasma
membrane, oscillate between the cytosol and plasma membrane, actively process its substrate
MARCKS) during the first ~10 min of Ag and TCS co-exposure—even while the delays in PKC
(from ~2.7 to 4.2 min) and MARCKS (from ~2.8 to 4 min) movement are early indicators of
problems to come. The major disruptive events caused by TCS do not commence until ~15 min,
including ~20% decrease in integrated cytosolic Ca2+ level, significantly inhibited PLD activity,
and disruption in microtubule formation (Table 3.2): defects which are key to inhibiting
degranulation.
Even though PLD activity is inhibited by TCS by 15 min post Ag, translocation of PLD1
is unaffected, likely because its movement toward the plasma membrane begins within ~2 min
post-Ag and has occurred to a large degree with the first 10 min. However, after PLD has been
largely re-located to or near the plasma membrane, its activity is inhibited. Taken together, these
PKC and PLD studies strongly suggest that a significant accumulated decrease in cytosolic Ca2+
concentration, which does not occur until ~15 min post-Ag, is the key event leading to inhibition
of degranulation. Below we discuss how dampened cytosolic Ca2+ could cause the inhibitory
events in Table 2 (red arrows: translocation delays, decreased PLD activity, and inhibited
microtubule polymerization).
Our lab and others previously demonstrated that TCS is a proton ionophore mitochondrial
uncoupler, which disrupts mitochondrial function in multiple cell types (Ajao et al., 2015;
Weatherly et al., 2016; Weatherly et al., 2018) and in zebrafish embryos (Shim et al., 2016b;
Raftery et al., 2017). We previously showed, though, that mitochondrial uncoupling is not the
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main mechanism causing triclosan’s inhibition of degranulation (Weatherly et al., 2018).
However, proton ionophoric effects of TCS on the mast cell plasma membrane may be the cause
of degranulation inhibition. Support for this hypothesis includes findings of a recent study which
demonstrated that TCS is a proton ionophore in artificial bilayer lipid membranes and can
depolarize bacterial membrane potential (Popova et al., 2018). Because Ca2+ flows down its
electrochemical gradient through mast cell plasma membrane CRAC channels following Ag
stimulation, TCS perturbation of plasma membrane potential could be the mechanism underlying
TCS disruption of Ca2+ influx into the cytosol. Future studies will address whether triclosan’s
proton ionophore nature perturbs the electrochemical potential of the mast cell plasma membrane
(preliminary experiments using membrane potential sensitive organic dyes were inconclusive
due to TCS interference with the dye’s fluorescence (Weatherly et al., 2018)).
Sucralose, the active ingredient in artificial sweetener Splenda®, exhibits structural
similarities to TCS: both molecules are comprised of two carbon rings combined in ether
linkage and decorated with a total of three chlorines (Fig. B4). However, unlike TCS, sucralose
does not affect degranulation, indicating that presence of the three chlorines on the two etherlinked rings is insufficient to affect mast cell function, at least during the one hour time frame
assessed (Fig. B4). This result lends further support to the hypothesis that the proton ionophore
nature of TCS is the key determinant of its modulation of mast cells (Weatherly et al., 2016).
While we suspect that TCS lowers Ag-stimulated cytosolic Ca2+ levels by disrupting the
plasma membrane potential and, hence, by disrupting a driving force for Ca2+ influx, there are
other potential mechanisms underlying TCS inhibition of cytosolic Ca2+. One is that TCS could
inhibit the early phosphorylation cascade that leads to PLC γ activation. PLC γ inhibition would
lead to decreases in both DAG and IP3 generation, which would subsequently result in hindered
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IP3-mediated ER Ca2+ release. However, TCS does the opposite: Ag-stimulated ER Ca2+ release
is actually enhanced by TCS with Ag (Weatherly et al., 2018), and this result strongly suggests
that biochemical events upstream of ER Ca2+ mobilization are uninhibited by TCS—hence our
focus on effectors of Ca2+ influx, PKC and PLD, in this study.
Table 3.2. Triclosan effects on mast cell degranulation pathway: Time to first signaling
defect, following co-exposure to Ag+ TCS
Signaling Event*

TCS Effect on
this event**

Efflux of Ca2+
from ER
Influx of Ca2+ into
mitochondria
Mitochondrial
Ca2+ oscillations
Influx of Ca2+ into
cytosol
PKC βII and
PKCδ
translocation
PKC activity

Time of first defect caused by
TCS***
3 min
4 min
10 min

Delay

MARCKS
translocation
Actin cytoskeleton
ruffling

Delay

PLD1
translocation
PLD activity

None

10 min (~10% )
15 min (~20% )
1 hr (~50% )
Delayed from ~ 2.7 min (-TCS, +
Ag) to ~ 4.2 min (+ TCS, +Ag)

References
(Weatherly et
al., 2018)
(Weatherly et
al., 2018)
(Weatherly et
al., 2018)
(Weatherly et
al., 2018)
Fig. 3.2C &
3.3C

45 min

Fig. 3.1B

Delayed from ~ 2.8 min (-TCS, +
Ag) to ~ 4 min (+ TCS, +Ag)
10 min

Fig. 3.4C

Within 10 min

Fig. 3.2D,
3.3D, 3.4D &
3.6C
Fig. 3.6B

15 min

Fig. 3.5A

(Weatherly et
al., 2018)
~45 min
(Weatherly et
al., 2018)
* Ag concentration used:0.005 -0.1μg/mL(these doses caused roughly maximal degranulation
in absence of TCS.
** Items in red indicate mechanisms of TCS inhibition of degranulation.
*** TCS concentration used: 10-20μM
Microtubule
polymerization
ROS formation

15 min
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Delays in PKC translocation caused by TCS may be due to attenuation of microtubule
polymerization by TCS (Weatherly et al., 2018) at early time points after Ag stimulation. In
CHO cells, microtubule integrity is required for translocation of PKC δ, in a complex with
cytoskeletal protein Annexin V (Kheifets et al., 2006). Though drastic TCS inhibition of
microtubule polymerization was documented at 15 min post Ag in (Weatherly et al., 2018), and
that time point was chosen for its unambiguous TCS effects, defects in microtubule formation
may potentially begin to accumulate at earlier time points and may thereby explain slowed PKC
translocation. TCS may inhibit microtubule polymerization via its depression of cytosolic Ca2+:
Ag-stimulated elevation of cytosolic Ca2+ levels stimulates the association of the positive
regulator protein GIT1 with tubulin, in turn leading to enhanced microtubule polymerization and
degranulation (Sulimenko et al., 2015).
PKC βII phosphorylates myosin and also binds actin in mast cells (Ludowyke et al.,
2006). Myosin phosphorylation is thought important for degranulation (Ludowyke et al., 1989;
Choi et al., 1994). Moreover, the C2-like domain of PKC δ binds to F-actin to regulate actin
redistribution in neutrophils (Lopez-Lluch et al., 2001) as well as in airway epithelial cells
(Smallwood et al., 2005). Thus, inhibition of actin polymerization, as shown by inhibition of
membrane ruffling, could be another explanation of triclosan’s delay of PKC movement to the
plasma membrane.
PLD plays important roles in mast cell degranulation (Brown et al., 1998; Cissel et al.,
1998; Way et al., 2000), and its Ag-stimulated activity is inhibited by TCS (Table 3.2).
Transient expression PLD experiments in RBL-2H3 cells show both isoforms are activated by
Ag stimulation (Chahdi et al., 2002; O'Luanaigh et al., 2002). In mast cells, PLD1 is associated
with granule membranes while PLD2 with the plasma membrane (Brown et al., 1998; Choi et
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al., 2002). PLD1 has low basal activity, and its activation requires interactions with PKC and/or
small GTPases such as ADP-ribosylation factor (ARF) and Rho family members (Liscovitch et
al., 2000; Peng and Frohman, 2012). PLD1 is stimulated in vitro and in vivo directly by Ca2+dependent cPKC isoforms (PKCα and β) (Hammond et al., 1997; Kim et al., 1999; Zhang et
al., 1999) in a PIP2-dependent manner (Hammond et al., 1995; Rumenapp et al., 1995; Bae et
al., 1998). In contrast, PLD2 is constitutively active and is more dependent on the presence of
PIP2 than other activators (Lopez et al., 1998; Sung et al., 1999). Background studies of basal
PLD activity showed that TCS has no effect on constitutive PLD activity (data not shown), even
as TCS strongly inhibits Ag-stimulated PLD activity (Fig. 3.5A). These results suggest that
constitutively-active PLD2 is less of a target of TCS than is PLD1, due to PLD1’s low basal
activity and high activation potential.
FIPI, a potent dual inhibitor for PLD1 and PLD2, was employed in our study as a
comparison to triclosan’s inhibitory action on PLD activity and on degranulation. FIPI
irreversibly binds to a serine residue within the HKD (histidine, lysine, aspartic acid) domain in
the catalytic site of PLD, preventing the cleavage of phosphatidylcholine, thus blocking PA
production (Su et al., 2009b). While we observed decreased PLD activity by FIPI, to our
surprise, FIPI’s inhibition of both PLD isoforms had no effect on overall degranulation in Agstimulated mast cells. Currently there is some controversy about the role of PLD1 and PLD2 in
mast cells. It has been long believed that both PLD1 and PLD2 play a positive role in mast cell
degranulation, in that PLD1 is involved in the granule transport to the plasma membrane (Chahdi
et al., 2002; Hitomi et al., 2004; Peng and Beaven, 2005) and PLD2 is a fusogenic protein for
granule’s docking and fusion to the plasma membrane (Chahdi et al., 2002; Choi et al., 2002;
Lee et al., 2006; Marchini-Alves et al., 2012). However, an intriguing recent study using PLD1-
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and PLD2- knockout mice found that PLD1 positively regulates degranulation, while PLD2 is a
negative regulator (Zhu et al., 2015). RhoA, which is directly affected by Ca2+ (though does not
directly bind Ca2+), interacts with PLD2 to play a negative role in microtubule formation. The
authors also showed that mast cells isolated from double knockout mice (PLD1-/- and PLD2-/-)
exhibited normal degranulation compared to the control (Zhu et al., 2015), suggesting that PLD1
(positive) and PLD2 (negative) may effectively cancel out each other’s roles in regulating
degranulation. Another recent study from this group demonstrates the importance of PLD1, but
not PLD2, in T cell activation (Zhu et al., 2018). Thus, our study using FIPI agrees with this
finding that equally impeding the two PLD isoforms simultaneously yields no change in
degranulation. Taken together with our results showing a lack of TCS effect on basal PLD
activity, these findings provide further credence to the idea that triclosan’s inhibitory action on
PLD activity is targeted to PLD1, which is a positive regulator in degranulation--such that
decreased PLD activity by TCS results in decreased degranulation.
Our study with purified PLD protein in vitro suggests that TCS does not directly bind to
and inhibit activity of PLD; thus, PLD activity is more likely indirectly inhibited by TCSinduced decreases in cytosolic Ca2+ level. The PLD used in this study was derived from Arachis
hypogaea and has an HKD domain which contains a serine residue and which is highly
homologous to the HKD domains found in rat and human PLD1 and PLD2 proteins. Even
though PLD does not directly interact with Ca2+, the activities of its activation cofactors, such as
small GTPase proteins, PKC, and PIP2, are dependent on Ca2+ signaling (Wakelam et al., 1997).
Moreover, several studies have demonstrated that degranulation requires activation of PLD
accompanied by sustained cytosolic Ca2+ levels (Lin and Gilfillan, 1992; Ozawa et al., 1993a;
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Cissel et al., 1998; Chahdi et al., 2002). Thus, the data suggest that PLD activity and, hence,
degranulation, is inhibited by triclosan’s inhibition of Ca2+ influx into the cytosol.
The role of PLD has been implicated in various essential cellular functions in various cell
types: signal transduction in embryonic kidney cells (Fang et al., 2001), cell migration in breast
cancer cells (Hui et al., 2006), membrane vesicular trafficking (Du et al., 2003) and cytoskeletal
reorganization (Colley et al., 1997) in fibroblasts, autophagy (Dall'Armi et al., 2010) in cervical
cancer cells, and viral infections (Oguin et al., 2014) in alveolar basal epithelial cells. Due to
these diverse roles of PLD in biology, PLD is involved in numerous physiological and disease
states, including cancer (Su et al., 2009a), neurodegenerative disorders (Cai et al., 2006),
cardiovascular problems (Chiang, 1994), and infectious diseases (Taylor et al., 2015). Therefore,
inhibition of PLD by TCS might affect these different health problems.
In conclusion, we have elucidated biochemical mechanisms underlying inhibition of mast
cell function by TCS, at dosages relevant to human exposure, by interrogating the activity and
localization of key signaling enzymes. Combined with our previous findings on triclosan’s
effects on calcium mobilization and microtubules, these results provide the temporal details of
TCS-induced defects in PKC and PLD signaling steps, which lead to degranulation inhibition. In
addition to TCS inhibition of mast cells, any cell type that depends on PLD function may be
inhibited by TCS.

94

CHAPTER 4
SEARCHING FOR TRYPTASE IN THE RBL-2H3 MAST CELL MODEL:
PREPARATION FOR COMPARATIVE MAST CELL TOXICOLOGY
STUDIES WITH ZEBRAFISH2
4.1 Abstract
Mast cells comprise a physiologically and toxicologically important cell type that is
ubiquitous among species and tissues. Mast cells undergo degranulation, in which characteristic
intracellular granules fuse with the plasma membrane and release many bioactive substances,
such as the enzymes β-hexosaminidase and tryptase. Activity of mast cells in the toxicology
model organism zebrafish has been monitored via tryptase release and cleavage of substrate
BAPNA. An extensively-used in vitro mast cell model for studying toxicant mechanisms is the
RBL-2H3 cell line. However, instead of tryptase, granule contents such as β-hexosaminidase
have usually been employed as RBL-2H3 degranulation markers. In order to align RBL-2H3 cell
toxicological studies to in vivo mast cell studies using zebrafish, we aimed to develop an RBL2H3 tryptase assay. Unexpectedly, we discovered that tryptase release from RBL-2H3 cells is
not detectable, using BAPNA substrate, despite optimized assay that can detect as little as 1 ng
tryptase. Additional studies performed with another substrate, tosyl-Gly-Pro-Lys-pNA, and with
an ELISA also revealed a lack of tryptase protein released from stimulated RBL-2H3 cells.
Furthermore, none of the eight rat tryptase genes (Tpsb2, Tpsab1, Tpsg1, Prss34, Gzmk, Gzma,
Prss29, Prss41) are expressed in RBL-2H3 cells, even though all are found in RBL-2H3
genomic DNA and even though β-hexosaminidase mRNA is constitutively expressed. Therefore,
mast cell researchers should utilize β-hexosaminidase or another reliable marker for RBL-2H3

2

A portion (15%) of this work was performed by Rachel Kennedy with the remainder being performed by Juyoung
Shim

95

degranulation studies, not tryptase. Comparative toxicity testing in RBL-2H3 cells in vitro and in
zebrafish mast cells in vivo will require use of a degranulation reporter different from tryptase.

4.2 Short Abstract
Mast cells degranulate, releasing substances such as β-hexosaminidase and tryptase. Mast
cell activity in zebrafish is monitored via tryptase release. To align in vitro RBL-2H3 mast cell
line studies to in vivo mast cell zebrafish studies, we aimed to develop an RBL-2H3 tryptase
assay. However, tryptase protein is not released from stimulated RBL-2H3 cells. Also, no rat
tryptase gene is expressed in RBL-2H3s. Comparative toxicity testing in RBL-2H3 cells and in
zebrafish mast cells will require a non-tryptase degranulation reporter.

4.3 Introduction
Mast cells (MCs) are highly granulated cells that are typically recognized for their role in
allergies and asthma (Kuby, 1997). However, they are also involved in many helpful immune
functions such as host defense (Galli et al., 2008; Abraham and St John, 2010), bacterial and
parasitic clearance (Pawankar, 2005), and recruitment of neutrophils to sites of infection
(Echtenacher et al., 1996; Malaviya et al., 1996). MCs possess additional immune-related
functions that affect diseases such as cancer (Coussens et al., 1999; Gounaris et al., 2007),
autoimmune disorders (Lee et al., 2002), and inflammatory bowel disease (Wilcz-Villega et al.,
2013). Interestingly, MCs also have roles in neurological processes and diseases such autism
(Theoharides et al., 2012b), anxiety disorders (Silver et al., 1996; Nautiyal et al., 2008), and
multiple sclerosis (Rozniecki et al., 1995). MCs, found in nearly all human tissues, are
prominent in tissues in contact with the external environment, such as skin, blood capillaries,
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nerve terminals, gastrointestinal tract, respiratory mucosa, etc. (reviewed in (Galli et al., 2005b)).
Also MCs are found in numerous different organisms (Baccari et al., 2011). Due to their
physiological importance, ubiquity, and location near surface tissues, MCs are key toxicological
targets.
MCs exhibit the unmistakably distinctive morphological feature of densely populated
cytoplasmic granules, which get secreted upon MC stimulation: a process called degranulation
(Kuby, 1997). Degranulation is typically initiated via multivalent antigen (Ag) crosslinking of
immunoglobulin E (IgE) receptor-bound FcεRI receptors but can be stimulated in numerous
ways, including via compound 48/80 (c48/80) or calcium ionophore application. The resulting
signaling cascade culminates in degranulation, the release of granule-associated bioactive
mediators, such as histamine, serotonin, β-hexosamindase (β-hex), and tryptase (Schwartz and
Austen, 1980). Assays for release of these mediators (and more) have been extensively utilized
to test mast cell function.
Thus, the presence of granules containing tryptase is considered a canonical marker of
MCs, and release of tryptase (into cell supernatant in vitro or into the bloodstream in vivo) has
often been utilized as a test of mast cell stimulation and function (Irani et al., 1986). Mast cell
tryptase is a family of trypsin-like serine proteases that cleave sites after basic amino acids such
as Arg and Lys (Lehninger et al., 2005). Tryptase requires the glycosaminoglycan heparin for its
activity (Hallgren et al., 2001). In general, tryptases can be grouped into three main types, α (III), β (I-III), and γ (transmembrane). Most tryptase purified from human tissues is a mixture of β
isoforms which are the products of two genes, TPSB2 and TPSAB1 (Caughey, 2011). Numerous
distinct roles of mast cell tryptase have been reported: some protective/anti-inflammatory, and
some pro-inflammatory (reviewed in (Caughey, 2011)). One example of a mechanism of action
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of tryptase is cleavage and inactivation of calcitonin gene-related peptide, thus regulating
vasodilation (Tam and Caughey, 1990; Walls et al., 1992). Tryptase acts upon many other
substrates as well. Mast cell tryptase is also involved in angiogenesis (Stack and Johnson, 1994;
Crivellato et al., 2004) and in development of multiple sclerosis (Rozniecki et al., 1995). In the
laboratory, the presence of active tryptase in a solution can be detected by incubation with a
chromogenic substrate such as N-α-benzoyl-DL-Arg-p-nitroanilide (BAPNA) or tosyl-Gly-ProLys-p-nitroanilide: tryptase cleaves the bond between the Arg or Lys and the p-nitroaniline
(pNA), releasing yellow-colored pNA, measurable in a plate reader (Lavens et al., 1993). Other
chromogenic and fluorogenic tryptase substrates are also available.
Zebrafish (Danio rerio) (ZF) are a powerful, human-disease relevant (Ward and
Lieschke, 2002; Lieschke and Currie, 2007) model organism for toxicology studies (Garcia et
al., 2016). Zebrafish and humans share a highly conserved FcεRI receptor, and mast cells of
both species share similarities in innate and adaptive immune responses (Dobson et al., 2008;
Da'as et al., 2011; Da'as et al., 2015). Two methods for assessing mast cell function in zebrafish
have recently been developed. Both methods use tryptase as the mast cell marker. First, a method
has been developed to quantify mast cell degranulation in adult ZF, by assaying for tryptase in
blood, using the substrate BAPNA (Dobson et al., 2008; Da'as et al., 2011). Intraperitoneal
injection of adult zebrafish with an MC stimulant (such as c48/80) causes a large rise in blood
plasma tryptase level (pNA production), as compared to saline-injected control animals (Dobson
et al., 2008). Zebrafish have granzyme A (also known as granzyme K-like), a gene orthologue
for human granzyme K (GZMK), which is conserved in rat (Gzmk), mouse, and ZF. Granzyme
tryptases, including granzyme A and K, are serine proteases and shown to cleave after the basic
residues Arg and Lys ((Plasman et al., 2014), so this ZF granzyme tryptase may be the enzyme
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cleaving BAPNA in this ZF assay. Also, Dobson et al. (Dobson et al., 2008) and Balci et al.
(Balci et al., 2014) detected staining of ZF tissues with a monoclonal anti-human MC tryptase
antibody specific for TPSAB1, although an orthologue to this specific gene has not yet been
cloned from ZF. Second, a tryptase assay using ZF embryos also has been developed (Yang et
al., 2015). In this method, all the drugs and reagents, including stimulant (e.g., c48/80) and
substrate (e.g., BAPNA), are directly added to the fish water.
In addition to animal models for studies of mast cells, in vitro mast cell models have
contributed enormously to scientists’ understanding of the biochemical details of mast cell
signaling and of drug and toxicant modes of action on MCs. Among mast cell models, the rat
basophilic leukemia - clone 2H3 (RBL-2H3) cell line has been used widely as a well-accepted
model of mast cell signaling and function (Barsumian et al., 1981). RBL-2H3 cells, used
extensively for over 40 years, are an important mast cell model for in vitro studies of MC
toxicology and pharmacology. Other experimental mast cells exist, but each has advantages and
disadvantages, such as human HMC-1 cells which lack FcεRI (Nilsson et al., 1994), human
LAD2 cells which contain FcεRI but which require >2 weeks for each doubling (Jensen et al.,
2005), P815 cells which are largely non-adherent, and primary bone marrow-derived mouse mast
cells which senesce after a brief time in culture. RBL-2H3 (“RBL”) cells are easy to quickly and
continuously culture in large quantities, contain the core signaling machinery of mature human
mast cells (Fewtrell, 1979; Metzger et al., 1982), and are functionally homologous to rodent
mucosal mast cells (Seldin et al., 1985). Many molecular similarities between human and rodent
mast cells have been detailed in (Abramson and Pecht, 2007). The pathway leading to
degranulation in RBL cells is very well described, allowing for the identification of pathway
targets for toxicants or drugs that affect this signaling system.
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For many of the studies documented to date, RBL degranulation has been quantified via
measurement of released β-hex: β-hex in the supernatant over stimulated cells is incubated with
fluorogenic substrate 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide (4-MU), and the
resulting fluorescent product is detected in a microplate reader (Naal et al., 2004). β-hex enzyme
catalyzes degradation of GM2 ganglioside, and mutations in this enzyme lead to
neurodegenerative diseases (Bayleran et al., 1987; Tifft and Proia, 1997). β-hex has been
successfully used as a MC function marker because it is released in parallel with canonical MC
marker histamine (Schwartz et al., 1979). The homologs of β-hex genes have been identified in
ZF (hexa and hexb)(Zizioli et al., 2014). Of note, activated human primary lung mast cells
secrete tryptase in parallel with histamine (Schwartz et al., 1981), but tryptase release has not
typically been used as a RBL-2H3 degranulation marker.
Previously, we discovered that MC degranulation is disrupted by environmental
toxicants, such as arsenic (Hutchinson et al., 2011; Shim et al., 2016a), and by the antimicrobial
drug triclosan (TCS) (Palmer et al., 2012; Weatherly et al., 2013). Along with other cell types,
these studies utilized RBL-2H3 cells and β-hex detection to quantify MC degranulation.
However, all published studies of mast cells in ZF have, instead, utilized tryptase as the
biochemical marker of mast cell function. Thus, in order to align our cell culture-based
toxicological studies in this proven RBL mast cell model to in vivo toxicological studies of mast
cells in the ZF model organism, we became interested in using tryptase as a marker for
degranulation of RBL-2H3 cells. Measurement of tryptase release from RBL-2H3 cells would
lay the groundwork for comparative/confirmative high-throughput toxicology assays of mast cell
function and signaling that could use both ZF and this canonical mast cell model, RBL cells. For
example, we are interested in studying and comparing effects of TCS on mast cells in ZF as a
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whole organism follow-up to our findings that TCS inhibits function of RBL-2H3 cells (Palmer
et al., 2012) and of human HMC-1 mast cells (Weatherly et al., 2016). Parallel studies of RBL2H3 mast cells and ZF have already proven to be instructive in toxicology: for example, ZF
mitochondrial function is inhibited by TCS (Shim et al., 2016b) at similar doses and time frames
that also depress mitochondrial function in RBL-2H3 cells (Weatherly et al., 2016). Thus, we
were motivated to develop a tryptase release assay from RBL-2H3 cells in order to design
parallel assays of toxicant effects on MC function in both ZF and RBL-2H3, for applied
toxicology investigations linking in vitro and in vivo systems. Background studies showing that
TCS does not directly affect activity of purified tryptase (Kennedy, 2013) further bolstered our
belief that it would be possible to use this degranulation marker for comparative mast cell
toxicology studies of TCS.
In this study, we have optimized the conditions of a substrate-based assay for tryptase
activity and have applied it to assess degranulation of RBL-2H3 cells. We report the results of
three separate assay methods for detecting tryptase protein secreted from degranulated RBL-2H3
cells, as well as of PCRs performed to detect mRNA transcripts of eight distinct tryptase genes
within these cells.

4.4 Materials and Methods
4.4.1 Chemicals and reagents
Purified human lung tryptase (E.C. Number 3.4.21.59; corresponds to human gene
symbols TPSD1, TPSB2, TPSAB1) was purchased from Calbiochem /EMD Millipore (Billerica,
MA, USA) and was stored as aliquots wrapped in aluminum foil at -20 °C. BAPNA (Nα Benzoyl -D,L-arginine-p-nitroanilide • HCl) tryptase substrate (Bachem, Bubendorf,
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Switzerland) was stored at -20°C in an amber bottle and wrapped in aluminum foil. Antidinitrophenyl (DNP) mouse Immunoglobulin E (IgE) (monoclonal, clone SPE-7), Ca2+
ionophore A23187, heparin, dimethyl sulfoxide (DMSO) were purchased through Sigma (St.
Louis, MO, USA). Triton-X 100 (TX) was obtained from Thermo (Rockford, IL, USA).
Tryptase from human lung (TFHL) buffer was prepared to match the buffer contained in
the purified tryptase purchased through Calbiochem, and contained 1 M NaCl, 50 mM acetate
buffer, and 0.05 mM heparin (0.09% heparin), which was titrated to pH 5 with 10 N sodium
hydroxide. 15-mL aliquots were frozen at -20 °C, and thawed as needed.
The components of Tyrodes buffer are that of (Hutchinson et al., 2011) and (Weatherly et
al., 2013). Modified Tyrodes buffer (mT), pH 7.4, contained lower NaCl and lower CaCl2 than
typical Tyrodes, and was made by combining 100 mM NaCl, 5 mM KCl, 0.9 mM CaCl2, 1 mM
MgCl2, 20 mM HEPES, and 5.6 mM glucose. As needed, bovine serum albumin (BSA) at 1
mg/ml was added to mT on the day of an experiment. BAPNA buffer solution I was prepared by
first combining 1 mM MgCl2, 0.1 M Trizma base (Sigma, St. Louis, MO, USA), and 1 M
glycerol (Promega, Madison, WI, USA). After mixing well, 0.02% heparin (w/v) was added, and
the pH of this solution was titrated to either 9 or 8, depending on the experiment. Similarly,
BAPNA solution II was prepared in the same manner as solution I, only it contained the added
component of 0.8 mM BAPNA (in assays, final concentration of BAPNA was 0.4 mM). These
two buffer solutions were made fresh daily.
A23187 Ca2+ ionophore was prepared by dissolving A23187 powder into 100% DMSO
for a final concentration of 2.5 mg mL-1 h and stored as aliquots wrapped in aluminum foil at 20 °C. On the day of an experiment, this stock was diluted directly into Tyrodes-BSA solution or
mT-BSA to create necessary ionophore concentrations.
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Cell harvest buffer (10X) was prepared with 1.35 M NaCl, 0.05 M KCl, 0.17 M HEPES,
and 0.02 M EDTA, which was titrated to pH 7.6.
Chemicals of the highest possible purity were used. All buffers and media were sterile
filtered using 0.2 μM VacuCap filters (Pall Corporation, Port Washington, NY, USA).

4.4.2 Purified tryptase assay
Purified tryptase working solutions containing 1-500 ng tryptase were prepared by
making dilutions in TFHL buffer. Using a clear 96-well half-area plate (Grenier Bio-One,
Monroe, NC, USA), 50 μL of 0.02% heparin (w/v) mT-BSA was added to each sample well.
From all wells, 1 μL was removed, and tryptase (1 μL) at the varying levels indicated replaced
this volume. To these 50-μL samples, 50 μL BAPNA solution II (containing BAPNA substrate)
was added; controls lacking BAPNA substrate contained 50 μL BAPNA solution I (containing
no BAPNA substrate). Tryptase activity was detected spectrophotometrically in a Synergy 2
plate reader (Biotek, Winooski, VT, USA) by measuring the colorimetric cleavage product pnitroaniline (pNA) at 410 nm. The plate was read immediately (t = 0), as well as periodically, up
to 72 h (Lavens et al., 1993). During incubation at 37 °C/5% CO2, the plate was tightly sealed
with parafilm, and the plate lid was weighted down by a lead ring; these methods, along with
glycerol, aided in preventing sample loss over the 72-h time period.

4.4.3 Cell culture
RBL culture methods were those of (Hutchinson et al., 2011) and NIH-3T3 mouse
fibroblast culture methods were those of (Weatherly et al., 2016).

103

4.4.4 Stimulation of RBL-2H3 cells induced via IgE-receptor crosslinking by antigen or
Ca2+ ionophore
Cells were stimulated with either DNP-BSA multivalent antigen (Ag) (following IgE
sensitization) or A23187 Ca2+ ionophore, essentially as described (Weatherly et al., 2013) except
that mT-BSA buffer was used in place of BT buffer. DMSO (0.004% final) was also used in
spontaneous, 0.2% TX, and background wells to control for vehicle effects.
Following cell stimulation for 1h at 37°C, resulting β-hex or tryptase released into cell
supernatant was quantified as described in (Weatherly et al., 2013) or tryptase assay described in
“RBL-2H3 cell degranulation assay for tryptase release, measured by BAPNA substrate,” below.
Additionally, to test the effects of heparin on this process, 0.02% heparin was added to A23187,
spontaneous, 0.2% TX, and background samples.

4.4.5 RBL-2H3 cell degranulation assay for tryptase release, measured by BAPNA
substrate
Following treatment for cell stimulation described above, cell supernatant (50 μL) was
transferred to a 96-well half-area plate (Grenier Bio-One, Monroe, NC, USA) that contained 50
μL of BAPNA solution II. The absorbance of the colorimetric cleavage product pNA was
detected over a 72-h period as with the purified tryptase experiments.

4.4.6 RBL-2H3 cell degranulation assay for tryptase release, measured by commercial kit
utilizing tosyl-Gly-Pro-Lys-pNA substrate
All the reagents were prepared following manufacturer’s protocol (EMD Millipore,
Billerica, MA, USA) unless otherwise indicated in individual figure legends. RBL supernatant
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were obtained as described in previous section. Lysates from RBL cells were obtained in 2 steps:
first, RBL cells were harvested using 1X cell harvest buffer (diluted from 10X with cell culture
water) and centrifuged for 8 min at 500xg. After removal of supernatant, cell pellet was washed
with PBS and resuspended in 1X assay buffer. Next, the cell supernatant from the lysate was
obtained as described under Syk ELISA assay in (Shim et al., 2016a) and incubated with tosylGly-Pro-Lys-pNA substrate. For statistical analysis, first raw absorbance data from each
treatment were processed by subtracting average background values (1X assay buffer with
substrate) from each sample, and the background-adjusted triplicates were then averaged. These
values were normalized to the unstimulated (no Ag or no ionophore) control for each
experimental day when compared among supernatants. For comparison between RBL
supernatant and RBL lysates, values were normalized to the RBL supernatant.
Lysates from NIH-3T3 cells were obtained in the same manner as the RBL cell lysis
methods as described above. To determine total protein concentration from the RBL and NIH3T3 cell lysates, the bicinchoninic acid (BCA) assay (Pierce BCA protein assay kit [Thermo])
was performed, following the manufacturer’s protocol. Raw tryptase degranulation absorbance
data obtained from lysate samples were averaged after subtracting average background values
(1X assay buffer with substrate) from each sample. Background-subtracted values were then
divided by the total protein concentration of that particular sample. Finally, these values were
normalized to RBL lysates for each experimental day.

4.4.7 Tryptase (TPSAB1) ELISA
Tryptase ELISA kit (Cell Signaling Technologies, Beverly, MA, USA) was used to
detect levels of rat (Rattus norvegicus) TPSAB1 protein according to the manufacturer’s
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instructions. For this assay, RBL-2H3 were cultured in 6-well plates, stimulated and lysed as
described under Syk ELISA assay in (Shim et al., 2016a). A volume of 300 µL of cell lysate
supernatant was placed into an appropriate ELISA well in duplicates per treatment. The
remaining steps were carried out according to the manufacturer’s directions.

4.4.8 RNA extraction and cDNA synthesis from RBL-2H3 cells
Total RNA was isolated from RBL-2H3 cells using Trizol® reagent (Life Technologies,
Grand Island, NY, USA) following the manufacturer’s instructions. The concentration and purity
of the total RNA were determined by Nanodrop-1000 UV-Vis spectrometer (Thermo Scientific,
Rockford, IL, USA). Total RNA (10 μg per sample) was treated with TURBO DNA-free kit
(Ambion, Grand Island, NY, USA) to remove any contaminating genomic DNA. The RNA
preparation was reverse-transcribed to cDNA using an iScript cDNA synthesis kit (Bio-Rad,
Hercules, CA, USA) according to the manufacturer’s protocol.

4.4.9 Genomic DNA extraction from RBL-2H3 cells
DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA, USA) was used for genomic DNA
extraction from RBL-2H3 cells by following the manufacturer’s instructions. The concentration
of genomic DNA was measured using Nanodrop-1000 UV-Vis spectrometer (Thermo scientific,
Rockford, IL, USA).
4.4.10 Polymerase chain reaction (PCR) for rat tryptase genes
Primers for each Rattus norvegicus tryptase genes were inferred from NCBI
(http://www.ncbi.nlm.nih.gov). Primers were designed using NCBI Primer Blast
(http://www.ncbi.nlm.nih.gov/tools/primer-blast) and IDT Oligoanalyzer software
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(https://www.idtdna.com/analyzer/Applications/OligoAnalyzer), and synthesized by Integrated
DNA Technologies (Coralville, Iowa, USA). Sequences for PCR primer pairs, annealing
temperatures, and size of the transcripts for tryptase genes are shown in Fig 4.6C and Fig 4.7B.
PCR was carried out in a 50uL reaction volume, utilizing 100ng of the cDNA or genomic
DNA as a template and 0.4 μM of each primer. The amplicons were generated using a Phusion
High-Fidelity DNA polymerase from New England Biolabs (Ipswich, MA, USA) and following
PCR conditions: initial one cycle of 98°C for 30sec, then 35 cycles of 98°C for 10sec, 51.558.5C (depending on the genes) for 30sec, and 72°C for 30sec and followed by one cycle of a
final 72°C extension for 5 min. A mock PCR, in which the DNA template was excluded, was
also performed as a negative control. Amplification of rat β-actin, rat β-hexosaminidase A and B
genes were used as positive controls.
For gel electrophoresis, Seakeam LE agarose (Cambrex, Rockland, ME, USA) and 1Kb
plus DNA ladder (Life Technologies, Grand Island, NY, USA) were purchased. The PCR
products were analyzed in a 1% agarose gel and stained with 0.5 μg/mL of ethidium bromide
(Sigma, St Louis, MO, USA).

4.4.11 Sequencing analyses
To confirm the identity of amplified sequences, the PCR products were separated in a 1%
agarose gel to extract the single specific band, which was subsequently purified using a Qiaquick
Gel extraction kit (Qiagen, Valencia, CA, USA). Each purified product was then sequenced at
the University of Maine Sequencing facility using an ABI 3730 DNA sequencer (Applied
Biosystems, Foster City CA, USA). The obtained DNA sequences were confirmed by NCBI
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BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and ClustalW2 alignment program
(http://www.ebi.ac.uk/Tools/msa/clustalw2).

4.4.12 Statistical analysis
Unless otherwise indicated in individual figures, results from degranulation experiments
are reported as mean ± SEM, with significant differences determined by either a One-Way
ANOVA (Analysis of Variance) followed by Tukey's post-hoc test or One-sample t-test, using
Graphpad Prism software (San Diego, CA, USA).

4.5 Results
4.5.1 The tryptase activity assay is optimized to detect as low as 1 ng of purified human
lung tryptase using BAPNA (Nα-Benzoyl-D, L-Arg-p-nitroanilide) substrate.
Eight rat tryptase or tryptase-like genes were found in the rat genome database (RGD:
http://rgd.mcw.edu) and were compared to their human orthologs (HGNC:
http://www.genenames.org) (Table 4.1).
Before testing RBL-2H3 mast cells, we optimized the tryptase assay in cell-free system,
based on the protocol developed by Lavens et al. (Lavens et al., 1993), which is able to detect
tryptase by measuring the cleavage product (p-nitroanilide [pNA]) of a known tryptase substrate
BAPNA and purified human lung tryptase. The purified human lung tryptase that was utilized
contains three tryptase species: TPSAB1, TPSB2 and TPSD1.
When various doses of purified tryptase (0-500ng) were incubated with BAPNA and
absorbance at 410 nm was read in a plate reader, detection of pNA plateaued within 72 hours
(Fig. 4.1A). Following optimization of both timing (Fig. 4.1A; including modifying assay
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parameters to minimize sample loss) and of buffer components (pH, heparin concentration,
levels of Ca2+ and Na+, addition of heparin and bovine serum albumin, etc), we successfully
detected pNA production from as little as 1ng of purified tryptase tested (Fig. 4.1B). Previously,
the lowest level of pNA detected by Lavens et al. was 10ng (Lavens et al., 1993).
Table 4.1. Tryptase and tryptase-like proteins in rats and human
Rat
Gene Symbols

Tpsb2

Mast cell protease-7; Tryptase βI; Tryptase α/β1;Skin
tryptase
Mast cell protease-6; Tryptase-β2; Tryptase-2

Tpsg1

Transmembrane tryptase; Tryptase γ1

TPSG1

Gzmk

Granzyme K; Natural Killer (NK)-tryptase-2

GZMK

Prss29

Serine protease 29; tryptase δI

Prss41

Serine protease 41; testis serine protease 1

PRSS29P/
TPSD1
PRSS41

Gzma

Granzyme A

GZMA

Prss34

Mastin; Serine Protease 34

-

Tpsab1

A

TPSAB1
TPSB2

B
1.0

1.0

purified tryptase

0.9

72 h

**

0.9

0.8

0.8

0.6
0.5
0.4
0.3
0.2
0.1

***

0.7

A(410)

0 ng
1 ng
10 ng
25 ng
50 ng
75 ng
100 ng
250 ng
500 ng

0.7

A(410)

Human
Orthologs

Alternative Names

0.6
0.5
0.4

**

0.3
0.2
0.1
0.0

0.0
0

8

16

24

32

40

48

56

64

0

72

1

10

25

50

75

100

250

500

Tryptase (ng)

Time (h)

Figure 4.1. Measurement of interaction of purified human lung tryptase
(TPSAB1/TPSB2/TPSD1) with N-benzoyl-DL-arginine-p-nitroanilide (BAPNA) substrate.
(A) As described in Materials & Methods, purified tryptase was incubated at the concentrations
indicated over 72 hours with BAPNA. A410 is plotted against the time in h. In (B) tryptase
concentration is detected at a single, 72-h time point; tryptase (ng) is depicted versus the pNA
signal. Statistical significance was determined GraphPad Prism using a one-way ANOVA
followed by a Tukey’s post test; ***p<0.001, **p<0.01.
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4.5.2 Tryptase is not detectable in the supernatant from degranulated RBL-2H3 mast cells,
using BAPNA substrate.
Following our purified tryptase experiments, our next goal was to detect tryptase released
from a mast cell model line RBL-2H3 using the same tryptase substrate, BAPNA, incubated for
a period of 72 h. Because the plan was to stimulate RBL-2H3 to degranulate for one hour with
Ca2+ ionophore A23187 and to collect the cell supernatants to test for the presence of tryptase by
measuring pNA production, we first tested the conditions of a modified Tyrodes buffer with no
BSA on A23187 ionophore dose response degranulation curve in RBL-2H3. We monitored the
release of β-hexosaminidase from these cells using 4-MU (4-methylumbelliferone) substrate.
As seen in Fig. 4.2A, we detected robust increases in β-hexosaminidase released from
RBL-2H3 due to ionophore stimulation. Then we used the same exact conditions for stimulating
RBL-2H3 to degranulate, with the exception that now we assayed the cell supernatant for
tryptase activity (pNA) using BAPNA substrate.
Surprisingly, we were unable to detect any significant release of tryptase from RBL-2H3
cells (Fig. 4.2B). Importantly, we performed control studies in which 25 ng purified tryptase was
incubated with BAPNA in a background of various reagents used in the degranulation assay
(A23187 ionophore, DMSO [ionophore vehicle], TX, and BSA), and found that these variables
do not significantly affect the ability of purified tryptase to cleave BAPNA substrate (Fig.C1).
Taken together, these data indicate that RBL-2H3 cells likely do not release active
tryptase protein that is able to cleave the BAPNA substrate.

110

Figure 4.2. Measurement of β-hexosaminidase and tryptase in the supernatant of RBL-2H3
mast cells stimulated with calcium ionophore A23187. RBL-2H3 cells were incubated for one
hour with A23187 ionophore in modified Tyrodes buffer, and degranulation was quantified after
incubation with (A) 4-Methylumbelliferone (4MU) substrate for β-hexosaminidase or with (B)
BAPNA substrate for tryptase. Data are from one representative experiment; values represent
means ± SD of triplicate samples. Statistical significance was determined by one-way ANOVA
followed by Tukey’s post test.

4.5.3 Tryptase is not detectable in the supernatants from degranulated RBL-2H3 mast
cells, using tosyl-Gly-Pro-Lys-pNA substrate.
After observing no tryptase detection from degranulated RBL cells using the BAPNA
tryptase substrate, we utilized the commercially available tryptase degranulation kit from EMD
Millipore, which contains another known tryptase substrate: tosyl-Gly-Pro-Lys-pNA, instead of
BAPNA. First, a high dose of antigen (1μg/mL) in modified Tyrodes buffer (following IgE
sensitization) was applied for RBL cell stimulation, but no tryptase was detected from the
supernatants of stimulated RBL cells (Fig. 4.3A). Then we examined the release of tryptase after
stimulating RBL cells with 1μg/mL antigen in the proprietary assay buffer which was provided
in the kit, and, again, no tryptase was detected (Fig. 4.3B). Lastly, we stimulated RBL cells with
A23187 ionophore, strictly following the manufacturer’s protocol provided by EMD Millipore,
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and measured the production of pNA from the cell supernatant. There was no significant
difference compared
unstimulatedNorm
control
cells in this condition, either (Fig. 4.3C).
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Figure 4.3. Measurement of tryptase in the supernatant of RBL-2H3 mast cells stimulated
withOne
antigen
or A23187Agionophore using tosyl-gly-pro-lys-pNA tryptase substrate. RBLsample t test
Theoretical
mean sensitized
1.000
2H3 cells
were
for one hour with 0.1μg mL-1anti-DNP mouse IgE in RBL media (A
Actual mean
0.8645
and B).
In (A), plated0.1355
cells were treated with DNP-BSA Ag (1μg mL-1) for 15 minutes in
Discrepancy
95% CI of discrepancy
-0.5513 to 0.2803
modified
Tyrodes buffer.
In (B), cells in suspension were treated with DNP-BSA Ag (1μg mL-1)
t, df
t=1.402 df=2
P value (two tailed)
treatment
for 1 hour 0.2959
in 1X Assay buffer provided in the Mast cell degranulation assay kit (EMD
Significant (alpha=0.05)? No
Millipore). In (C), cells in suspension were stimulated with 200nM A23187 ionophore for 1
hour. Degranulation was quantified with tosyl-gly-pro-lys-pNA tryptase substrate provided by
the Mast cell degranulation assay kit (EMD Milipore). Error bars represent the standard error of
the mean of the data from three experiments; triplicates per sample were done on each
experimental day. No statistical significance was determined by one-sample t-tests.

4.5.4 Lysates from RBL-2H3 mast cells and from NIH-3T3 fibroblast cells contain a
substance that can cleave the tosyl- Gly-Pro-Lys-pNA substrate.
Since tryptase release from RBL cells was not detectable using either of those tryptase
substrates, we next tested RBL cell lysates. Compared to the signal from RBL cell supernatant,
lysates from RBL cells displayed significantly higher readings when incubated with tosyl-GlyPro-Lys-pNA substrate (Fig. 4.4A). To test whether the signals obtained from the RBL lysates
were due to the presence of tryptase, we also examined NIH-3T3 cell lysates because NIH-3T3
cells are non-granulated fibroblasts which do not contain mast cell markers. We found that there
was no significant difference between NIH-3T3 lysates and RBL-2H3 lysates (Fig. 4.4B).
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Figure 4.4. Measurement of tryptase from RBL-2H3 and NIH-3T3 Samples
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4.5.5 Tryptase is not detectable in the supernatants from degranulated RBL-2H3 mast
cells, using rat TPSAB1 ELISA.
Using two different tryptase substrates, BAPNA (Fig. 4.2) and tosyl- Gly-Pro-Lys-pNA
(Fig. 4.3), no active tryptase protein (capable of cleaving either of these substrates) was detected
in the supernatants of degranulated RBL-2H3 mast cells. Those data suggest that no active
tryptase protein is present in the RBL cells’ granules. To further investigate whether
degranulated RBL cell supernatants contain tryptase, regardless of protein activity level, we
utilized a sandwich ELISA kit, which detects one of the key rat tryptase protein types, TPSAB1.
This ELISA kit detects as little as 0.3 ng/mL tryptase (as shown in a standard curve generated
using purified rat TPSAB1 protein [provided in the kit], Fig. C2). Again, no tryptase was
detected in the supernatants of Ag-stimulated, degranulated RBL cells (compare “RBL control
supernatant” to “RBL Ag supernatant” in Fig. 4.5), another indication that tryptase is not present
in the granules of RBL cells. However, the phenomenon of apparent tryptase signal found in
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RBL lysates, as in Fig. 4, was also found in RBL lysates via this ELISA measurement (Fig. 4.5).
Again, though, the TPSAB1 ELISA signal from RBL lysates was equivalent to the ELISA signal
arising from NIH-3T3 cell lysates (Fig. 4.5). Thus, the apparent TPSAB1 signal in RBL cell
lysates is not a granule-associated protein.
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Figure 4.5. Measurement of Tpsab1 tryptase from RBL and NIH cells by ELISA. RBL-2H3
cells were sensitized with anti-DNP IgE (0.1μg mL-1) for 1 hr before being treated with DNPBSA Ag (1μg mL-1) for 15 min. Rat tryptase protein (Tpsab1) was measured using a sandwich
ELISA kit (Biomatik). Data are from one representative experiment; values represent means ±
SD of duplicate samples. Statistical significance was determined as compared to the RBL control
supernatant sample, by one-way ANOVA followed by Tukey’s post test. ***p<0.001

4.5.6 No rat tryptase mRNA was detected in RBL-2H3 cells using PCR.
Because three distinct methods of tryptase protein detection (Figs. 4.2, 4.3, and 4.5)
failed to find tryptase protein released from degranulated RBL cells, we next used PCR to
investigate whether tryptase mRNA transcripts are present in RBL cells. To generate cDNA
template, total RNA was extracted from antigen-stimulated RBL-2H3 cells and was reversetranscribed. Numerous cell treatment experimental conditions prior to the RNA extraction are
listed in supplementary material Table C1, including several variations of IgE sensitization,
antigen stimulation, and timeframe conditions. Primer pairs and the size of amplicons for eight
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rat tryptase genes are shown in Fig. 4.6C. In addition, mRNA of two rat β-hexosaminidase genes
(Hexa and Hexb) and of β-actin (Actb) were amplified as positive controls.

B

C

(bp) MW NTC Hexa Hexb
MW
1000
850
650

Figure 4.6. Measurement of rat tryptase and β-hexosaminidase mRNA from RBL-2H3 cells
using PCR. Eight target rat tryptase genes’ mRNA (A) and two β-hexosaminidase genes’
mRNA (B) were analyzed. Total RNA was extracted from RBL-2H3 cells, and reverse
transcription was performed as described in Materials & Methods in order to generate cDNA,
which was amplified by PCR. Actin was used as a positive control. The primer pairs and the size
of PCR products are listed in the table (C). The PCR amplicons were subjected to electrophoresis
in 1% agarose gels, and the target bands were extracted for sequencing to be confirmed (data not
shown). Data shown are representative of all cell stimulation conditions and timeframes
(supplement table S1). None of tryptase genes’ mRNA was found in any of the stimulation
conditions whereas actin and β-hexosaminidase genes’ mRNA were always detected. NTC is no
template control; MW is molecular weight marker.
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In fifteen separate testing conditions, from unstimulated controls to cells treated with
high Ag doses to various RNA collection timepoints up to 24 hours post Ag stimulation, none of
the eight tested tryptase genes’ mRNA was detected by PCR (Fig. 4.6A). This lack of tryptase
transcript detection stands in contrast to consistent robust detection of actin transcripts (Fig. 4.
6A) and of both β-hexosaminidase mRNAs (Fig. 4.6B), over all fifteen cell-treatment conditions
listed in Table C1. Therefore, these findings show that no tryptase genes are expressed in RBL2H3 cells.

4.5.7 Genomic DNA of all rat tryptase genes was detected using PCR, in RBL-2H3 cells.
A

B

Figure 4.7. Measurement of rat tryptase genomic extracted from RBL-2H3 cells using
PCR. A) Eight target tryptase genes’ genomic DNA were amplified by PCR as described in
Materials & Methods. The primer pairs and the size of PCR products are listed in the table (B).
PCR amplicons were subjected to electrophoresis in 1% agarose, and the target bands were
extracted for sequencing confirmation (data not shown). MW is molecular weight marker.
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Because none of the tryptase genes’ mRNA was detected, we next questioned whether
tryptase genomic DNA is present in this cell line. To determine whether these eight tryptase
genes exist in the RBL genome, we extracted genomic DNA from RBL-2H3 cells and amplified
with the gene-specific primer pairs shown in Fig. 4.7B. Genomic DNA from all eight tryptase
genes was detected by PCR (Fig. 4.7A), and each band was excised, cleaned, sequenced, and
confirmed as the correct gene (sequence data not shown). Overall, our results suggest that RBL2H3 cells do not transcribe and translate tryptase genes even though all tryptase genes exist in
the genomic DNA of RBL-2H3 cells.

4.6 Discussion
In this study, we optimized an assay, based upon cleavage of BAPNA substrate, for
detection of as little as 1 ng active tryptase per sample. While this assay is 10-fold more sensitive
than the BAPNA-based method published by Lavens et al. (which could pick up ≥10 ng tryptase)
(Lavens et al., 1993), we were unable to find any tryptase released from stimulated, degranulated
RBL-2H3 cells. In this assay, ~100,000 RBL-2H3 cells per well of a 96-well plate were
stimulated under conditions causing robust degranulation and β-hex release, and one-quarter of
the resulting cell supernatant (50 μL out of 200 μL supernatant in each well; equivalent to the
contents released from ~25,000 RBL-2H3 cells) was incubated with BAPNA substrate.
According to Lavens et al. (1993), human lung mast cells contain 11.2 ± 0.7 pg tryptase
per cell, so, if RBL-2H3 cells contained similar tryptase levels, we would expect ~280 ng
tryptase per sample from fully-degranulated cells or perhaps 28 ng tryptase per sample from
modestly-degranulated cells—levels far above the assay’s sensitivity, 1 ng. Therefore, our results
with the BAPNA substrate suggest that RBL-2H3 cells contain very little or no active tryptase
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protein. Additional studies with an alternative tryptase substrate, tosyl-Gly-Pro-Lys-pNA, and
with ELISA assays for TPSAB1 protein also revealed a lack of tryptase protein released from
RBL-2H3 cells stimulated via multiple means.
Thus, we also investigated whether tryptase mRNA transcripts are found in RBL-2H3
cells. We found none of the mRNA transcripts of the rat tryptase genes (Tpsb2, Tpsab1, Tpsg1,
Prss34, Gzmk, Gzma, Prss29, Prss41) in RBL-2H3 cells, whereas genomic DNA of all the
tryptase genes was readily detected by PCR. Since these genes were found in genomic DNA, we
looked for tryptase gene expression following a wide range of RBL-2H3 stimulation conditions,
from 1 to 24 hours post antigen stimulation (Table C1), but no mRNA transcripts were found
under any condition. The reason for testing at varied time points is that mast cells undergo
recovery and regeneration/refilling of the granules after degranulation (Dvorak et al., 1986;
Dvorak et al., 1988), so we had hypothesized that tryptase gene expression may fluctuate over
time, before and after degranulation. Also, we performed clonogenic cytotoxicity assays and
found that RBL-2H3 cells survive post-degranulation (data not shown), a necessary control for
Table C1 experiments. We did find that mRNA levels of another MC granule component, βhexosaminidase (both forms A and B), are constitutively robust in RBL-2H3 cells, regardless of
time point or stimulation method: further evidence that, if any of these eight tryptase genes were
expressed in RBL-2H3 cells, we would have been able to find its transcript in at least one of the
sixteen cell stimulation conditions tested.
There were occasional, faint bands in gels assessing mRNA expression of tryptase genes
(Fig. 4.6A), though these were not the correct product sizes of the expected tryptases (Fig. 4.6C).
For example, from one gel, a faint band was excised from the Prss34 lane, purified, sequenced,
and determined to be not tryptase but, rather, carboxypeptidase A3 (data not shown). The
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nucleotide sequence homology between rat Prss34 and carboxypeptidase A3 is significant, so,
most likely, the primers used for Prss34 accidentally amplified a small amount of this off-target
gene after multiple rounds of PCR. Another time, a faint band from the Tpsab1 lane was
sequenced and found to correspond to a histone deacetylase. Attempts to isolate and sequence a
faint band, positioned below the expected Gzma size, from the Gzma lane were unsuccessful,
likely because there was very little material present. Also, other researchers reported a lack of
Gzma mRNA in RBL-2H3 cells (Nakajima et al., 1995). Overall, no tryptase mRNA was
detected for any of the eight tested tryptase genes.
Other researchers have previously reported a lack of certain tryptases in RBLs. Similar to
our Fig. 4.2 results, two other studies also observed a lack of tryptase via BAPNA assay in
supernatants of degranulated RBL cells, even while β-hex release was readily measured in the
same supernatants (Peng et al., 2011; Tang et al., 2012). Mass spectrometry analyses of cell
supernatants from degranulated RBL-2H3s also found no tryptase proteins (Sadroddiny et al.,
2012a; Sadroddiny et al., 2012b). Furthermore, Ide et al. reported that no mRNA of Tpsb2
(noted as rMCT [rat mast cell tryptase] in the article) was located in RBL-2H3 cells (Ide et al.,
1995). However, one publication did report high levels of tryptase (as measured by BAPNA
reaction) released into the supernatants of unstimulated RBL-2H3 cells, with further increases
due to hypoxia (Maxova et al., 2010). This result is puzzling because, typically, very low levels
of spontaneous degranulation occur in unstimulated (no antigen, no ionophore, etc) RBL-2H3
cells.
Two additional studies have reported detection of tryptase in RBL-2H3 cells (Small-Howard and
Turner, 2005; Song et al., 2016). However, these two studies measured tryptase (via ELISA in
Song et al. and via substrate activity assay in Small-Howard and Turner) within cell lysates, not
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from the supernatants of stimulated intact cells. Since our current study demonstrated that lysates
from both RBL-2H3 and NIH-3T3 cells processed tosyl-Gly-Pro-Lys-pNA substrate (Fig. 4.4)
and yielded tryptase ELISA absorbance (Fig. 4.5), these signals are likely not from MC granule
tryptases. Rather, other, non-granule-associated serine proteases may be picked up by these two
studies and in Figs.4.4 and 4.5. For example, retinoid-inducible serine carboxypeptidase 1 (also
known as carboxypeptidase C) is found in RBL-2H3 cells (Sadroddiny et al., 2012a). Also, the
substrate tosyl-Gly-Pro-Lys-pNA can be cleaved by enzymes other than tryptase, including
plasmin/plasminogen (Wiedow et al., 1997; Vakili et al., 2001; Drinane et al., 2006). The key
mast cell function is release of granule contents from safe storage in intracellular granules, into
extracellular fluids, via plasma membrane fusion; thus, analyzing the contents of MC whole-cell
lysates is an erroneous measure of MC function.
Because tryptase is known to be localized within granules and exclusively expressed in
mast cells (Schwartz et al., 1987; da Silva et al., 2014), we had anticipated to find tryptase
released into the supernatants of degranulated RBL-2H3 cells in this study. One possible reason
for our findings is that RBL cells are physiologically similar to rodent mucosal mast cells (Seldin
et al., 1985). MCs display a high degree of heterogeneity in contents of granules, as a
consequence of their ubiquitous location and a wide range of microenvironments they encounter
(da Silva et al., 2014). Human MCs are divided into two subsets based on protease content:
MCTC, containing tryptase, chymase, and carboxypeptidases, or MCT, containing only tryptase
(Irani et al., 1986). Rodent MCs are subcategorized into mucosal mast cells (MMCs) and
connective tissue mast cells (CTMCs) (Metcalfe et al., 1997). While tryptase is present in all
human MCs (Irani et al., 1986), rodent MMCs do not express tryptase but, rather, predominantly
express chymase (Le Trong et al., 1987; Reynolds et al., 1990; Serafin et al., 1990; Huang et
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al., 1991; Lutzelschwab et al., 1997). Thus, RBL-2H3 cells’ similarity to MMCs might explain
the lack of tryptase expression.
In summary, this current study is the first comprehensive report on detection of tryptase
protein and transcripts from RBL-2H3 cells. Multiple lines of experimental evidence indicate
that mRNA from eight tryptase genes is not present and that tryptase protein is either not present
or is below detection limits of the assay in supernatants from degranulated RBL-2H3 cells.
Instead, mast cell researchers should utilize β-hex, histamine, serotonin, or other reliable markers
for RBL-2H3 degranulation studies. Comparative studies of toxicant effects on RBL-2H3 mast
cells in vitro and in zebrafish in vivo will require use of a degranulation reporter different from
tryptase.
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CHAPTER 5
TRICLOSAN IS A MITOCHONDRIAL UNCOUPLER IN LIVE ZEBRAFISH
5.1 Abstract
Triclosan (TCS) is a synthetic antimicrobial agent used in many consumer goods at
millimolar concentrations. As a result of exposure, TCS has been detected widely in humans.
We have recently discovered that TCS is a proton ionophore mitochondrial uncoupler in multiple
types of living cells. Here we present novel data indicating that TCS is also a mitochondrial
uncoupler in a living organism: 24 hour post fertilization zebrafish embryos. These experiments
were conducted using a Seahorse Bioscience XFe 96 Extracellular Flux Analyzer modified for
bidirectional temperature control, using the XF96 spheroid plate to position and measure one
zebrafish embryo per well. Using this method, following acute exposure to TCS, basal oxygen
consumption rate (OCR) increases, without a decrease in survival or heartbeat rate. TCS also
decreases ATP-linked respiration and spare respiratory capacity and increases proton leak: all
indicators of mitochondrial uncoupling. Our data indicate, that TCS is a mitochondrial uncoupler
in vivo, which should be taken into consideration when assessing the toxicity and/or
pharmaceutical uses of TCS. This is the first example of usage of a Seahorse Extracellular Flux
Analyzer to measure bioenergetic flux of a single zebrafish embryo per well in a 96 well assay
format. The method developed in this study provides a high-throughput tool to identify
previously-unknown mitochondrial uncouplers in a living organism.

5.2 Short Abstract
Antimicrobial agent triclosan (TCS) is a mitochondrial uncoupler in multiple cell types.
Here we present data, obtained with a Seahorse Bioscience XFe 96 Extracellular Flux Analyzer,
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indicating that TCS is also a mitochondrial uncoupler in living zebrafish (24 hpf; 1
embryo/well). TCS increases oxygen consumption rate and proton leak and decreases ATPlinked respiration and spare respiratory capacity without affecting survival or heartbeat rate.
These data indicate, for the first time, that TCS is a mitochondrial uncoupler in vivo.

5.3 Introduction
Triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol; TCS) is a synthetic antimicrobial
agent (Lyman and Furia, 1968) that has been used in hospitals since the 1970’s. TCS can be
found in soaps, deodorants, mouthwashes, toothpastes, household cleaners, and more products
typically at concentrations up to several mM (Jones et al., 2000; Rodricks et al., 2010). Most
U.S. citizens are exposed to triclosan (Calafat et al., 2008). Chronic exposure of zebrafish
embryo/larvae to TCS has been found to cause delayed development, malformations, delayed
hatching and inhibition of growth (Oliveira et al., 2009).
Recently, it has been published that TCS is a proton ionophore mitochondrial uncoupler
in living rat (RBL-2H3) and human (HMC-1) mast cells, mouse fibroblasts (NIH-3T3), and
primary human keratinocytes (Weatherly et al., 2016). Without cytotoxicity, TCS reduces ATP
production and increases oxygen consumption rate (OCR), while its non-protonated sister
compound TCS-methyl causes no such effects (Weatherly et al., 2016). Triclosan has also been
shown to impair mitochondrial function in isolated rat liver mitochondria (Newton et al., 2005;
Ajao et al., 2015). Additionally, in vitro studies suggest that TCS inhibits mitochondrial
membrane potential (Attene-Ramos et al., 2015), an indicator of proton ionophore mitochondrial
uncoupling (Suzuki et al., 2006; Kuznetsov et al., 2011).
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In the present study, we investigate whether TCS is a mitochondrial uncoupler in an
intact living organism, the 24 hour post fertilization (hpf) zebrafish embryo. Carbonyl cyanide
p-triflouromethoxyphenylhydrazone (FCCP) is an ionophore proton ion carrier which disrupts
ATP synthesis by transporting hydrogen ions across the inner mitochondrial membrane, thus
bypassing the proton channel of ATP synthase (Heytler and Prichard, 1962). In this study, we
utilized FCCP, a known mitochondrial uncoupler, as a reference compound to compare the
effects of TCS on mitochondrial fidelity. This study is the first demonstration of TCS’s
mitochondrial effects in vivo, and our results indicate that the previous in vitro findings are valid.
Recently, Seahorse Bioscience XF-24 Extracellular Flux Analyzers have been used
successfully to assess the bioenergetics of zebrafish (Stackley et al., 2011; Gibert et al., 2013;
Bestman et al., 2015). One of the studies measured OCR and bioenergetics of zebrafish from 3
to 48 hpf (Stackley et al., 2011). They also validated the XFe 24 measurements with the Clark
electrode method (Stackley et al., 2011). Another XF-24 study analyzed the bioenergetics effects
of the known mitochondrial uncoupler 2,4-dinitrophenol (DNP) on 3-72 hpf zebrafish (Bestman
et al., 2015). However, these published studies have utilized relatively low-throughput 24-well
plates, time-consuming placement of islet capture screens, and multiple fish per well (required to
attain suitable signal-to-noise ratios). The present study is the first instance of using chorionated
zebrafish in a custom-modified Seahorse Bioscience XFe 96 Extracellular Flux Analyzer, which
allows temperature-controlled, high-throughput (96-well) bioenergetic measurements with a
single embryo per well, without a need of an islet capture screen.

124

5.4 Materials and Methods
5.4.1 Animals and Ethics Statement
The fertilized eggs of wild-type zebrafish (Danio rerio, AB strain) were obtained from
the Zebrafish Facility at the University of Maine by natural crosses. Embryos were maintained in
egg water (60µg/mL Instant Ocean sea salts [Aquarium Systems, Mentor, OH, USA]) at 28 ºC
with a 14/10 hr light/dark cycle. All experiments were performed with 24 hpf zebrafish, which
remain in the chorion at this stage. Animal studies were approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Maine and performed in accordance with
the defined guidelines for use of zebrafish embryos.

5.4.2 TCS preparation
Triclosan (TCS) was purchased from Sigma-Aldrich (St. Louis, MO, USA) (“irgasan,”
≥97% by HPLC; CAS no. 3380-34-5). A starting TCS stock (22.5 or 45 µM) was freshly
prepared for each experimental day by dissolving TCS in egg water, without use of organic
solvents, following our published protocol (Weatherly et al., 2013). TCS concentration was
determined by UV-Vis spectrophotometry (Weatherly et al., 2013).

5.4.3 Mitochondrial oxygen consumption assay
A modified XFe 96 Extracellular Flux Analyzer (Seahorse Bioscience, North Billerica,
MA, USA; details of the commercially-available instrument are found at
http://www.seahorsebio.com/products/how-xf-works.php) was used to measure oxygen
consumption rate (OCR). Three modifications of published methods were used for this study: 1.)
instrument re-configuration to allow for bi-directional temperature control; 2.) use of chorionated
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zebrafish embryos to obviate the need for islet capture screens; and 3.) the use of one embryo per
well rather than the two or more embryos required per well in previous studies. A novel
modification of this instrument was made to allow for bi-directional temperature control, in order
to allow temperature stabilization at the moderate levels (28-29ºC) favored by zebrafish. Prior to
each run, calibration was performed using XF Calibrant solution (200 µL per well) (Seahorse
Bioscience) in a XFe 96 Extracellular Flux assay kit (Seahorse Bioscience) using an automated
process by the analyzer.
Live zebrafish embryos (24 hpf) were arrayed in XFe 96 Spheroid microplate (Seahorse
Bioscience) with 50 µL of egg water (1 embryo/well). These chorionated embryos were briefly
checked to confirm that they had settled into the center of the wells. We found that the chorion
provides enough mass to weigh down the embryos to keep them settled at the bottom centers of
the wells, where they remained for the duration of the assays, thus obviating the need for timeconsuming placement of islet capture screens. In contrast to the previously published zebrafish
work utilizing the XF-24 Seahorse equipment (Bestman et al., 2015; Gibert et al., 2013; Stackley
et al., 2011), only one embryo per well (rather than multiple fish) were required to attain a robust
signal-to-noise ratio. The XF-24 system’s micro-chambers utilize a measurement volume of 7
μL, whereas the XFe 96’s flux measurements occur in a volume of <2 μL. This ~4X reduction in
volume translates to improved sensitivity which allows for the use of a single embryo per well.
OCR values resulting from one 24 hpf zebrafish embryo/well were 100-150 pmol/min, and OCR
values resulting from background control wells which contained egg water but no fish were close
to 0 pmol/min, ± 9-11 pmol/min (standard deviation). Thus, the signal from one chemicallyuntreated 24 hpf embryo is 10-15 times the noise, a robust signal-to-noise level.
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Next, 100 µL of either 22.5 µM or 45 µM of TCS were added to the appropriate wells,
for final concentrations of 15 and 30 µM TCS, respectively. FCCP (provided in the XF Mito
Stress Test Kit, Seahorse Bioscience), at a final concentration of 0.5µM, was also added (100
µL) as a positive control to the appropriate wells. Measurements of total zebrafish OCR were
started immediately and performed according to the manufacturer’s instructions. Thirteen basal
readings were performed, each with 2 minutes of mixing and 3 minutes of measuring. When the
readings were completed, the mortality of each embryo was determined by heartbeat
measurement manually by eye under the light microscope for 30 seconds per embryo (Oliveira et
al., 2009; Nesan and Vijayan, 2012; Pylatiuk et al., 2014).

5.4.4 XF Cell Mito Stress Test Kit OCR assay
The XF Cell Mito Stress Test kit (Seahorse Bioscience) contains three inhibitors,
oligomycin, FCCP, and rotenone/antimycin-A, which target the functions of ATP synthase,
mitochondrial uncoupling, and complex I/III, respectively. Oligomycin is used to distinguish the
percentage of oxygen consumption devoted to ATP synthesis and the percentage of oxygen
consumption required to overcome the natural proton leak across the inner mitochondrial
membrane. The OCR stimulated by FCCP treatment can be used to calculate the spare
respiratory capacity of cells, which is highly effective for determining mitochondrial fidelity and
function. Rotenone/antimycin-A shuts down mitochondrial respiration and enables the
delineation of mitochondrial versus non-mitochondrial OCR fractions contributing to respiration.
All drugs were prepared following the manufacturer’s recommendations and were
dissolved in egg water. The inhibitors were then loaded into XFe 96 extracellular flux assay plate
(Seahorse Bioscience). Titrations were performed to determine the optimal concentration of each
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inhibitor (data not shown). Before successive injections of these three drugs, basal OCR (±
TCS) was measured for ~1 hour (12 cycles, each consisting of 1.5 min mixing and 3 min
measurement). Then, sequential injections of 12.5 µM oligomycin, 2 µM FCCP, and 0.5 µM
rotenone/antimycin-A were performed, and OCR measurements were recorded for 3 minutes
(following 2 minutes of mixing) for 14, 3, and 14 times, respectively. Proton leak (which is
defined as [lowest OCR measurement following oligomycin addition] - [OCR following
rotenone/antimycin-A treatment]), ATP-linked respiration (which is defined as [final basal OCR
measurement before oligomycin addition] - [lowest OCR measurement following oligomycin
addition]), and spare respiratory capacity (which is defined as [maximal respiration following
FCCP injection] - [final basal OCR measurement before oligomycin addition)] were calculated
by the XF Cell Mito Stress Test Report Generator (Seahorse Bioscience). The applied
concentrations of oligomycin and FCCP were previously found not to cause zebrafish embryo
death (Stackley et al., 2011).

5.4.5 Statistical Analysis
OCR was calculated by the Seahorse Wave software (Seahorse Bioscience). For figure
5.1A, data from 16-22 embryo replicates per treatment group per experimental day were
averaged at each time point. These averages were then normalized to the last time point of the
30 µM TCS sample average. These results were then further normalized by comparing them to
the 0 µM TCS control from the corresponding experimental day and by multiplying by 100% to
get the percent of control. Next, these normalized data from 3 independent biological replicate
experiments performed on different days were averaged together and were plotted as mean ±
standard error of the mean (SEM).
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The data representing proton leak, ATP-linked respiration, and spare respiratory capacity
from 4 independent biological replicate experiments performed on different days (each
experiment consisted of 14-16 embryo replicates per treatment group per experimental day) were
analyzed by the XF Cell Mito Stress Test Report Generator (Seahorse Bioscience). Next, each
set of experimental data was normalized to either the 0 µM control or 30 µM TCS sample. These
normalized data (4 experiments) were averaged together to generate the Figure 5.2 bar charts.
The significance was assessed via one-way analysis of variance (ANOVA) with Tukey’s or
Dunnett’s post-hoc test, using Prism software (Graphpad, San Diego, CA, USA).

5.5 Results
5.5.1 Triclosan increases oxygen consumption rate in living zebrafish.
One embryo at 24hpf was placed in each well with egg water. Various concentrations of
TCS or FCCP were added right before the assay plate was placed in the analyzer for immediate
OCR measurements for ~1 hour. The first OCR measurement of each experiment was recorded
~5 minutes after TCS or FCCP exposures began. Both 15 µM and 30 µM TCS cause
significantly higher basal OCR compared to control (Fig. 5.1A). FCCP (0.5 µM) also displays
higher OCR compared to the control group (Fig. 5.1A). Also, ANOVA with Tukey’s post-test
analysis indicates that the 15 μM TCS sample is different from the 0.5 μM FCCP sample (p <
0.001) and that the 30 μM TCS sample is different from the 0.5 μM FCCP sample (p < 0.05).
For each experiment, 4-6 wells were assigned as background wells, that contained egg
water ± TCS, but no embryos. Background OCR levels were not significantly altered by 30 µM
TCS compared to control (data not shown), indicating that the effect on OCR is due to a
biological response to TCS. When the assay was completed, the heartbeat of each embryo was
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measured for 30 seconds under a light microscope. No mortality was observed in any of the
groups (Fig. 5.1B). Also, TCS exposure did not affect heartbeat rate; however, 0.5 µM FCCP
seemed to slow heartbeat rate compared to control, although this effect was not statistically
significant (Fig 5.1B).

Figure 5.1. Measurement of basal OCR of living zebrafish embryos exposed to TCS. A)
Basal OCR was measured for ~1 hour (13 readings), immediately after 24 hpf embryos were
exposed to 0, 15, 30 µM TCS or 0.5 µM FCCP in egg water. At each timepoint, measurements
were normalized to the first reading from the 0 µM control for that experimental day. Values
represent means ± SEM for three independent experiments, where 16-22 embryos per treatment
group were tested for each experiment. One-way ANOVA with Dunnett’s post-tests (compared
to the 0 µM control) were performed using Graphpad Prism software; *p< 0.05, **p< 0.01. B)
Immediately after each basal OCR assay was completed, measurements of heartbeat of
individual embryos were taken for 30 seconds, and the survival rate was determined. No
significance was determined by one-way ANOVA with Dunnett’s post-tests (compared to the 0
µM control).
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5.5.2 Triclosan causes uncoupled mitochondrial respiration in living zebrafish
To further assess whether non-lethal doses of TCS disrupt mitochondrial function, the XF
Cell Mito Stress Test Kit, which contains oligomycin, FCCP, and rotenone/antimycin-A, was
utilized. Immediately following TCS or 0 μM control exposure, 12 measurements of basal OCR
were taken before sequential injection of oligomycin (12.5 µM), FCCP (2 µM) and
rotenone/antimycin-A (0.5 µM).
B

A

C

Figure 5.2. TCS as a mitochondrial uncoupler in living zebrafish. Zebrafish embryos (24 hpf)
were exposed to TCS for ~1 hr (12 measurements of basal OCR), then the Mito Stress Test kit
(Seahorse Bioscience) was performed. A) Proton leak, B) ATP-linked respiration, and C) Spare
respiratory capacity were calculated using the Mito Stress Test Report Generator V2 (Seahorse
Bioscience). Data from individual experimental days were normalized either to 30 µM TCS (A)
or to 0 µM TCS (B and C) and values represent means ± SEM for four independent experiments,
where 14-16 embryos per treatment group were tested in each experiment. One-way ANOVA
with Dunnett’s post-tests (compared to the 0 µM TCS) were performed using Graphpad Prism
software; *p< 0.05, **p< 0.01
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The proton leak, ATP-linked respiration and spare respiratory capacity were calculated as
described before using the XF Cell Mito Stress Test Report Generator (Seahorse Bioscience).
Both 15 and 30 µM TCS cause significant increases in proton leak, compared to 0 µM TCS
control (Fig. 5.2A). High proton leak values indicate high levels of mitochondrial uncoupling
and inefficient ATP production (Brand and Nicholls, 2011). ATP-linked respiration (that is, the
respiration that is correlated with mitochondrial production of ATP) is inhibited by TCS (Fig.
5.2B). Spare respiratory capacity also decreases significantly at 30 µM TCS (Fig. 5.2C),
indicating mitochondrial dysfunction during conditions of increased energy demand (Brand and
Nicholls, 2011).

5.6 Discussion
Assessment of chemicals that can cause adverse human health and environmental effects
needs to be conducted robustly and in a cost-effective manner. Zebrafish offer an effective, highthroughput low-cost alternative to mammalian testing. Zebrafish embryos have become a useful
model in the field of toxicology (Nagel, 2002; Langheinrich, 2003; Braunbeck et al., 2005;
Parng, 2005; McGrath and Li, 2008). This method we have developed could be a potential
high-throughput in vivo assay to screen a variety of toxicants or drugs in order to identify novel
mitochondrial uncoupler or other effectors of bioenergetic function.
Using zebrafish embryos, here we show that TCS is a mitochondrial uncoupler in vivo.
We show that basal OCR increases with an increase in TCS and does not decrease survival or
heartbeat rate at these concentrations. We also show TCS inhibition of ATP-linked respiration
and spare respiratory capacity and TCS stimulation of proton leak. Triclosan’s inhibition of
ATP-linked respiration indicates that TCS inhibits mitochondrial ATP production. The increase
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in proton leak indicates mitochondrial uncoupling (Brand and Nicholls, 2011) caused by TCS.
Spare respiratory capacity is a measure of the organism’s ability to respond to an increase in
energy requirement (Yadava and Nicholls, 2007), and its inhibition by TCS indicates
mitochondrial dysfunction (Brand and Nicholls, 2011). Decrease in ATP production and increase
in OCR, both of which are shown here to be caused by TCS in 24 hpf zebrafish, are two of the
main hallmarks of a mitochondrial uncoupler (Poe et al., 1967; Hanstein, 1976; Brand and
Nicholls, 2011).
Zebrafish embryos (24-72 hpf) were previously used to assess the bioenergetics of a
known mitochondrial uncoupler, 2,4-dinitrophenol (DNP), as an in vivo model (Bestman et al.,
2015). This earlier study utilized the XF-24 Extracellular Flux Analyzer (Seahorse Bioscience).
An islet capture screen was utilized to keep the zebrafish in place. As in a previous study, two
embryos per well were necessary at the 7-30 hpf stages, and 3 embryos per well were required at
the 3 hpf stages, in order to achieve sufficient OCR levels. With 3 hr exposure to 0.5 µM DNP,
beginning at 3hpf, basal OCR levels were significantly increased in zebrafish embryos (Bestman
et al., 2015). In comparison, we found that basal respiration of 24 hpf embryos is also increased
due to TCS exposure for 1 hour at 15 and 30 µM (Fig. 5.1A). Proton leak in 24 hpf zebrafish
embryos that had been treated with 0.5 µM DNP for total of 21 hours was increased (Bestman et
al., 2015). Similar to this, at 24 hpf, 15 and 30 µM TCS exposure for 1 hour cause significant
increases in proton leak (Fig. 5.2A). At 24-72 hpf, zebrafish embryos’ ATP-linked respiration
was decreased after exposure to 0.5 µM DNP for 21-69 hrs (Bestman et al, 2015). Similarly, 1
hour of TCS exposure inhibits ATP-linked respiration (Fig. 5.2B). Our finding that TCS causes
similar effects on the key bioenergetic parameters basal OCR, ATP-linked respiration, and
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proton leak, compared to the known mitochondrial uncoupler DNP, further support the idea that
TCS is a mitochondrial uncoupler in vivo.
The robust effects of TCS (by immersion) on zebrafish bioenergetics that we report (Fig.
5.1A and Fig. 5.2) strongly suggest that TCS passes through the chorion. However, no complete
assessment of the differential permeability of the chorion, which remains intact in 24 hpf
embryos, has been performed, but the chorion has been shown to act as a barrier to various
compounds (Braunbeck et al., 2005; Carlsson et al., 2013). The chorion discriminates against
certain compounds depending on chemical structure (Harvey et al., 1983; Braunbeck et al.,
2005; Sachidanandan et al., 2008; Kais et al., 2013). However, the exact nature of which
compounds pass more easily through the chorion is contradictory. When TCS is in egg water
(pH 7.0), ~90% of TCS molecules are protonated and, thus, lipophilic. The lipophilicity of the
compound does seem to be a factor in the permeability across the chorion, but whether or not
more lipophilic compounds increase or decrease the permeability remains up for debate
(Braunbeck et al., 2005; Sachidanandan et al., 2008), and lipophilicity is likely only one of many
structural factors determining chorion permeability of a particular chemical. A study found that
exposure to 1.1 µM fipronil (a broad-use insecticide), starting at 1 hpf and ending at 48 hpf,
caused notochord degeneration in zebrafish (Stehr et al., 2006). The exposure and subsequent
notochord degeneration occurred while the embryos were still in the chorion, indicating that the
fipronil most likely crossed the chorion barrier. Fipronil and TCS have similar two-ring
organohalogen structures.
Thus, along with the fact that TCS caused extensive bioenergetic effects on the zebrafish,
it is highly likely that at least some fraction of the applied TCS crossed the chorion during the
treatment period. Size of the compound of interest also seems to be a factor in chorion
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permeability. A study found that 3,000 Da fluorescent dextrans were able to pass through the
chorion while 10,000 Da dextrans could not permeate the chorion (Creton, 2004). Because
triclosan’s molecular weight is ~289 Da, its size is likely not too large to penetrate the chorion.
However, given the published data relating to the ability of the chorion to present a barrier to
various xenobiotics (Braunbeck et al., 2005), it is probable that TCS’s potency is greater in
dechorionated embryos.
The present investigation demonstrates that the ubiquitous antimicrobial TCS causes
mitochondrial uncoupling, with no mortality, in a living organism at concentrations ~1000-fold
lower than those used in personal care products. TCS at 30 μM is nearly as potent as 0.5 μM
FCCP in 24 hpf zebrafish (Fig. 5.1A), and TCS’s uncoupling effect is a biochemical mechanism
that likely underlies many organismal health effects. Because triclosan’s toxicity is currently
being reviewed by U.S. and other government agencies, these live animal, mechanistic data are
critical. This study was performed using a novel method, utilizing live, single, chorionated
zebrafish embryos in a 96-well high-throughput format with bidirectional temperature control.
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CHAPTER 6
SUMMARY AND CONCLUSIONS
Arsenic is an environmental toxicant which causes many human health problems. Arsenic
exposure has been reported globally since its major route of exposure is via drinking water or
diet. In some countries, large populations are exposed to high dosages of arsenic. Triclosan is an
antimicrobial agent, which was found in nearly all the soap products in the late 2000s. Although
the FDA recently banned its usage in most soap products (consumer and hospital settings),
triclosan remains as an active ingredient in many consumer products, including a top-selling
toothpaste, and in household products such as toys and kitchenware.
Mast cells are important immune cells that are involved in numerous physiological
functions and diseases, including allergic reaction, inflammatory responses, host defense,
neurological processes and more. Mast cells reside in nearly every tissue, particularly in where
they interface with environment. Therefore, mast cells are easily targeted by toxicants.
Our lab has found that arsenic and triclosan inhibit mast cell degranulation, which is the
release of granules containing many active biomediators to the extracellular space. Based on
these findings, we have investigated the mechanisms underlying inhibitory action by arsenic and
triclosan. In Chapter 2, we showed that one of arsenic’s targets is phosphorylation of tyrosine
kinase Syk, which is found in early mast cell signaling pathway. Additionally, we found that
phosphorylation/activation of PI3K, one of the direct substrates of Syk, is also inhibited by
arsenic. Inhibition of Syk and PI3K activation leads to decreased calcium mobilization, which is
a critical step leading to MC degranulation.
Studies in Chapter 3 elucidated triclosan’s effects two key molecules: phospholipase D
(PLD) and protein kinase C (PKC). Even though we also revealed that triclosan dampens
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cytosolic calcium levels as seen in arsenic studies, triclosan does not inhibit tyrosine
phosphorylation-initiated events such as calcium efflux from the ER. PKC and PLD are central
players in degranulation after cytosolic calcium rise. We have shown that triclosan decreases
PLD activity while PKC activity is not inhibited. However, triclosan delays the translocation of
PKC βII and PKC δ isoforms to the plasma membrane, and subsequently slows down
dissociation of MARCKS, a substrate of PKC, from the plasma membrane to cytosol. The
functions of PKC and PLD are shared in many other cell types and signaling pathways.
Therefore, our findings on triclosan’s effects on PKC and PLD provide mechanisms of the
numerous human health problems reported in recent epidemiological studies.
In addition to revealing triclosan’s targets in the mast cell signaling pathway, we have
also investigated triclosan toxicity as a mitochondrial uncoupler (MU). Structural similarities
between triclosan and other known MUs led us to explore this hypothesis. In previous work, we
first identified that triclosan is indeed an MU in vitro, using several cell types, including mast
cells, fibroblasts, and primary human skin cells. To compare this in vitro finding, we developed
an in vivo assay to measure mitochondrial function using zebrafish embryos. Due to
advantageous of utilizing zebrafish as a model organism, this assay is a high-throughput, 96
well-microplate based assay which can quickly evaluate a toxicant’s effect in living organism.
Using this assay, we have shown that mitochondrial toxicity is another mechanism of triclosan,
in vivo (Chapter 5).
Finally, Chapter 4 reported our findings on tryptase detection in RBL-2H3 cells. The
RBL-2H3 cell line has been extensively utilized as an in vitro mast cell model, but βhexosaminidase or histamine have usually been employed as RBL-2H3 degranulation markers
even though tryptase is considered a canonical marker of mast cells. Since mast cell activity in
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zebrafish has been measured solely via tryptase release to date, we aimed to develop an RBL2H3 tryptase assay in order to align RBL-2H3 cell toxicological studies to in vivo zebrafish mast
cell studies. Unexpectedly, we have found that neither mRNA nor protein of rat tryptase genes
are expressed in the RBL-2H3 cell line. Our comprehensive investigation to detect tryptase in
RBL cells delivers an important message to the mast cell community and necessitates
development of a separate marker for comparative studies between these two model systems.
Overall, the findings in this dissertation provide molecular and biochemical mechanisms
for many human health problems due to arsenic and triclosan and establish groundwork for
developing comparative toxicological studies using zebrafish to study mast cell toxicology and
biology.
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APPENDIX A
SUPPLEMENTARY INFORMATION TO CHAPTER 2

Figure A.1. As inhibits degranulation of RBL-2H3 cells following 15-min exposure to DNPBSA antigen. Effect of As on (A) 15-min Ag-mediated degranulation (an average absolute
degranulation response of 9.4% ± 0.8% [SEM] in the absence of As) or (B) 15-min spontaneous
release (an average absolute degranulation response of 1.4% ± 0.1% [SEM] in the absence of As).
Values represent means ± SEM for 5-11 experiments in (A) or n = 3 in (B), where three replicates
were performed for each condition. Significance was determined by one-way ANOVA followed
by Tukey’s post test; ** indicates p<0.01, as compared to the 1 ppb column.
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Figure A.2. ATP levels and cytotoxicity in RBL-2H3 cells exposed to As. (A-B) Exposure to
various concentrations of As in galactose media and (C-D) in glucose media. Percent untreated
control is 100% multiplied by the quotient of the fluorescence or luminescence value of each
sample by the average value of the untreated control. Values are means ± SEM of three
independent experiments (each with three replicates per dose). One-way ANOVA followed by
Tukey’s post-hoc test revealed no statistical significance.
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Figure A.3. F-actin ruffling during antigen-stimulated degranulation of RBL-2H3 cells. Factin was visualized using Alexa Fluor 488 conjugated phalloidin. RBL-2H3 cells were exposed
to 0.0004 μg mL-1 Ag (left) or to 0.0004 μg mL-1 Ag plus 750 ppb As (right) for one hour before
being fixed. A representative set of images is shown.

A

B

Figure A.4. Combined exposure of experimental As and A23187 ionophore doses causes no
cytotoxicity in RBL-2H3 cells as determined by lactate dehydrogenase (LDH) cytotoxicity
assay. To measure the impact of A23187 ionophore and As on viability of RBL-2H3 cells, an
LDH assay kit was utilized as described in Methods. Arsenic was diluted into A23187 solutions
of (A) 1.5 x 10-7 M or (B) 2 x 10-7 M to create 100-750 ppb As samples. “True zero” contains
neither As nor ionophore but does contain the vehicle conditions of the experimental parameters.
No statistically significant effects were found, by one-way ANOVA and Tukey’s post test. Values
represent means ± SEM of three experiments of three replicates per experiment.
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Figure A.5. LDH enzymatic activity is not affected by As and A23187 ionophore
concentrations used in the degranulation assays. In order to test whether or not the LDH enzyme
activity is altered by various chemical combinations used in the LDH experiment, LDH standard
testing was performed in the presence of 2 x 10-7 M A23187, As, and vehicle conditions (0.004%
DMSO). In a clear 96-well plate, a 50 μL sample of 0.000625 U/mL purified LDH enzyme
standard (Cayman chemical company; Ann Arbor, MI, USA) was incubated with an equal volume
of A23187/2x As, no A23187 or DMSO, A23187 only, or 0.002% DMSO (2x concentration of
0.004% DMSO vehicle) for one hour (37 °C/5% CO2). The final A23187 concentration was 1.0 x
10-7 M; the final As concentrations represented a range from 100 to 750 ppb. The remainder of the
experiment followed manufacturer’s recommended protocol (Cytotoxicity detection kit LDHPLUS;
Roche Diagnostics). Absorbance values for experimental data sets were normalized against the 0
ppb As/LDH standard control, and plotted against treatment conditions. Statistical testing was
performed in Prism using a one-way ANOVA and Tukey’s post test. Values represent means ±
SEM of two data sets (3 replicates per experiment) for each treatment condition.
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Figure A.6. DMSO vehicle concentration used for A23187 dilutions has no effect on
antigen-stimulated degranulation of RBL-2H3 cells. Antigen-stimulated degranulation
experiments were carried out to examine the effect of 0.004% DMSO vehicle used for A23187
dilutions. (A-B) IgE-sensitized mast cells were stimulated using a 0.00016 μg mL-1 dilution of
DNP-BSA (no A23187 was utilized); in (A), all samples contained 0.004% DMSO. The plate
was read in a fluorescence microplate reader (Synergy 2, Biotek), using 360/40 nm excitation
and 460/40 nm emission filters. Data processing was performed as described by Palmer et
al.(Palmer et al., 2012). Following one-way ANOVA, a Tukey’s post test was used to assess
significance (comparisons made to 0 ppb As). In (A-B) error bars represent means ± SD from
three replicate data sets, and significance is indicated; ***p<0.001,**p<0.01, *p<0.05. In (C) a
direct comparison of the data found separately in (A) and (B) is made. For these combined data,
a two-way ANOVA with Bonferroni post test was performed to compare the Ag-stimulated
degranulation in the presence and absence of 0.004% DMSO. No significant difference was
found between either set of experiments.
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(A)

(B)

Figure. B.1. TCS does not affect PKC activity in Ag-stimulated RBL-2H3 mast cells within
15 (A) or 30 min (B). Cells were stimulated with 0.005 g/ml Ag ± 10 µM TCS in BT. After
exposure, PKC activity was measured via ELISA, and absorbance was read at 450 nm using a
microplate reader. Raw data were processed as described in the main text Methods section to
normalize to both total protein concentration and to unstimulated controls, in order to calculate
percentage increase of PKC activity over unstimulated control. Data presented are means ± SEM
of at least three independent experiments; duplicates per treatment per experiment. No statistical
significance was determined by one tailed t-test (GraphPad prism).
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(B)

(A)

Figure. B.2. TCS does not interfere with components (choline oxidase [A] and horseradish
peroxidase [B]) in the Amplex® Red phospholipase D assay kit. The Amplex® kit (Thermo
Scientific), containing phosphatidylcholine, choline oxidase, horseradish peroxidase (HRP), and
Amplex® Red reagent, works in the following process: PLD cleaves the substrate
phosphatidylcholine into choline and phosphatidic acid. Choline is then oxidized by choline
oxidase into betaine and hydrogen peroxide. HRP uses Amplex® red as an electron donor in the
reduction of hydrogen peroxide to water, in a 1:1 stoichiometry to convert Amplex® red into
resorufin whose fluorescence is measured at 530/25 excitation and 590/30 emission. To test the
effects of TCS on the components of the kit, we initiated this process at different points and
measured the fluorescence when exposed to varying TCS concentrations, from 0-20 M. (A) We
first examined the effect of TCS on choline oxidase activity. Choline chloride was purchased
(MP Biomedicals) to initiate the cascade at the choline oxidase step. Choline chloride was
prepared in 0.2% Triton-X (TX) and co-exposed with various concentrations of TCS (dissolved
in BT) for 15 min. Next, 100 L of the choline chloride ± TCS was added to 100 L of master
mix of the Amplex® Red kit for 30 min, followed by fluorescence measurement as described in
the main text Methods section. Final choline chloride concentration was 1.5 M, a level chosen
to result in RFU readings similar to those obtained in the cellular PLD experiments. Overall, this
control experiment’s components were designed to utilize the same buffer conditions and
concentrations as those found in cellular PLD experiments such as in main text Fig. 3.5A. (B) A
similar experiment was used to determine whether TCS could inhibit HRP activity. This time the
cascade was initiated by using hydrogen peroxide that was provided in the Amplex® kit.
Fluorescence of resorufin was measured as in Methods. Values were normalized to 0 M TCS of
each experiment and represented as means ± SEM of three independent experiments; three
replicates per treatment per experiment. No statistical significance was determined by one-way
ANOVA followed by Tukey’s post-hoc test (GraphPad Prism). Data show that TCS does not
interfere with this PLD activity assay.
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Figure. B.3. TCS has no effect on purified PLD from Streptomyces chromofuscus. Purified
Streptomyces chromofuscus PLD (Sigma P0065) was diluted from glycerol stock in Tyrodes buffer
and further diluted with 0.2% Triton X incubated with TCS ranging from 0- 20µM concentrations
to be 0.125U/mL. After a 15 min exposure, PLD activity was measured using the Amplex® Red
PLD assay kit (Thermo Scientific), which was prepared following the manufacturer’s instructions.
Overall, this experiment’s components were designed to utilize the same buffer conditions and
concentrations as those found in cellular PLD experiments such as in main text Fig. 3.5A. Values
were normalized to 0 M TCS of each experiment and represented as means ± SEM of three
independent experiments; three replicates per treatment per experiment. No statistical significance
was determined by one-way ANOVA followed by Tukey’s post-hoc test (GraphPad Prism).
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sucralose (CAS # 56038-13-2)

triclosan (CAS # 3380-34-5)

(images from Sigma)

Figure. B.4. Sucralose shares structural similarities with triclosan but does not affect
degranulation of Ag-stimulated RBL-2H3 cells. Similarities between triclosan and sucralose
(both pictured above) include presence of two carbon rings combined in ether linkage, three
chlorines decorating the two rings, and presence of hydroxyl groups on the rings. Sucralose
(>98.0%) (TCI America) was dissolved for 20 min with stirring into Tyrodes buffer to prepare a 1
mM sucralose solution. Cells were sensitized with with 0.1µg/mL IgE for 1 hr, and stimulated
with ± 0.0002 µg/mL Ag ± sucralose (0.1 to 500 M) in BT buffer for 1 hr. Degranulation was
assessed as a measurement of β-hexosaminisase release, described in (Weatherly et al., 2013), and
the 0.0002 µg/mL Ag dose elicited a moderate absolute degranulation percentage response of ~18%
in the absence of sucralose. Concentrations of sucralose tested were biologically relevant: these
levels were detected in human blood plasma and urine samples following consumption of
beverages containing sucralose at concentrations similar to those found in commercial products
(de Ruyter et al., 2012; Sylvetsky et al., 2017a; Sylvetsky et al., 2017b; Rother et al., 2018). As
an amphipathic molecule, sucralose is able to traverse cellular plasma membranes through simple
diffusion, down its concentration gradient. Sucralose has been observed to passively diffuse from
the gastro-intestinal tract into the blood (Grice and Goldsmith, 2000), though it can be metabolized
by cytochrome p-450 and can be subject to efflux via p-glycoprotein (Abou-Donia et al., 2008).
Values are normalized to the Ag control (no sucralose) and represented as means ± SEM from
three independent experiments, with three replicates pre- treatment group per experiment. No
statistical significance was determined by one-way ANOVA followed by Tukey's post test
(GraphPad Prism). Thus, we conclude that the presence of two carbon rings in ether linkage and
three chlorines positioned on the rings are insufficient for mast cell effects caused by triclosan,
lending further evidence that the proton ionophoric properties of triclosan caused its effects.
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Figure C.1. Various buffer components do not interfere with BAPNA-tryptase substrateenzyme reaction. Various buffer components, as indicated, were incubated with 25 ng tryptase
for 72 h, after which absorbance at 410 nm was detected. Values represent triplicates replicates
from one experiment (with the exception of 0.004% DMSO sample, which contains duplicates).
No significant difference was determined by one-way ANOVA followed by Tukey’s post test,
with comparisons made to the mT buffer.
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Figure C.2. TPSAB1 tryptase standard samples measured by ELISA. Rat TPSAB1 standard
protein, provided in the tryptase ELISA kit (Biomatik), was measured. Values represent means ±
SD of duplicate samples.
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Table C.1. Various RBL-2H3 cell stimulation conditions before RNA extraction for PCR
Time of
collection**

Tps
b2

Tpsab
1

Tpsg1

Gz
mk

Prss
29

Prss
41

Gz
ma

Prss
34

Hex
a

Hex
b

Actb

No IgE, No Ag

24h

Overnight IgE,
No Ag
Overnight IgE+
1h high*Ag
1 hr IgE+ 1h low*
Ag
1 hr IgE+ 1h high
Ag
1 hr IgE+ 1h high
Ag
1 hr IgE+ 1h high
Ag
1 hr IgE+ 1h high
Ag
1 hr IgE, No Ag

24h

-

-

-

-

-

-

-

-

+
+

+
+

+
+

4h

-

-

-

-

-

-

-

-

+

+

+

24h

-

-

-

-

-

-

-

-

+

+

+

1h

-

-

-

-

-

-

-

-

+

+

+

4h

-

-

-

-

-

-

-

-

+

+

+

16h

-

-

-

-

-

-

-

-

+

+

+

24h

-

-

-

-

-

-

-

-

+

+

+

immediately
immediately

-

-

-

-

-

-

-

-

+
+

+
+

+
+

immediately

-

-

-

-

-

-

-

-

+

+

+

immediately

-

-

-

-

-

-

-

-

+

+

+

immediately

-

-

-

-

-

-

-

-

+

+

+

immediately

-

-

-

-

-

-

-

-

+

+

+

immediately

-

-

-

-

-

-

-

-

+

+

+

Stimulation
Conditions

1 hr IgE+ 5 min
high Ag
1 hr IgE+ 10 min
high Ag
1 hr IgE+ 15min
high Ag
1 hr IgE+ 20 min
high Ag
1 hr IgE+ 30 min
high Ag
1 hr IgE+ 1h high
Ag

*High Ag dose: 1 g/mL; Low Ag dose: 0.1 g/mL
**Time of collection: time between the end of Ag stimulation (stopped by washing) and cell
harvest for Trizol® extraction.
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Figure D.1. Effects of TCS on maximal respiration and non-mitochondrial respiration in
living zebrafish. Zebrafish embryos (24 hpf) were exposed to TCS for ~1 hr (12 measurements of
basal OCR), then the Mito Stress Test kit (Seahorse Bioscience) was performed. A) Maximal
respiration and B) Non-mitochondrial respiration were calculated using the Mito Stress Test
Report Generator V2 (Seahorse Bioscience). Data from individual experimental days were
normalized either to 0 µM TCS and values represent means ± SEM for four independent
experiments, where 14-16 embryos per treatment group were tested in each experiment. One-way
ANOVA with Dunnett’s post-tests (compared to the 0 µM TCS) were performed using Graphpad
Prism software.
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Table D.1. Optimizing 24hpf ZF microinjection to measure the effect of TCS using
Seahorse analyzer*
Injection conditions**
Results
Microinjection (of HSBB+ Phenol red Needle is not readily going into the yolk.
dye[ “dye”] to visualize the droplet
The droplets are stuck in the injection site, not
from the injector) to the yolk, which is being spread.
~80-90% of the body mass at 24hpf
ZF
Microinjection (dye) to the vein
Impossible due to the lack of vein
development at 24hpf
Microinjection(dye) to any parts of
Impossible due to the movement of fish (since
the body, excluding the yolk
they are not euthanized)
Microinjection(dye) into the chorion,
More than 4nL/injection volume harms the
not into the animal
chorion (either the chorion will be torn or
ruptured when pulling off the needle).
More than 40nL total (4nL/injection*10
times) leads to damage to the chorion.
Microinjection of FCCP into the
40nL (4nL/injection x 10 times) of 1.7uM
chorion
FCCP (final FCCP in the chorion is ~0.8uM)
increased OCR with ~45% mortality.
20nL (4nL/injection x 5 times) of 2.4uM
FCCP (final FCCP in the chorion is ~0.7uM)
increased OCR without mortality.
Microinjection of TCS into the
24nL (4nL/injection x 6 times) of 56.4uM
chorion
TCS (final TCS concentration is ~19.6 uM
TCS) causes ~17% mortality.
40nL (4nL/injection x 10 times) of 56.4uM
TCS (final TCS concentration is ~26.5 uM
TCS) causes ~25% mortality.
*Embryos are not euthanized during the injection.
** These microinjection to the ZF were also attempted by other students (Hina Hashmi and
Denise Jay) in the Kim lab who are proficient in microinjection.
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